WO2014065498A1 - Organic electroluminescent device - Google Patents

Organic electroluminescent device Download PDF

Info

Publication number
WO2014065498A1
WO2014065498A1 PCT/KR2013/007669 KR2013007669W WO2014065498A1 WO 2014065498 A1 WO2014065498 A1 WO 2014065498A1 KR 2013007669 W KR2013007669 W KR 2013007669W WO 2014065498 A1 WO2014065498 A1 WO 2014065498A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
synthesis
inv
mol
formula
Prior art date
Application number
PCT/KR2013/007669
Other languages
French (fr)
Korean (ko)
Inventor
김태형
엄민식
김회문
백영미
박호철
이창준
신진용
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Publication of WO2014065498A1 publication Critical patent/WO2014065498A1/en

Links

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/10Triplet emission

Abstract

The present invention relates to an organic electroluminescent device, in which a light-emitting layer using an indole-based compound and an iridium compound as a host material and dopant material, respectively, is introduced into the organic electroluminescent device so that the organic electroluminescent device can be provided with improved luminous efficiency, driving voltage, life characteristics, and the like.

Description

유기 전계 발광 소자Organic electroluminescent element
본 발명은 구동전압, 발광효율 및 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to an organic electroluminescent device having improved characteristics such as driving voltage, luminous efficiency and lifetime.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서 정공이 음극에서 전자가 각각 유기물층으로 주입되고, 정공과 전자가 만나 엑시톤(exciton)이 형성되며, 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected from the anode and electrons are injected from the cathode into the organic material layer, holes and electrons meet to form an exciton, and when the exciton falls to the ground, it shines. do. The material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to a function.
발광 물질은 발광색에 따라 청색, 녹색 및 적색의 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색의 발광 물질로 구분될 수 있다. 또한 색순도의 증가와 에너지 전이를 통해 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다.The light emitting material may be classified into blue, green, and red light emitting materials and yellow and orange light emitting materials required to realize a better natural color according to the light emitting color. In addition, in order to increase luminous efficiency through increasing color purity and energy transfer, a host / dopant system may be used as a light emitting material.
도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 인광 도판트의 개발은 이론적으로 형광 도판트에 비해 4배까지 발광 효율을 향상시킬 수 있기 때문에 인광 도판트 뿐만 아니라 인광 호스트에 대해서도 연구되고 있다.The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of phosphorescent dopants, in theory, can improve the luminous efficiency up to four times compared to fluorescent dopants, and therefore, research has been conducted on phosphorescent dopants as well as phosphorescent hosts.
현재까지 정공 수송 물질. 정공 주입 물질, 전자 수송 물질로는 NPB, BCP, Alq3 등이 알려져 있으며, 발광 물질로는 안트라센 유도체가 알려져 있다. 또한 발광 물질 중 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물은 청색(blue), 녹색(green), 적색(red)의 인광 도판트 물질로 사용되고 있으며, CBP는 인광 호스트 물질로 사용되고 있다.Hole transport material to date. NPB, BCP, Alq 3 and the like are known as hole injection materials and electron transport materials, and anthracene derivatives are known as light emitting materials. Among the light emitting materials, metal complex compounds including Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 are blue, green, and red phosphorescent dopant materials. CBP is used as a phosphorescent host material.
그러나 종래의 발광 물질은 발광 특성이 양호하나, 유리전이온도가 낮아 열적 안정성이 좋지 않기 때문에 유기 전계 발광 소자의 수명 측면에서 만족할 만한 수준이 되지 못하는 실정이다. 따라서 우수한 성능을 가지는 발광 물질을 포함하는 유기 전계 발광 소자의 개발이 요구되고 있다.However, the conventional luminescent material has good luminescence properties, but the glass transition temperature is low, so the thermal stability is not good, and thus it is not a satisfactory level in terms of the lifetime of the organic EL device. Therefore, there is a demand for the development of an organic electroluminescent device including a light emitting material having excellent performance.
본 발명은 상기한 문제점을 해결하기 위해 구동전압, 발광효율 및 수명 등의 특성이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.An object of the present invention is to provide an organic electroluminescent device having improved characteristics such as driving voltage, luminous efficiency and lifetime in order to solve the above problems.
상기한 목적을 달성하기 위해 본 발명은 양극; 음극; 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 하기 화학식 1로 표시되는 화합물과 하기 화학식 3으로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자를 제공한다.The present invention to achieve the above object; cathode; And one or more organic material layers interposed between the anode and the cathode, wherein at least one of the one or more organic material layers comprises a compound represented by Formula 1 and a compound represented by Formula 3 below. It provides an organic electroluminescent device.
[화학식 1][Formula 1]
Figure PCTKR2013007669-appb-I000001
Figure PCTKR2013007669-appb-I000001
상기 화학식 1에서,In Chemical Formula 1,
Y1 내지 Y4는 각각 독립적으로, N 또는 CR3이고, Y1과 Y2, Y2와 Y3, 또는 Y3와 Y4 중 하나는 하기 화학식 2로 표시되는 축합 고리를 형성하며,Y 1 to Y 4 are each independently N or CR 3 , and one of Y 1 and Y 2 , Y 2 and Y 3 , or Y 3 and Y 4 forms a condensed ring represented by the following Chemical Formula 2,
[화학식 2][Formula 2]
Figure PCTKR2013007669-appb-I000002
Figure PCTKR2013007669-appb-I000002
상기 화학식 2에서,In Chemical Formula 2,
점선은 화학식 1의 화합물과 축합이 이루어지는 부위를 의미하며, Y5 내지 Y8은 각각 독립적으로, N 또는 CR4이고,The dotted line means a site where condensation occurs with the compound of Formula 1, and Y 5 to Y 8 are each independently N or CR 4 ,
상기 X1 및 X2는 각각 독립적으로, O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고, 이때, X1 및 X2 중에서 적어도 하나는 N(Ar1)이며,X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ), wherein At least one of X 1 and X 2 is N (Ar 1 ),
상기 R1 내지 R4 및 Ar1 내지 Ar5는 각각 독립적으로, 수소, 중수소, 할로겐기, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,R 1 to R 4 and Ar 1 to Ar 5 are each independently hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C Alkynyl group of 2 to C 40 , cycloalkyl group of C 3 to C 40 , heterocycloalkyl group of 3 to 40 nuclear atoms, aryl group of C 6 to C 60 , heteroaryl group of 5 to 60 nuclear atoms, C 1 ~ C 40 alkyloxy group of, C 6 ~ aryloxy C 60, C 1 ~ C 40 alkyl silyl group, C 6 ~ aryl silyl group of C 60, C 1 ~ C 40 group of an alkyl boron, C 6 is selected from ~ C 60 aryl boron group, the group consisting of C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl group of an amine of,
상기 R1 내지 R4는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,R 1 to R 4 may be bonded to an adjacent group to form a condensed ring,
상기 R1 내지 R4 및 Ar1 내지 Ar5의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있고,The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group of R 1 to R 4 and Ar 1 to Ar 5 , Alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and arylamine group are each independently deuterium, halogen, cyano group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 Heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 boron alkyl group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ from the group consisting of an aryl amine of the C 60 of the May be substituted with one or more selected
[화학식 3][Formula 3]
Figure PCTKR2013007669-appb-I000003
Figure PCTKR2013007669-appb-I000003
상기 화학식 3에서,In Chemical Formula 3,
X-Y는 유기 리간드로서, X는 핵원자수 3 내지 40의 헤테로아릴기이고, Y는 C6~C40의 아릴기 또는 핵원자수 3 내지 40의 헤테로아릴기이며, R11 내지 R18은 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, n 은 1 내지 3의 정수이다.XY is an organic ligand, X is an aryl heteroaryl of nuclear atoms of 3 to 40 group, Y is a C 6 ~ C 40 heteroaryl group of the aryl group or nuclear atoms of 3 to 40, R 11 to R 18 are each Independently, hydrogen, deuterium, halogen, cyano group, nitro group, amino group, C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 to C 60 the aryl group, the number of nuclear atoms aryl of from 5 to 60 heteroaryl group, a C 1 ~ C 40 alkyloxy group of, C 6 ~ aryloxy C 60, C 1 ~ C 40 alkyl silyl group, C 6 ~ C 60 aryl silyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ It is selected from the group consisting of C 60 arylamine groups, may be bonded to adjacent groups to form a condensed ring, n is an integer of 1 to 3.
본 발명에서 사용되는 알킬은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 이의 비제한적인 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등이 있다.Alkyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain saturated hydrocarbon of 1 to 40 carbon atoms, non-limiting examples thereof are methyl, ethyl, propyl, isobutyl, sec-butyl , Pentyl, iso-amyl, hexyl and the like.
본 발명에서 사용되는 알케닐(alkenyl)은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있다.Alkenyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond. Non-limiting examples thereof include vinyl, allyl, isopropenyl, 2-butenyl and the like.
본 발명에서 사용되는 알키닐(alkynyl)은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있다.Alkynyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond. Non-limiting examples thereof include ethynyl, 2-propynyl and the like.
본 발명에서 사용되는 시클로알킬은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 시클로프로필, 시클로펜틸, 시클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등이 있다.Cycloalkyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms (saturated cyclic hydrocarbon). Non-limiting examples thereof include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine and the like.
본 발명에서 사용되는 헤테로시클로알킬은 핵원자수 3 내지 40의 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비제한적인 예로는 모르폴린, 피페라진 등이 있다.Heterocycloalkyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a non-aromatic hydrocarbon (saturated cyclic hydrocarbon) having 3 to 40 nuclear atoms, and preferably at least one carbon in the ring, preferably 1 To 3 carbons are substituted with a hetero atom such as N, O or S. Non-limiting examples thereof include morpholine, piperazine and the like.
본 발명에서 사용되는 아릴은 단독 고리 또는 2 이상의 고리가 조합된 탄소수 6 내지 60의 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이때, 2 이상의 고리는 서로 단순 부착되거나 축합된 형태로 부착될 수 있다. 이의 비제한적인 예로는 페닐, 비페닐, 트리페닐, 터페닐(terphenyl), 나프틸, 플루오레닐, 페난트릴, 안트라세닐, 인데닐 등이 있다.Aryl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from an aromatic hydrocarbon having 6 to 60 carbon atoms alone or in combination of two or more rings. In this case, the two or more rings may be attached in a simple or condensed form with each other. Non-limiting examples thereof include phenyl, biphenyl, triphenyl, terphenyl, naphthyl, fluorenyl, phenanthryl, anthracenyl, indenyl and the like.
본 발명에서 사용되는 헤테로아릴은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기로서, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 질소(N), 산소(O), 황(S) 또는 셀레늄(Se)과 같은 헤테로원자로 치환된다. 이때, 헤테로아릴은 2 이상의 고리가 서로 단순 부착되거나 축합된 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함할 수 있다. 이러한 헤테로아릴의 비제한적인 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리; 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있다.Heteroaryl used in the present invention is a monovalent functional group obtained by removing a hydrogen atom from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 Carbons are substituted with heteroatoms such as nitrogen (N), oxygen (O), sulfur (S) or selenium (Se). In this case, the heteroaryl may be attached in a form in which two or more rings are simply attached or condensed with each other, and may also include a condensed form with an aryl group. Non-limiting examples of such heteroaryls include six-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl; Polycyclics such as phenoxathienyl, indolinzinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl ring; And 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl, and the like.
본 발명에서 사용되는 알킬옥시는 RO-로 표시되는 1가의 작용기를 의미하며, 상기 R은 탄소수 1 내지 40개의 알킬로서, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 이러한 알킬옥시의 비제한적인 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있다.Alkyloxy used in the present invention means a monovalent functional group represented by RO-, wherein R is alkyl having 1 to 40 carbon atoms, and may include a linear, branched, or cyclic structure. Can be. Non-limiting examples of such alkyloxy include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
본 발명에서 사용되는 아릴옥시는 R′O-로 표시되는 1가의 작용기를 의미하며, 상기 R′는 탄소수 6 내지 60의 아릴이다. 이러한 아릴옥시의 비제한적인 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다.Aryloxy used in the present invention means a monovalent functional group represented by R'O-, wherein R 'is an aryl having 6 to 60 carbon atoms. Non-limiting examples of such aryloxy include phenyloxy, naphthyloxy, diphenyloxy and the like.
본 발명에서 사용되는 알킬실릴은 탄소수 1 내지 40의 알킬로 치환된 실릴을 의미하며, 아릴실릴은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미하고, 아릴아민은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.Alkylsilyl used in the present invention means silyl substituted with alkyl having 1 to 40 carbon atoms, arylsilyl means silyl substituted with aryl having 6 to 60 carbon atoms, and arylamine is substituted with aryl having 6 to 60 carbon atoms. Amine.
본 발명에서 사용되는 축합 고리는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.As used herein, the condensed ring means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
이하, 본 발명을 설명한다.Hereinafter, the present invention will be described.
본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자에 있어서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물과 상기 화학식 3으로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.The present invention provides an organic electroluminescent device comprising an anode, a cathode and one or more organic material layers interposed between the anode and the cathode, wherein at least one of the one or more organic material layers is a compound represented by Formula 1 and the It provides an organic electroluminescent device comprising a compound represented by the formula (3).
상기 화학식 1로 표시되는 화합물은 인돌계 기본 골격에 축합 탄소고리 또는 축합 헤테로환 모이어티, 바람직하게는 축합 헤테로환 모이어티가 연결되고, 여러 치환체에 의해 에너지 레벨이 조절됨으로써 넓은 밴드갭 (sky blue ~ red)을 갖는다. 따라서 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층에 사용할 경우 인광특성이 개선됨과 동시에 전자 및/또는 정공 수송 능력, 발광 능력을 높일 수 있다.Compound represented by the formula (1) is a condensed carbon ring or a condensed heterocyclic moiety, preferably a condensed heterocyclic moiety is connected to the indole-based skeleton, the energy level is controlled by a number of substituents wide band gap (sky blue ~ red) Therefore, when the compound represented by Formula 1 is used in the organic material layer of the organic electroluminescent device, the phosphorescence property may be improved, and the electron and / or hole transport ability and the light emitting ability may be enhanced.
여기서 본 발명의 화학식 1로 표시되는 화합물은 유기물층 중 정공 수송층, 전자 수송층 및 발광층에 사용되는 것이 바람직하며, 인돌계 기본골격으로 인해 종래의 CBP에 비해 발광 호스트 물질로써 우수한 특성을 나타내기 때문에 발광층의 호스트 물질로 사용되는 것이 더욱 바람직하다.Herein, the compound represented by Formula 1 of the present invention is preferably used in the hole transport layer, the electron transport layer and the light emitting layer of the organic material layer, and because of the indole-based skeleton exhibits excellent properties as a light emitting host material compared to the conventional CBP, More preferably used as the host material.
구체적으로, 상기 화학식 1로 표시되는 화합물은 인돌계 기본골격에 다양한 방향족 환(aromatic ring)이 치환체로 결합되어 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도가 향상되어 종래 CBP보다 높은 열적 안정성을 가질 수 있다. 또한 다양한 방향족 환 치환체로 인해 분자 전체가 바이폴라(bipolar)한 성격을 가지면서 정공과 전자의 결합력을 높일 수 있기 때문에 종래 CBP에 비해 발광층의 호스트 재료로서의 우수한 특성을 나타낼 수 있다.Specifically, the compound represented by Chemical Formula 1 has various aromatic rings bonded to the indole-based backbone as a substituent to significantly increase the molecular weight of the compound, thereby improving glass transition temperature and higher thermal stability than conventional CBP. Can have In addition, since the whole molecule has a bipolar (bipolar) nature of the various aromatic ring substituents, the binding force between the holes and the electrons can be increased, and thus it can exhibit excellent characteristics as a host material of the light emitting layer compared to the conventional CBP.
이러한 화학식 1로 표시되는 화합물의 Y1 내지 Y4에서 축합 고리를 형성하지 않는 것은 모두 CR3인 것이 바람직하고, 이때, 복수개의 R3는 서로 동일하거나 상이할 수 있다. 또한, 화학식 1로 표시되는 화합물의 Y5 내지 Y8은 모두 CR4인 것이 바람직하며, 이때, 복수개의 R4는 서로 동일하거나 상이할 수 있다.It is preferable that all of the compounds represented by the formula (1) that do not form a condensed ring in Y 1 to Y 4 is CR 3 , wherein a plurality of R 3 may be the same or different from each other. In addition, it is preferable that all of Y 5 to Y 8 of the compound represented by Formula 1 are CR 4 , and at this time, a plurality of R 4 may be identical to or different from each other.
한편 화합물의 넓은 밴드갭(band-gap)과 열안정성을 고려할 때, 상기 화학식 1의 R1 내지 R4는 각각 독립적으로 수소, C6~C60의 아릴기(예: 페닐, 나프틸, 비스페닐) 또는 핵원자수 5 내지 60의 헤테로아릴기(예: 피리딘)인 것이 바람직하다.On the other hand, considering the wide band-gap and thermal stability of the compound, R 1 to R 4 of Formula 1 are each independently hydrogen, an aryl group of C 6 ~ C 60 (eg phenyl, naphthyl, bis Phenyl) or a heteroaryl group having 5 to 60 nuclear atoms (for example, pyridine).
이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택되는 것이 바람직하다.The compound represented by the formula (1) of the present invention is preferably selected from the group consisting of the compound represented by the formula (1a) to 1f.
[화학식 1a][Formula 1a]
Figure PCTKR2013007669-appb-I000004
Figure PCTKR2013007669-appb-I000004
[화학식 1b][Formula 1b]
Figure PCTKR2013007669-appb-I000005
Figure PCTKR2013007669-appb-I000005
[화학식 1c][Formula 1c]
Figure PCTKR2013007669-appb-I000006
Figure PCTKR2013007669-appb-I000006
[화학식 1d][Formula 1d]
Figure PCTKR2013007669-appb-I000007
Figure PCTKR2013007669-appb-I000007
[화학식 1e][Formula 1e]
Figure PCTKR2013007669-appb-I000008
Figure PCTKR2013007669-appb-I000008
[화학식 1f][Formula 1f]
Figure PCTKR2013007669-appb-I000009
Figure PCTKR2013007669-appb-I000009
상기 화학식 1a 내지 1f에서, X1, X2 및 R1 내지 R4는 상기에서 정의한 바와 같다.In Formulas 1a to 1f, X 1 , X 2 and R 1 to R 4 are the same as defined above.
한편 유기 전계 발광 소자의 발광 효율, 구동 전압 및 수명 등의 특성을 고려할 때, 상기 화학식 1의 X1 및 X2는 각각 독립적으로, N(Ar1) 또는 S인 것이 바람직하다. 즉, X1이 N(Ar1)이고 X2가 S이거나, X1이 S이고 X2가 N (Ar1)이거나, X1 및 X2가 모두 N(Ar1)인 것이 바람직하다.On the other hand, in consideration of characteristics such as luminous efficiency, driving voltage, and lifespan of the organic EL device, X 1 and X 2 of Formula 1 are each independently N (Ar 1 ) or S is preferred. That is, it is preferable that X 1 is N (Ar 1 ) and X 2 is S, X 1 is S and X 2 is N (Ar 1 ), or both X 1 and X 2 are N (Ar 1 ).
이러한 본 발명의 화학식 1로 표시되는 화합물은 보다 구체적으로, 하기 화학식 C1 내지 C66으로 표시되는 화합물로 이루어진 군에서 선택될 수 있다.The compound represented by the formula (1) of the present invention may be more specifically selected from the group consisting of compounds represented by the following formula C1 to C66.
Figure PCTKR2013007669-appb-I000010
Figure PCTKR2013007669-appb-I000010
Figure PCTKR2013007669-appb-I000011
Figure PCTKR2013007669-appb-I000011
Figure PCTKR2013007669-appb-I000012
Figure PCTKR2013007669-appb-I000012
Figure PCTKR2013007669-appb-I000013
Figure PCTKR2013007669-appb-I000013
상기 화학식 C1 내지 C66에서, R1 내지 R4는 상기에서 정의한 바와 같으며, 이때, 복수개의 R3 및 R4는 서로 동일하거나 상이할 수 있다. 또한, Ar1 내지 Ar5는 상기에서 정의한 바와 같은데, 그 중에서도 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하다. 구체적으로, Ar1 내지 Ar5는 각각 독립적으로, 하기 치환체(작용기) 그룹(S1-S192)으로부터 선택되는 것이 더욱 바람직하다.In Formulas C1 to C66, R 1 to R 4 are as defined above, wherein a plurality of R 3 and R 4 may be the same or different from each other. Further, Ar 1 to Ar 5 are sounds as defined above, particularly C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, and a C 6 ~ C 60 of which is selected from the group consisting of an aryl amine It is preferable. Specifically, Ar 1 to Ar 5 are each independently selected from the following substituent (functional group) groups (S1-S192).
Figure PCTKR2013007669-appb-I000014
Figure PCTKR2013007669-appb-I000014
Figure PCTKR2013007669-appb-I000015
Figure PCTKR2013007669-appb-I000015
Figure PCTKR2013007669-appb-I000016
Figure PCTKR2013007669-appb-I000016
한편 상기 화학식 3으로 표시되는 화합물은 이리듐(Ir)을 중심으로, 한쪽에는 방향족 환이 연결되고, 다른 한쪽에는 유기 리간드가 연결된다. 이러한 본 발명의 화학식 3으로 표시되는 화합물은 유기 리간드가 연결되어 있기 때문에 HOMO와 삼중항 MLCT 상태의 에너지 갭을 증가시킬 수 있다. 따라서 화학식 3으로 표시되는 화합물을 유기 전계 발광 소자의 유기물층, 구체적으로, 정공 주입층, 정공 수송층 및 발광층에 사용할 경우 인광특성이 개선됨과 동시에 색순도를 높일 수 있다.Meanwhile, the compound represented by Chemical Formula 3 has an iridium (Ir) as its center, and an aromatic ring is connected to one side, and an organic ligand is connected to the other side. The compound represented by Formula 3 of the present invention may increase the energy gap between the HOMO and triplet MLCT states because the organic ligand is linked. Therefore, when the compound represented by Chemical Formula 3 is used in the organic material layer of the organic EL device, specifically, the hole injection layer, the hole transport layer, and the light emitting layer, phosphorescence characteristics may be improved and color purity may be increased.
특히, 상기 화학식 1로 표시되는 화합물과 함께 유기 전계 발광 소자에 사용할 경우 그 성능을 높일 수 있다. 즉, 유기 전계 발광 소자의 유기물층 중 발광층은 호스트/도펀트 물질로 이루어지는데, 본 발명은 호스트/도펀트 사이에 에너지가 효율적으로 전달될 수 있도록 상기 화학식 1로 표시되는 화합물을 발광층의 호스트 물질로, 상기 화학식 3으로 표시되는 화합물을 발광층의 도펀트 물질로 사용하여 구동전압, 발광 효율, 수명 특성뿐만 아니라 색순도가 우수한 유기 전계 발광 소자를 제공할 수 있는 것이다.In particular, when used in the organic electroluminescent device with the compound represented by the formula (1) can improve the performance. That is, the light emitting layer of the organic material layer of the organic EL device is made of a host / dopant material, the present invention is a compound represented by the formula (1) as a host material of the light emitting layer so that energy can be efficiently transferred between the host / dopant, By using the compound represented by Formula 3 as a dopant material of the light emitting layer, it is possible to provide an organic EL device having excellent color purity as well as driving voltage, luminous efficiency, and lifetime characteristics.
이러한 본 발명의 화학식 3으로 표시되는 화합물에서, X 및 Y는 서로 결합하여 X-Y로 표시되는 유기 리간드를 형성하는 것으로, 이때, X는 핵원자수 3 내지 40의 헤테로아릴기, 바람직하게는 N-함유 헤테로아릴기이고, Y는 C6~C40의 아릴기 또는 핵원자수 3 내지 40의 헤테로아릴기이다.In the compound represented by the formula (3) of the present invention, X and Y are bonded to each other to form an organic ligand represented by XY, wherein X is a heteroaryl group having 3 to 40 nuclear atoms, preferably N- and containing heteroaryl group, Y is a heteroaryl group of C 6 ~ C 40 aryl group or a nuclear atoms of 3 to 40.
상기 X 및 Y의 아릴기 또는 헤테로아릴기는 할로겐, 시아노기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C1~C40의 알콕시기, C6~C40의 아릴기 및 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있다. 또한, 상기 치환기는 인접하는 기와 결합하여 축합 고리 또는 스피로 결합을 형성할 수 있다.The aryl group or heteroaryl group of X and Y is halogen, cyano group, amino group, C 1 ~ C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 2 ~ C 40 alkenyl, C alkynyl group of 2 ~ C 40, C 1 ~ C 40 alkoxy group, C 6 ~ C 40 aryl group and a nuclear atoms least one member selected from the group consisting of a heteroaryl group of from 5 to 40 substituents It may be substituted by. In addition, the substituents may be bonded to adjacent groups to form a condensed ring or a spiro bond.
본 발명의 화학식 3으로 표시되는 화합물은 하기 화학식 3a 내지 3d로 표시되는 화합물로 이루어진 군에서 선택되는 것이 바람직하다.The compound represented by the formula (3) of the present invention is preferably selected from the group consisting of the compound represented by the formulas (3a to 3d).
[화학식 3a][Formula 3a]
Figure PCTKR2013007669-appb-I000017
Figure PCTKR2013007669-appb-I000017
[화학식 3b][Formula 3b]
Figure PCTKR2013007669-appb-I000018
Figure PCTKR2013007669-appb-I000018
[화학식 3c][Formula 3c]
Figure PCTKR2013007669-appb-I000019
Figure PCTKR2013007669-appb-I000019
[화학식 3d][Formula 3d]
Figure PCTKR2013007669-appb-I000020
Figure PCTKR2013007669-appb-I000020
상기 화학식 3a 내지 3d에서, X, Y, n 및 R11 내지 R18은 상기에서 정의한 바와 동일하다.In Formulas 3a to 3d, X, Y, n, and R 11 to R 18 are the same as defined above.
상기 Ra 및 R21 내지 R25는 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, 상기 m은 0 내지 3의 정수이다.Ra and R 21 to R 25 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, nuclear atom 3 to 40 Heterocycloalkyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 Alkyl silyl group, C 6 ~ C 60 aryl silyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 Is selected from the group consisting of an aryl phosphine oxide group and an arylamine group of C 6 ~ C 60 , may be combined with adjacent groups to form a condensed ring, wherein m is an integer of 0 to 3.
상기 화학식 3에서 유기 리간드인 X-Y는 유기 전계 발광 소자의 특성을 고려할 때, 하기 A1-A24로 표시되는 구조로 이루어진 군에서 선택되는 것이 바람직하다.X-Y, which is an organic ligand in Chemical Formula 3, is preferably selected from the group consisting of structures represented by A1-A24 in consideration of characteristics of the organic electroluminescent device.
Figure PCTKR2013007669-appb-I000021
Figure PCTKR2013007669-appb-I000021
상기 A1 내지 A24로 표시되는 구조의 R31 내지 R42는, 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있다.R 31 to R 42 of the structure represented by A1 to A24 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, amino group, C 1 -C 40 alkyl group, C 3 -C 40 cycloalkyl group , Heterocycloalkyl group having 3 to 40 nuclear atoms, aryl group having 6 to C 60 atoms, heteroaryl group having 5 to 60 nuclear atoms, alkyloxy group having 1 to C 40 atoms, aryl jade having 6 to C 60 atoms group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C aryl silyl group of 60, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic of, C 6 ~ aryl phosphine of C 60 It is selected from the group consisting of a pin group, a C 6 ~ C 60 aryl phosphine oxide group and a C 6 ~ C 60 arylamine group, it may be combined with adjacent groups to form a condensed ring.
이러한 본 발명의 화학식 3으로 표시되는 화합물의 구체적인 예로 하기 화합물들(1-170)을 들 수 있지만, 이에 한정되는 것은 아니다.Specific examples of the compound represented by Formula 3 of the present invention include, but are not limited to, the following compounds (1-170).
Figure PCTKR2013007669-appb-I000022
Figure PCTKR2013007669-appb-I000022
Figure PCTKR2013007669-appb-I000023
Figure PCTKR2013007669-appb-I000023
Figure PCTKR2013007669-appb-I000024
Figure PCTKR2013007669-appb-I000024
Figure PCTKR2013007669-appb-I000025
Figure PCTKR2013007669-appb-I000025
Figure PCTKR2013007669-appb-I000026
Figure PCTKR2013007669-appb-I000026
Figure PCTKR2013007669-appb-I000027
Figure PCTKR2013007669-appb-I000027
Figure PCTKR2013007669-appb-I000028
Figure PCTKR2013007669-appb-I000028
Figure PCTKR2013007669-appb-I000029
Figure PCTKR2013007669-appb-I000029
이상에서 설명한 본 발명의 화학식 1로 표시되는 화합물과 화학식 3으로 표시되는 화합물은 하기 합성예를 바탕으로 다양하게 합성할 수 있다.The compound represented by the formula (1) and the compound represented by the formula (3) of the present invention described above can be synthesized in various ways based on the following synthesis examples.
한편 본 발명의 유기 전계 발광 소자는 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는데, 상기 1층 이상의 유기물층 중 어느 하나 이상이 상기 화학식 1 및 3으로 표시되는 화합물을 포함하는 것을 제외하고는 당업계에 공지된 물질 및 구조로 이루어질 수 있다.Meanwhile, the organic electroluminescent device of the present invention includes an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, and any one or more of the one or more organic material layers may be represented by the above chemical formula. Except for including the compounds represented by 1 and 3 may be made of materials and structures known in the art.
구체적으로 본 발명의 유기 전계 발광 소자는 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 또한 전극(양극 또는 음극)과 유기물층의 계면에 절연층 또는 접착층이 삽입된 구조일 수도 있다.Specifically, the organic EL device of the present invention may have a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked. It may also be a structure in which an insulating layer or an adhesive layer is inserted at the interface between the electrode (anode or cathode) and the organic material layer.
상기 유기물층에 해당되는 정공 주입층, 정공 수송층 및 발광층 중 하나 이상은 상기 화학식 1 및 화학식 3으로 표시되는 화합물을 포함하는 것이 바람직하다. 보다 바람직하게는 본 발명의 화학식 1로 표시되는 화합물은 발광층의 인광 호스트로, 화학식 3으로 표시되는 화합물은 발광층의 인광 도펀트로 사용될 수 있다.At least one of the hole injection layer, the hole transport layer, and the light emitting layer corresponding to the organic material layer may preferably include a compound represented by Chemical Formulas 1 and 3. More preferably, the compound represented by Formula 1 of the present invention may be used as a phosphorescent host of the light emitting layer, and the compound represented by Formula 3 may be used as a phosphorescent dopant of the light emitting layer.
상기 기판으로는 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름이나 시트 등이 사용될 수 있다.As the substrate, a silicon wafer, quartz, glass plate, metal plate, plastic film or sheet may be used.
상기 양극 물질로는 바나듐, 크롬, 구리, 아연, 금 등의 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO) 등의 금속 산화물; ZnO:Al 또는 SnO2:Sb 등의 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린 등의 전도성 고분자; 또는 카본블랙 등이 사용될 수 있다.The anode material may be a metal such as vanadium, chromium, copper, zinc, gold, or an alloy thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO) and indium zinc oxide (IZO); A combination of a metal and an oxide such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black and the like can be used.
상기 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 납 등의 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al 등의 다층 구조 물질 등이 사용될 수 있다.The negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, lead, or an alloy thereof; Multilayer structure materials such as LiF / Al or LiO 2 / Al and the like.
이외에 전자 주입층 및 전자 수송층은 당업계에 공지된 물질이라면 특별히 한정하지 않고 사용할 수 있다.In addition, the electron injection layer and the electron transport layer may be used without particular limitation as long as it is a material known in the art.
이러한 본 발명의 유기 전계 발광 소자의 제조방법은 당업계에 공지된 방법이라면 특별히 한정되지 않으나, 상기 유기물층은 진공증착법이나 용액 도포법에 의하여 형성될 수 있다. 여기서, 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등을 들 수 있다.The manufacturing method of the organic EL device of the present invention is not particularly limited as long as it is known in the art, but the organic material layer may be formed by a vacuum deposition method or a solution coating method. Here, examples of the solution coating method may include spin coating, dip coating, doctor blading, inkjet printing or thermal transfer.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples. However, the following examples are merely to illustrate the present invention and the present invention is not limited by the following examples.
[준비예 1] IC-1의 합성Preparation Example 1 Synthesis of IC-1
<단계 1> 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성<Step 1> Synthesis of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole
Figure PCTKR2013007669-appb-I000030
Figure PCTKR2013007669-appb-I000030
질소 기류 하에서 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd(dppf)Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3) under nitrogen stream , 2-dioxaborolane) (48.58 g, 0.191 mol), Pd (dppf) Cl 2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) were mixed and 130 ° C Stir at 12 h.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22.32 g, 수율 72%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 10: 1 (v / v)), and purified by 5- (4,4,5,5-tetramethyl). -1,3,2-dioxaborolan-2-yl) -1H-indole (22.32 g, yield 72%) was obtained.
1H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.95 (s, 1H), 8.21 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.95 (s, 1H), 8.21 ( s, 1 H)
<단계 2> 5-(2-nitrophenyl)-1H-indole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000031
Figure PCTKR2013007669-appb-I000031
질소 기류 하에서 1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol)과 상기 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22 g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) 및 THF/H2O(400 ml/200 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(4.36 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol) and 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole (22) under nitrogen stream g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) and THF / H 2 O (400 ml / 200 ml) were mixed and Pd (PPh 3 ) 4 (4.36 g, 5 mol%) was added at 40 ° C. Put and stirred at 80 ℃ for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1H-indole (11.32 g, 수율 63%)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the organic layer obtained was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to give 5- (2-nitrophenyl) -1H-indole (11.32 g, 63% yield).
1H-NMR: δ 6.47 (d, 1H), 7.25 (d, 1H), 7.44 (d, 1H), 7.53 (d, 1H), 7.65 (t, 1H), 7.86 (t, 1H), 7.95 (s, 1H), 8.00 (d, 1H), 8.09 (t, 1H), 8.20 (s, 1H) 1 H-NMR: δ 6.47 (d, 1H), 7.25 (d, 1H), 7.44 (d, 1H), 7.53 (d, 1H), 7.65 (t, 1H), 7.86 (t, 1H), 7.95 ( s, 1H), 8.00 (d, 1H), 8.09 (t, 1H), 8.20 (s, 1H)
<단계 3> 5-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000032
Figure PCTKR2013007669-appb-I000032
질소 기류 하에서 상기 5-(2-nitrophenyl)-1H-indole (11 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K2CO3 (6.38 g, 46.17 mmol), Na2SO4 (6.56 g, 46.17 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 5- (2-nitrophenyl) -1H-indole (11 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K 2 CO 3 (6.38 g, 46.17 mmol), Na 2 SO 4 (6.56 g, 46.17 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C. for 12 hours.
반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1-phenyl-1H-indole (10.30 g, 수율 71%)을 얻었다. After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer, which was freed of water, and then purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to give 5- (2-nitrophenyl) -1-phenyl-1H-indole (10.30 g, yield). 71%).
1H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.45 (m, 3H), 7.55 (m, 4H), 7.63 (t, 1H), 7.84 (t, 1H), 7.93 (s, 1H), 8.01 (d, 1H), 8.11 (t, 1H) 1 H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.45 (m, 3H), 7.55 (m, 4H), 7.63 (t, 1H), 7.84 (t, 1H), 7.93 ( s, 1H), 8.01 (d, 1H), 8.11 (t, 1H)
<단계 4> IC-1의 합성Step 4 Synthesis of IC-1
Figure PCTKR2013007669-appb-I000033
Figure PCTKR2013007669-appb-I000033
질소 기류 하에서 상기 5-(2-nitrophenyl)-1-phenyl-1H-indole (5 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) 및 1,2-dichlorobenzene (50 ml)를 혼합하고 12시간 동안 교반하였다.Mix the above 5- (2-nitrophenyl) -1-phenyl-1H-indole (5 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) and 1,2-dichlorobenzene (50 ml) under nitrogen stream for 12 hours Was stirred.
반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane:MC=3:1 (v/v))로 정제하여 IC-1 (2.38 g, 수율 53%)을 얻었다. After the reaction was completed, 1,2-dichlorobenzene was removed and extracted with dichloromethane. Water was removed with MgSO 4 and the resulting organic layer was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain IC-1 (2.38 g, yield 53%).
1H-NMR: δ 6.99 (d, 1H), 7.12 (t, 1H), 7.27 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.50 (d, 1H), 7.60 (m, 5H), 7.85 (d, 1H), 8.02 (d, 1H), 10.59 (s, 1H) 1 H-NMR: δ 6.99 (d, 1H), 7.12 (t, 1H), 7.27 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.50 (d, 1H), 7.60 ( m, 5H), 7.85 (d, 1H), 8.02 (d, 1H), 10.59 (s, 1H)
[준비예 2] IC-2의 합성Preparation Example 2 Synthesis of IC-2
Figure PCTKR2013007669-appb-I000034
Figure PCTKR2013007669-appb-I000034
상기 5-(2-nitrophenyl)-1-phenyl-1H-indole, triphenylphosphine 및 1,2-dichlorobenzene을 사용하여 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-1과 구조 이성질체인 IC-2을 얻었다.Using the 5- (2-nitrophenyl) -1-phenyl-1H-indole, triphenylphosphine and 1,2-dichlorobenzene, the same process as in <Step 4> of Preparation Example 1 was performed, and the IC-1 and the isomer of IC are structural isomers. -2 was obtained.
1H-NMR: δ 6.98 (d, 1H), 7.13 (t, 1H), 7.26 (t, 1H), 7.33 (d, 1H), 7.42 (t, 1H), 7.51 (s, 1H), 7.61 (m, 5H), 7.84 (d, 1H), 8.03 (s, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.98 (d, 1H), 7.13 (t, 1H), 7.26 (t, 1H), 7.33 (d, 1H), 7.42 (t, 1H), 7.51 (s, 1H), 7.61 ( m, 5H), 7.84 (d, 1H), 8.03 (s, 1H), 10.58 (s, 1H)
[준비예 3] IC-3의 합성Preparation Example 3 Synthesis of IC-3
<단계 1> 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성Step 1 Synthesis of 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole
Figure PCTKR2013007669-appb-I000035
Figure PCTKR2013007669-appb-I000035
5-bromo-1H-indole 대신 6-bromo-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.Except for using 6-bromo-1H-indole instead of 5-bromo-1H-indole by following the same procedure as in <Step 1> of Preparation Example 1 6- (4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl) -1H-indole was obtained.
1H-NMR: δ 1.25 (s, 12H), 6.52 (d, 1H), 7.16 (d, 1H), 7.21 (d, 1H), 7.49 (d, 1H), 7.53 (s, 1H), 8.15 (s, 1H) 1 H-NMR: δ 1.25 (s, 12H), 6.52 (d, 1H), 7.16 (d, 1H), 7.21 (d, 1H), 7.49 (d, 1H), 7.53 (s, 1H), 8.15 ( s, 1 H)
<단계 2> 6-(2-nitrophenyl)-1H-indole의 합성Step 2 Synthesis of 6- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000036
Figure PCTKR2013007669-appb-I000036
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 2>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1H-indole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 6- (4,4,5,5-tetramethyl-1,3,2- Except for using dioxaborolan-2-yl) -1H-indole was carried out the same procedure as in <Step 2> of Preparation Example 1 to obtain 6- (2-nitrophenyl) -1H-indole.
1H-NMR: δ 6.57 (d, 1H), 7.07 (d, 1H), 7.24 (d, 1H), 7.35 (s, 1H), 7.43 (t, 1H), 7.50 (d, 1H), 7.58 (t, 1H), 7.66 (d, 1H), 7.78 (d, 1H), 8.19 (s, 1H) 1 H-NMR: δ 6.57 (d, 1H), 7.07 (d, 1H), 7.24 (d, 1H), 7.35 (s, 1H), 7.43 (t, 1H), 7.50 (d, 1H), 7.58 ( t, 1H), 7.66 (d, 1H), 7.78 (d, 1H), 8.19 (s, 1H)
<단계 3> 6-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000037
Figure PCTKR2013007669-appb-I000037
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using the 6- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1H-indole was carried out the same process as in <Step 3> of Preparation Example 6 6- (2 -nitrophenyl) -1-phenyl-1H-indole was obtained.
1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.35 (s, 1H), 7.43 (d, 1H), 7.51 (m, 3H), 7.56 (m, 2H), 7.62 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H) 1 H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.35 (s, 1H), 7.43 (d, 1H), 7.51 (m, 3H), 7.56 ( m, 2H), 7.62 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H)
<단계 4> IC-3의 합성Step 4 Synthesis of IC-3
Figure PCTKR2013007669-appb-I000038
Figure PCTKR2013007669-appb-I000038
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1-phenyl-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-3을 얻었다.Except for using the 6- (2-nitrophenyl) -1-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole is the same as in <Step 4> of Preparation Example 1 The procedure was followed to obtain IC-3.
1H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.23 (t, 1H), 7.42 (d, 1H), 7.50 (m, 3H), 7.57 (m, 2H), 7.63 (m, 2H), 7.86 (d, 1H), 8.03 (d, 1H), 9.81 (s, 1H) 1 H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.23 (t, 1H), 7.42 (d, 1H), 7.50 (m, 3H), 7.57 (m, 2H), 7.63 ( m, 2H), 7.86 (d, 1H), 8.03 (d, 1H), 9.81 (s, 1H)
[준비예 4] IC-4의 합성Preparation Example 4 Synthesis of IC-4
Figure PCTKR2013007669-appb-I000039
Figure PCTKR2013007669-appb-I000039
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1-phenyl-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-3과 구조 이성질체인 IC-4를 얻었다.Except for using the 6- (2-nitrophenyl) -1-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole is the same as in <Step 4> of Preparation Example 1 The procedure was followed to obtain IC-3 and the structural isomer IC-4.
1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.43 (s, 1H), 7.51 (m, 3H), 7.58 (m, 2H), 7.64 (m, 2H), 7.85 (d, 1H), 8.02 (s, 1H), 9.82 (s, 1H) 1 H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.43 (s, 1H), 7.51 (m, 3H), 7.58 (m, 2H), 7.64 ( m, 2H), 7.85 (d, 1H), 8.02 (s, 1H), 9.82 (s, 1H)
[준비예 5] IC-5의 합성Preparation Example 5 Synthesis of IC-5
<단계 1> 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합 <Step 1> Synthesis of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole
Figure PCTKR2013007669-appb-I000040
Figure PCTKR2013007669-appb-I000040
5-bromo-1H-indole 대신 4-bromo-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.Except for using 4-bromo-1H-indole instead of 5-bromo-1H-indole by performing the same process as in <Step 1> of Preparation Example 1 4- (4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl) -1H-indole was obtained.
1H NMR: δ 1.26 (s, 12H), 6.43 (d, 1H), 7.26 (t, 1H), 7.48 (d, 1H), 7.74 (d, 1H), 7.85 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 1.26 (s, 12H), 6.43 (d, 1H), 7.26 (t, 1H), 7.48 (d, 1H), 7.74 (d, 1H), 7.85 (d, 1H), 8.23 (s , 1H)
<단계 2> 4-(2-nitrophenyl)-1H-indole의 합성<Step 2> Synthesis of 4- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000041
Figure PCTKR2013007669-appb-I000041
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-nitrophenyl)-1H-indole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 4- (4,4,5,5-tetramethyl-1,3,2- A 4- (2-nitrophenyl) -1H-indole was obtained by performing the same process as <Step 2> of Preparation Example 1, except that dioxaborolan-2-yl) -1H-indole was used.
1H NMR: δ 6.45 (d, 1H), 7.27 (t, 1H), 7.50 (d, 1H), 7.66 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 7.99 (d, 1H), 8.04 (d, 1H), 8.24 (s, 1H) 1 H NMR: δ 6.45 (d, 1H), 7.27 (t, 1H), 7.50 (d, 1H), 7.66 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 7.99 (d , 1H), 8.04 (d, 1H), 8.24 (s, 1H)
<단계 3> 4-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 4- (2-nitrophenyl) -1-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000042
Figure PCTKR2013007669-appb-I000042
5-(2-nitrophenyl)-1H-indole 대신 상기 4-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 4-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 4- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1H-indole, the same procedure as in <Step 3> of Preparation Example 1 was performed. nitrophenyl) -1-phenyl-1H-indole was obtained.
1H NMR: δ 6.47 (d, 1H), 7.28 (t, 1H), 7.47 (m, 2H), 7.52 (m, 2H), 7.60 (m, 2H), 7.67 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 8.00 (d, 1H), 8.06 (d, 1H) 1 H NMR: δ 6.47 (d, 1H), 7.28 (t, 1H), 7.47 (m, 2H), 7.52 (m, 2H), 7.60 (m, 2H), 7.67 (t, 1H), 7.75 (d , 1H), 7.89 (m, 2H), 8.00 (d, 1H), 8.06 (d, 1H)
<단계 4> IC-5의 합성Step 4 Synthesis of IC-5
Figure PCTKR2013007669-appb-I000043
Figure PCTKR2013007669-appb-I000043
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 4-(2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-5을 얻었다.The same procedure as in <Step 4> of Preparation Example 1, except that 4- (2-nitrophenyl) -1-phenyl-1H-indole is used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole. Was carried out to obtain IC-5.
1H NMR: δ 6.49 (d, 1H), 7.29 (t, 1H), 7.46 (m, 2H), 7.54 (m, 2H), 7.61 (d, 1H), 7.69 (t, 1H), 7.74 (d, 1H), 7.88 (m, 2H), 8.01 (d, 1H), 8.04 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 6.49 (d, 1H), 7.29 (t, 1H), 7.46 (m, 2H), 7.54 (m, 2H), 7.61 (d, 1H), 7.69 (t, 1H), 7.74 (d , 1H), 7.88 (m, 2H), 8.01 (d, 1H), 8.04 (d, 1H), 8.23 (s, 1H)
[준비예 6] IC-6의 합성Preparation Example 6 Synthesis of IC-6
<단계 1> 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성<Step 1> Synthesis of 7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole
Figure PCTKR2013007669-appb-I000044
Figure PCTKR2013007669-appb-I000044
5-bromo-1H-indole 대신 7-bromo-1H-indole를 사용하는 것을 제외하고는 준비예 1의 <단계 1>과 동일한 과정을 수행하여 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.Except for using 7-bromo-1H-indole instead of 5-bromo-1H-indole by following the same procedure as in <Step 1> of Preparation Example 1 7- (4,4,5,5-tetramethyl-1 , 3,2-dioxaborolan-2-yl) -1H-indole was obtained.
1H NMR: δ 1.25 (s, 12H), 6.43 (d, 1H), 7.25 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.71 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 1.25 (s, 12H), 6.43 (d, 1H), 7.25 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.71 (d, 1H), 8.22 (s , 1H)
<단계 2> 7-(2-nitrophenyl)-1H-indole의 합성Step 2 Synthesis of 7- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000045
Figure PCTKR2013007669-appb-I000045
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 7-(2-nitrophenyl)-1H-indole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 7- (4,4,5,5-tetramethyl-1,3,2- Except for using dioxaborolan-2-yl) -1H-indole was carried out the same process as <step 2> of Preparation Example 1 to obtain 7- (2-nitrophenyl) -1H-indole.
1H NMR: δ 6.42 (d, 1H), 7.24 (d, 1H), 7.43 (t, 1H), 7.55 (d, 1H), 7.70 (m, 2H), 7.88 (t, 1H), 8.01 (d, 1H), 8.11 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 6.42 (d, 1H), 7.24 (d, 1H), 7.43 (t, 1H), 7.55 (d, 1H), 7.70 (m, 2H), 7.88 (t, 1H), 8.01 (d , 1H), 8.11 (d, 1H), 8.23 (s, 1H)
<단계 3> 7-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 7- (2-nitrophenyl) -1-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000046
Figure PCTKR2013007669-appb-I000046
5-(2-nitrophenyl)-1H-indole 대신 상기 7-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 7- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1H-indole, the same procedure as in <Step 3> of Preparation Example 1 was performed to obtain 7- (2- nitrophenyl) -1-phenyl-1H-indole was obtained.
1H NMR: δ 6.43 (d, 1H), 7.26 (d, 1H), 7.44 (m, 3H), 7.56 (m, 4H), 7.71 (m, 2H), 7.89 (t, 1H), 8.02 (d, 1H), 8.10 (d, 1H) 1 H NMR: δ 6.43 (d, 1H), 7.26 (d, 1H), 7.44 (m, 3H), 7.56 (m, 4H), 7.71 (m, 2H), 7.89 (t, 1H), 8.02 (d , 1H), 8.10 (d, 1H)
<단계 4> IC-6의 합성Step 4 Synthesis of IC-6
Figure PCTKR2013007669-appb-I000047
Figure PCTKR2013007669-appb-I000047
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 7-(2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-6을 얻었다.The same procedure as in <Step 4> of Preparation Example 1, except that 7- (2-nitrophenyl) -1-phenyl-1H-indole is used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole. Was carried out to obtain IC-6.
1H NMR: δ 6.45 (d, 1H), 7.24 (d, 1H), 7.45 (m, 3H), 7.57 (m, 3H), 7.63 (d, 1H), 7.70 (d, 1H), 7.88 (t, 1H), 8.00 (d, 1H), 8.09 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 6.45 (d, 1H), 7.24 (d, 1H), 7.45 (m, 3H), 7.57 (m, 3H), 7.63 (d, 1H), 7.70 (d, 1H), 7.88 (t , 1H), 8.00 (d, 1H), 8.09 (d, 1H), 8.22 (s, 1H)
[준비예 7] IC-7의 합성Preparation Example 7 Synthesis of IC-7
<단계 1> 5-(5-bromo-2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 5- (5-bromo-2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000048
Figure PCTKR2013007669-appb-I000048
1-bromo-2-nitrobenzene 대신 2,4-dibromo-1-nitrobenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1H-indole을 얻었다.Except for using 2,4-dibromo-1-nitrobenzene instead of 1-bromo-2-nitrobenzene, the process was carried out in the same manner as in <Step 2> of Preparation Example 1 to 5- (5-bromo-2-nitrophenyl)- 1H-indole was obtained.
1H NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.45 (d, 1H), 7.55 (d, 1H), 7.64 (d, 1H), 7.85 (d, 1H), 7.96 (s, 1H), 8.13 (s, 1H), 8.21 (s, 1H) 1 H NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.45 (d, 1H), 7.55 (d, 1H), 7.64 (d, 1H), 7.85 (d, 1H), 7.96 (s , 1H), 8.13 (s, 1H), 8.21 (s, 1H)
<단계 2> 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 2> Synthesis of 5- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000049
Figure PCTKR2013007669-appb-I000049
5-(2-nitrophenyl)-1H-indole 대신 상기 5-(5-bromo-2-nitrophenyl)-1H-indole 을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 5- (5-bromo-2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1H-indole was carried out in the same manner as in <Step 3> of Preparation Example 5 -(5-bromo-2-nitrophenyl) -1-phenyl-1H-indole was obtained.
1H NMR: δ 6.44 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 4H), 7.65 (d, 1H), 7.86 (d, 1H), 7.95 (s, 1H), 8.11 (s, 1H) 1 H NMR: δ 6.44 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 4H), 7.65 (d, 1H), 7.86 (d, 1H), 7.95 (s , 1H), 8.11 (s, 1H)
<단계 3> IC-7의 합성Step 3 Synthesis of IC-7
Figure PCTKR2013007669-appb-I000050
Figure PCTKR2013007669-appb-I000050
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-7을 얻었다.<Step 4 of Preparation Example 1 except for using the 5- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-7 was obtained by following the same procedure as>.
1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.38 (m, 2H), 7.45 (d, 1H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 (d, 1H), 7.85 (d, 1H), 8.10 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.38 (m, 2H), 7.45 (d, 1H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 ( d, 1H), 7.85 (d, 1H), 8.10 (s, 1H), 8.23 (s, 1H)
[준비예 8] IC-8의 합성Preparation Example 8 Synthesis of IC-8
<단계 1> 6-(5-bromo-2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 6- (5-bromo-2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000051
Figure PCTKR2013007669-appb-I000051
1-bromo-2-nitrobenzene과 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 2,4-dibromo-1-nitrobenzene과 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1H-indole을 얻었다.2,4-dibromo-1-nitrobenzene and 6- instead of 1-bromo-2-nitrobenzene and 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole Except for using (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole, the same procedure as in <Step 2> of Preparation Example 1 was performed. (5-bromo-2-nitrophenyl) -1H-indole was obtained.
1H NMR: δ 6.51 (d, 1H), 7.31 (d, 1H), 7.50 (d, 1H), 7.60 (d, 1H), 7.69 (d, 1H), 7.90 (d, 1H), 8.01 (s, 1H), 8.14 (s, 1H), 8.25 (s, 1H) 1 H NMR: δ 6.51 (d, 1H), 7.31 (d, 1H), 7.50 (d, 1H), 7.60 (d, 1H), 7.69 (d, 1H), 7.90 (d, 1H), 8.01 (s , 1H), 8.14 (s, 1H), 8.25 (s, 1H)
<단계 2> 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 2> Synthesis of 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000052
Figure PCTKR2013007669-appb-I000052
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(5-bromo-2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 6- (5-bromo-2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1H-indole was carried out in the same manner as in <Step 3> of Preparation Example 6 -(5-bromo-2-nitrophenyl) -1-phenyl-1H-indole was obtained.
1H NMR: δ 6.49 (d, 1H), 7.30 (d, 1H), 7.51 (m, 3H), 7.61 (m, 4H), 7.70 (d, 1H), 7.91 (d, 1H), 8.00 (s, 1H), 8.16 (s, 1H) 1 H NMR: δ 6.49 (d, 1H), 7.30 (d, 1H), 7.51 (m, 3H), 7.61 (m, 4H), 7.70 (d, 1H), 7.91 (d, 1H), 8.00 (s , 1H), 8.16 (s, 1H)
<단계 3> IC-8의 합성Step 3 Synthesis of IC-8
Figure PCTKR2013007669-appb-I000053
Figure PCTKR2013007669-appb-I000053
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-8을 얻었다.<Step 4 of Preparation Example 1 except for using the 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-8 was obtained by following the same procedure as>.
1H-NMR: δ 6.47 (d, 1H), 7.28 (d, 1H), 7.40 (m, 2H), 7.47 (d, 1H), 7.53 (d, 1H), 7.59 (m, 3H), 7.66 (d, 1H), 7.87 (d, 1H), 8.12 (s, 1H), 8.25 (s, 1H) 1 H-NMR: δ 6.47 (d, 1H), 7.28 (d, 1H), 7.40 (m, 2H), 7.47 (d, 1H), 7.53 (d, 1H), 7.59 (m, 3H), 7.66 ( d, 1H), 7.87 (d, 1H), 8.12 (s, 1H), 8.25 (s, 1H)
[준비예 9] IC-9의 합성Preparation Example 9 Synthesis of IC-9
<단계 1> 5-(2-nitrophenyl)-1-o-tolyl-1H-indole의 합성<Step 1> Synthesis of 5- (2-nitrophenyl) -1-o-tolyl-1H-indole
Figure PCTKR2013007669-appb-I000054
Figure PCTKR2013007669-appb-I000054
Iodobenzene 대신 1-bromo-2-methylbenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1-o-tolyl-1H-indole을 얻었다.A 5- (2-nitrophenyl) -1-o-tolyl-1H-indole was obtained in the same manner as in <Step 3> of Preparation Example 1, except that 1-bromo-2-methylbenzene was used instead of iodobenzene.
1H-NMR: δ 1.92 (s, 3H), 6.47 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 3H), 7.64 (t, 1H), 7.85 (t, 1H), 7.94 (s, 1H), 8.00 (d, 1H), 8.12 (t, 1H) 1 H-NMR: δ 1.92 (s, 3H), 6.47 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 3H), 7.64 (t, 1H), 7.85 ( t, 1H), 7.94 (s, 1H), 8.00 (d, 1H), 8.12 (t, 1H)
<단계 2> IC-9의 합성Step 2 Synthesis of IC-9
Figure PCTKR2013007669-appb-I000055
Figure PCTKR2013007669-appb-I000055
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1-o-tolyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-9를 얻었다.Except for using the 5- (2-nitrophenyl) -1-o-tolyl-1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole and <Step 4> of Preparation Example 1 The same procedure was followed to obtain IC-9.
1H-NMR: δ 1.93 (s, 3H), 6.98 (d, 1H), 7.11 (t, 1H), 7.28 (t, 1H), 7.31 (d, 1H), 7.42 (t, 1H), 7.51 (d, 1H), 7.61 (m, 4H), 7.86 (d, 1H), 8.01 (d, 1H), 10.58 (s, 1H) 1 H-NMR: δ 1.93 (s, 3H), 6.98 (d, 1H), 7.11 (t, 1H), 7.28 (t, 1H), 7.31 (d, 1H), 7.42 (t, 1H), 7.51 ( d, 1H), 7.61 (m, 4H), 7.86 (d, 1H), 8.01 (d, 1H), 10.58 (s, 1H)
[준비예 10] IC-10의 합성Preparation Example 10 Synthesis of IC-10
<단계 1> 1-(biphenyl-4-yl)-5-(2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (biphenyl-4-yl) -5- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000056
Figure PCTKR2013007669-appb-I000056
Iodobenzene 대신 4-bromobiphenyl을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-4-yl)-5-(2-nitrophenyl)-1H-indole을 얻었다.A 1- (biphenyl-4-yl) -5- (2-nitrophenyl) -1H-indole was obtained in the same manner as in <Step 3> of Preparation Example 1, except that 4-bromobiphenyl was used instead of iodobenzene.
1H-NMR: δ 6.73 (d, 1H), 7.18 (d, 1H), 7.39 (m, 2H), 7.47 (m, 3H), 7.54 (d, 1H), 7.59 (m, 3H), 7.64 (m, 4H), 7.75 (d, 2H), 7.82 (d, 1H) 1 H-NMR: δ 6.73 (d, 1H), 7.18 (d, 1H), 7.39 (m, 2H), 7.47 (m, 3H), 7.54 (d, 1H), 7.59 (m, 3H), 7.64 ( m, 4H), 7.75 (d, 2H), 7.82 (d, 1H)
<단계 2> IC-10의 합성<Step 2> Synthesis of IC-10
Figure PCTKR2013007669-appb-I000057
Figure PCTKR2013007669-appb-I000057
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-4-yl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-10를 얻었다.Except for using 1- (biphenyl-4-yl) -5- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole < IC-10 was obtained by the same procedure as in step 4>.
1H-NMR: δ 6.75 (d, 1H), 7.20 (d, 1H), 7.42 (m, 2H), 7.51 (m, 3H), 7.56 (d, 1H), 7.62 (m, 3H), 7.68 (m, 3H), 7.76 (d, 2H), 7.85 (d, 1H), 10.45 (s, 1H) 1 H-NMR: δ 6.75 (d, 1H), 7.20 (d, 1H), 7.42 (m, 2H), 7.51 (m, 3H), 7.56 (d, 1H), 7.62 (m, 3H), 7.68 ( m, 3H), 7.76 (d, 2H), 7.85 (d, 1H), 10.45 (s, 1H)
[준비예 11] IC-11의 합성Preparation Example 11 Synthesis of IC-11
<단계 1> IC-11-1의 합성Step 1 Synthesis of IC-11-1
Figure PCTKR2013007669-appb-I000058
Figure PCTKR2013007669-appb-I000058
Iodobenzene 대신 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 IC-11-1을 얻었다.Except for using 1-bromo-3,5-diphenyl benzene instead of iodobenzene to obtain IC-11-1 by the same process as in <Step 3> of Preparation Example 1.
1H-NMR: δ 6.98 (d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (t, 2H), 7.46 (m, 6H), 7.58 (d, 1H), 7.81 (d, 4H), 7.87 (m, 4H), 7.93 (d, 1H), 7.99 (d, 1H) 1 H-NMR: δ 6.98 (d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (t, 2H), 7.46 (m, 6H), 7.58 (d, 1H), 7.81 ( d, 4H), 7.87 (m, 4H), 7.93 (d, 1H), 7.99 (d, 1H)
<단계 2> IC-11의 합성Step 2 Synthesis of IC-11
Figure PCTKR2013007669-appb-I000059
Figure PCTKR2013007669-appb-I000059
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 IC-11-1을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-11를 얻었다.Except for using IC-11-1 instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole, IC-11 was obtained by the same process as <Step 4> of Preparation Example 1.
1H-NMR: δ 6.97 (d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 (d, 4H), 7.86 (m, 3H), 7.92 (d, 1H), 7.98 (d, 1H), 10.60 (s, 1H) 1 H-NMR: δ 6.97 (d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 ( d, 4H), 7.86 (m, 3H), 7.92 (d, 1H), 7.98 (d, 1H), 10.60 (s, 1H)
[준비예 12] IC-12의 합성Preparation Example 12 Synthesis of IC-12
<단계 1> 5-(2-nitrophenyl)-1-(2-(trifluoromethyl)phenyl)-1H-indole의 합성<Step 1> Synthesis of 5- (2-nitrophenyl) -1- (2- (trifluoromethyl) phenyl) -1H-indole
Figure PCTKR2013007669-appb-I000060
Figure PCTKR2013007669-appb-I000060
Iodobenzene 대신 1-bromo-2-(trifluoromethyl)benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1-(2-(trifluoromethyl)phenyl)-1H-indole을 얻었다.Except for using 1-bromo-2- (trifluoromethyl) benzene instead of iodobenzene, the same process as in <Step 3> of Preparation Example 1 was carried out to give 5- (2-nitrophenyl) -1- (2- (trifluoromethyl) phenyl ) -1H-indole was obtained.
1H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.47 (m, 3H), 7.57 (m, 3H), 7.63 (t, 1H), 7.84 (t, 1H), 7.95 (s, 1H), 8.01 (d, 1H), 8.13 (t, 1H) 1 H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.47 (m, 3H), 7.57 (m, 3H), 7.63 (t, 1H), 7.84 (t, 1H), 7.95 ( s, 1H), 8.01 (d, 1H), 8.13 (t, 1H)
<단계 2> IC-12의 합성Step 2 Synthesis of IC-12
Figure PCTKR2013007669-appb-I000061
Figure PCTKR2013007669-appb-I000061
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1-(2-(trifluoromethyl)phenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-12를 얻었다.Preparation Example 1 except that 5- (2-nitrophenyl) -1- (2- (trifluoromethyl) phenyl) -1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-12 was obtained by performing the same procedure as in <Step 4>.
1H-NMR: δ 6.97 (d, 1H), 7.12 (t, 1H), 7.29 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.52 (d, 1H), 7.60 (m, 4H), 7.85 (d, 1H), 8.01 (d, 1H), 10.57 (s, 1H) 1 H-NMR: δ 6.97 (d, 1H), 7.12 (t, 1H), 7.29 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.52 (d, 1H), 7.60 ( m, 4H), 7.85 (d, 1H), 8.01 (d, 1H), 10.57 (s, 1H)
[준비예 13] IC-13의 합성Preparation Example 13 Synthesis of IC-13
<단계 1> 1-(biphenyl-3-yl)-5-(2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (biphenyl-3-yl) -5- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000062
Figure PCTKR2013007669-appb-I000062
Iodobenzene 대신 3-bromobiphenyl을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-3-yl)-5-(2-nitrophenyl)-1H-indole을 얻었다.A 1- (biphenyl-3-yl) -5- (2-nitrophenyl) -1H-indole was obtained in the same manner as in <Step 3> of Preparation Example 1, except that 3-bromobiphenyl was used instead of iodobenzene.
1H-NMR: δ 6.75 (d, 1H), 7.19 (d, 1H), 7.38 (m, 2H), 7.48 (m, 3H), 7.52 (d, 1H), 7.58 (m, 3H), 7.65 (m, 4H), 7.76 (m, 2H), 7.85 (d, 1H) 1 H-NMR: δ 6.75 (d, 1H), 7.19 (d, 1H), 7.38 (m, 2H), 7.48 (m, 3H), 7.52 (d, 1H), 7.58 (m, 3H), 7.65 ( m, 4H), 7.76 (m, 2H), 7.85 (d, 1H)
<단계 2> IC-13의 합성<Step 2> Synthesis of IC-13
Figure PCTKR2013007669-appb-I000063
Figure PCTKR2013007669-appb-I000063
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-3-yl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-13를 얻었다.Except for using 1- (biphenyl-3-yl) -5- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole, IC-13 was obtained by performing the same procedure as in Step 4>.
1H-NMR: δ 6.74 (d, 1H), 7.21 (d, 1H), 7.41 (m, 2H), 7.52 (m, 3H), 7.56 (d, 1H), 7.61 (m, 3H), 7.69 (m, 3H), 7.77 (m, 2H), 7.86 (d, 1H), 10.44 (s, 1H) 1 H-NMR: δ 6.74 (d, 1H), 7.21 (d, 1H), 7.41 (m, 2H), 7.52 (m, 3H), 7.56 (d, 1H), 7.61 (m, 3H), 7.69 ( m, 3H), 7.77 (m, 2H), 7.86 (d, 1H), 10.44 (s, 1H)
[준비예 14] IC-14의 합성Preparation 14 Synthesis of IC-14
<단계 1> 1-(biphenyl-3-yl)-6-(2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (biphenyl-3-yl) -6- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000064
Figure PCTKR2013007669-appb-I000064
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 3-bromobiphenyl를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-3-yl)-6-(2-nitrophenyl)-1H-indole을 얻었다.The same procedure as in <Step 3> of Preparation Example 1 was performed except that 6- (2-nitrophenyl) -1H-indole and 3-bromobiphenyl were used instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene. 1- (biphenyl-3-yl) -6- (2-nitrophenyl) -1H-indole was obtained.
1H-NMR: δ 6.76 (d, 1H), 7.18 (d, 1H), 7.37 (m, 2H), 7.47 (m, 3H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 (m, 4H), 7.75 (m, 2H), 7.86 (d, 1H) 1 H-NMR: δ 6.76 (d, 1H), 7.18 (d, 1H), 7.37 (m, 2H), 7.47 (m, 3H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 ( m, 4H), 7.75 (m, 2H), 7.86 (d, 1H)
<단계 2> IC-14의 합성Step 2 Synthesis of IC-14
Figure PCTKR2013007669-appb-I000065
Figure PCTKR2013007669-appb-I000065
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-3-yl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-14을 얻었다.Preparation Example 1 except that 1- (biphenyl-3-yl) -6- (2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-14 was obtained by the same procedure as in <Step 4>.
1H-NMR: δ 6.75 (d, 1H), 7.20 (d, 1H), 7.40 (m, 2H), 7.51 (m, 3H), 7.57 (d, 1H), 7.62 (m, 3H), 7.70 (m, 3H), 7.76 (m, 2H), 7.85 (d, 1H), 10.43 (s, 1H) 1 H-NMR: δ 6.75 (d, 1H), 7.20 (d, 1H), 7.40 (m, 2H), 7.51 (m, 3H), 7.57 (d, 1H), 7.62 (m, 3H), 7.70 ( m, 3H), 7.76 (m, 2H), 7.85 (d, 1H), 10.43 (s, 1H)
[준비예 15] IC-15의 합성Preparation Example 15 Synthesis of IC-15
<단계 1> 1-(biphenyl-4-yl)-6-(2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (biphenyl-4-yl) -6- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000066
Figure PCTKR2013007669-appb-I000066
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 4-bromobiphenyl을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-4-yl)-6-(2-nitrophenyl)-1H-indole을 얻었다.The same procedure as in <Step 3> of Preparation Example 1 was performed except that 6- (2-nitrophenyl) -1H-indole and 4-bromobiphenyl were used instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene. 1- (biphenyl-4-yl) -6- (2-nitrophenyl) -1H-indole was obtained.
1H-NMR: δ 6.74 (d, 1H), 7.19 (d, 1H), 7.40 (m, 2H), 7.46 (m, 3H), 7.55 (d, 1H), 7.58 (m, 3H), 7.63 (m, 4H), 7.75 (d, 2H), 7.83 (d, 1H) 1 H-NMR: δ 6.74 (d, 1H), 7.19 (d, 1H), 7.40 (m, 2H), 7.46 (m, 3H), 7.55 (d, 1H), 7.58 (m, 3H), 7.63 ( m, 4H), 7.75 (d, 2H), 7.83 (d, 1H)
<단계 2> IC-15의 합성Step 2 Synthesis of IC-15
Figure PCTKR2013007669-appb-I000067
Figure PCTKR2013007669-appb-I000067
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-4-yl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-15을 얻었다.Preparation Example 1 except that 1- (biphenyl-4-yl) -6- (2-nitrophenyl) -1H-indole is used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-15 was obtained by performing the same procedure as in <Step 4>.
1H-NMR: δ 6.74 (d, 1H), 7.19 (d, 1H), 7.43 (m, 2H), 7.52 (m, 3H), 7.57 (d, 1H), 7.63 (m, 3H), 7.69 (m, 3H), 7.75 (d, 2H), 7.86 (d, 1H), 10.46 (s, 1H) 1 H-NMR: δ 6.74 (d, 1H), 7.19 (d, 1H), 7.43 (m, 2H), 7.52 (m, 3H), 7.57 (d, 1H), 7.63 (m, 3H), 7.69 ( m, 3H), 7.75 (d, 2H), 7.86 (d, 1H), 10.46 (s, 1H)
[준비예 16] IC-16의 합성Preparation Example 16 Synthesis of IC-16
<단계 1> IC-16-1의 합성<Step 1> Synthesis of IC-16-1
Figure PCTKR2013007669-appb-I000068
Figure PCTKR2013007669-appb-I000068
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 IC-16-1을 얻었다.<Step 3 of Preparation Example 1 except that 6- (2-nitrophenyl) -1H-indole and 1-bromo-3,5-diphenyl benzene were used instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene. IC-16-1 was obtained by following the same procedure as>.
1H-NMR: δ 6.98 (d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (m, 2H), 7.45 (m, 6H), 7.57 (d, 1H), 7.80 (d, 4H), 7.86 (m, 4H), 7.92 (d, 1H), 7.98 (d, 1H) 1 H-NMR: δ 6.98 (d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (m, 2H), 7.45 (m, 6H), 7.57 (d, 1H), 7.80 ( d, 4H), 7.86 (m, 4H), 7.92 (d, 1H), 7.98 (d, 1H)
<단계 2> IC-16의 합성Step 2 Synthesis of IC-16
Figure PCTKR2013007669-appb-I000069
Figure PCTKR2013007669-appb-I000069
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 IC-16-1을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-16을 얻었다.Except for using the IC-16-1 instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole was carried out the same procedure as in <Step 4> of Preparation Example 1 to obtain an IC-16.
1H-NMR: δ 6.97 (d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 (d, 4H), 7.86 (m, 3H), 7.92 (d, 1H), 7.98 (d, 1H), 10.59 (s, 1H) 1 H-NMR: δ 6.97 (d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 ( d, 4H), 7.86 (m, 3H), 7.92 (d, 1H), 7.98 (d, 1H), 10.59 (s, 1H)
[준비예 17] IC-17의 합성Preparation 17 Synthesis of IC-17
<단계 1> 6-(2-nitrophenyl)-1-(3-(trifluoromethyl)phenyl)-1H-indole의 합성<Step 1> Synthesis of 6- (2-nitrophenyl) -1- (3- (trifluoromethyl) phenyl) -1H-indole
Figure PCTKR2013007669-appb-I000070
Figure PCTKR2013007669-appb-I000070
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 1-bromo-3-(trifluoromethyl)benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-(3-(trifluoromethyl)phenyl)-1H-indole을 얻었다.<Step 3 of Preparation Example 1 except that 6- (2-nitrophenyl) -1H-indole and 1-bromo-3- (trifluoromethyl) benzene were used instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene. 6- (2-nitrophenyl) -1- (3- (trifluoromethyl) phenyl) -1H-indole was obtained by following the same procedure as>.
1H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.21 (t, 1H), 7.36 (s, 1H), 7.42 (s, 1H), 7.50 (m, 2H), 7.55 (m, 2H), 7.63 (m, 2H), 7.86 (d, 1H), 8.01 (d, 1H) 1 H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.21 (t, 1H), 7.36 (s, 1H), 7.42 (s, 1H), 7.50 (m, 2H), 7.55 ( m, 2H), 7.63 (m, 2H), 7.86 (d, 1H), 8.01 (d, 1H)
<단계 2> IC-17의 합성<Step 2> Synthesis of IC-17
Figure PCTKR2013007669-appb-I000071
Figure PCTKR2013007669-appb-I000071
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1-(3-(trifluoromethyl)phenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-17을 얻었다.Preparation Example 1 except that 6- (2-nitrophenyl) -1- (3- (trifluoromethyl) phenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-17 was obtained by the same procedure as in <Step 4>.
1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.24 (t, 1H), 7.43 (d, 1H), 7.51 (m, 2H), 7.58 (m, 2H), 7.64 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H), 9.82 (s, 1H) 1 H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.24 (t, 1H), 7.43 (d, 1H), 7.51 (m, 2H), 7.58 (m, 2H), 7.64 ( m, 2H), 7.85 (d, 1H), 8.02 (d, 1H), 9.82 (s, 1H)
[준비예 18] IC-18의 합성Preparation Example 18 Synthesis of IC-18
<단계 1> 3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9-phenyl-9H-carbazole의 합성<Step 1> Synthesis of 3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9-phenyl-9H-carbazole
Figure PCTKR2013007669-appb-I000072
Figure PCTKR2013007669-appb-I000072
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 3-bromo-9-phenyl-9H-carbazole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9-phenyl-9H-carbazole을 얻었다.<Step of Preparation Example 1 except that 6- (2-nitrophenyl) -1H-indole and 3-bromo-9-phenyl-9H-carbazole were used instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene. 3> was carried out in the same manner to obtain 3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9-phenyl-9H-carbazole.
GC-Mass (이론치: 479.16 g/mol, 측정치: 479 g/mol)GC-Mass (Theoretical value: 479.16 g / mol, Measured value: 479 g / mol)
<단계 2> IC-18의 합성<Step 2> Synthesis of IC-18
Figure PCTKR2013007669-appb-I000073
Figure PCTKR2013007669-appb-I000073
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9-phenyl-9H-carbazole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-18을 얻었다.Except for using 3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9-phenyl-9H-carbazole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole Was obtained in the same manner as in <Step 4> of Preparation Example 1 to obtain an IC-18.
GC-Mass (이론치: 447.17 g/mol, 측정치: 447 g/mol)GC-Mass (Theoretical value: 447.17 g / mol, Measured value: 447 g / mol)
[준비예 19] IC-19의 합성Preparation Example 19 Synthesis of IC-19
<단계 1> 9-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9H-carbazole의 합성<Step 1> of 9- (4,6-diphenyl-1,3,5-triazin-2-yl) -3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9H-carbazole synthesis
Figure PCTKR2013007669-appb-I000074
Figure PCTKR2013007669-appb-I000074
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 9-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9H-carbazole을 얻었다.6- (2-nitrophenyl) -1H-indole and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene Except for using) -9H-carbazole, 9- (4,6-diphenyl-1,3,5-triazin-2-yl) -3- was carried out in the same manner as in <Step 3> of Preparation Example 1 (5- (2-nitrophenyl) -1H-indol-1-yl) -9H-carbazole was obtained.
GC-Mass (이론치: 634.21 g/mol, 측정치: 634 g/mol)GC-Mass (Theoretical value: 634.21 g / mol, Measured value: 634 g / mol)
<단계 2> 3-(9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazol-3-yl)-3,10-dihydropyrrolo[3,2-a]carbazole의 합성<Step 2> 3- (9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazol-3-yl) -3,10-dihydropyrrolo [3,2-a] Synthesis of carbazole
Figure PCTKR2013007669-appb-I000075
Figure PCTKR2013007669-appb-I000075
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 9-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-19을 얻었다.9- (4,6-diphenyl-1,3,5-triazin-2-yl) -3- (5- (2-nitrophenyl)-instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole Except for using 1H-indol-1-yl) -9H-carbazole was carried out the same process as in <Step 4> of Preparation Example 1 to obtain an IC-19.
GC-Mass (이론치: 602.22 g/mol, 측정치: 602 g/mol)GC-Mass (Theoretical value: 602.22 g / mol, Measured value: 602 g / mol)
[준비예 20] IC-20의 합성Preparation Example 20 Synthesis of IC-20
<단계 1> 5-bromo-2-phenyl-1H-indole의 합성<Step 1> Synthesis of 5-bromo-2-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000076
Figure PCTKR2013007669-appb-I000076
질소 기류 하에서 5-bromo-1H-indole (25 g, 0.13 mol), iodobenzene (31.22 g, 0.15 mol), Pd(OAc)2 (1.43 g, 5 mol%), Triphenylphosphine (1.67 g, 5 mol%), KOAc (37.55 g, 0.38 mol) 및 H2O (300 ml)를 혼합하고 110℃에서 24시간 동안 교반하였다.5-bromo-1H-indole (25 g, 0.13 mol), iodobenzene (31.22 g, 0.15 mol), Pd (OAc) 2 (1.43 g, 5 mol%), Triphenylphosphine (1.67 g, 5 mol%) under nitrogen stream , KOAc (37.55 g, 0.38 mol) and H 2 O (300 ml) were mixed and stirred at 110 ° C. for 24 h.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-bromo-2-phenyl-1H-indole (16.66 g, 수율 48%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 5-bromo-2-phenyl-1H-indole ( 16.66 g, yield 48%).
1H-NMR: δ 6.89 (dd, 1H), 7.20 (dd, 1H), 7.34 (m, 1H), 7.36 (d, 1H), 7.47 (t, 2H), 7.71 (d, 1H), 7.86 (dd, 2H), 11.74 (s, 1H) 1 H-NMR: δ 6.89 (dd, 1H), 7.20 (dd, 1H), 7.34 (m, 1H), 7.36 (d, 1H), 7.47 (t, 2H), 7.71 (d, 1H), 7.86 ( dd, 2H), 11.74 (s, 1H)
<단계 2> 5-(2-nitrophenyl)-2-phenyl-1H-indole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -2-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000077
Figure PCTKR2013007669-appb-I000077
질소 기류 하에서 2-nitrophenylboronic acid (11.04 g, 66.14 mmol)과 상기 5-bromo-2-phenyl-1H-indole (15 g, 55.12 mmol), NaOH (6.61 g, 165.36 mmol) 및 THF/H2O(200 ml/100 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(3.18 g, 5 mol)를 넣고 80℃에서 12시간 동안 교반하였다. 2-nitrophenylboronic acid (11.04 g, 66.14 mmol) and 5-bromo-2-phenyl-1H-indole (15 g, 55.12 mmol), NaOH (6.61 g, 165.36 mmol) and THF / H 2 O 200 ml / 100 ml) was mixed, Pd (PPh 3 ) 4 (3.18 g, 5 mol) was added at 40 ° C., and the mixture was stirred at 80 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 5:1 (v/v))로 정제하여 5-(2-nitrophenyl)-2-phenyl-1H-indole (10.74 g, 수율 62%)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 5: 1 (v / v)) to give 5- (2-nitrophenyl) -2-phenyl-1H-indole (10.74 g, yield 62%). Got.
1H-NMR: δ 6.88 (dd, 1H), 7.21 (d, 1H), 7.32 (m, 1H), 7.34 (d, 1H), 7.46 (m, 3H), 7.64 (m, 2H), 7.77 (d, 2H), 8.02 (d, 2H), 11.73 (s, 1H) 1 H-NMR: δ 6.88 (dd, 1H), 7.21 (d, 1H), 7.32 (m, 1H), 7.34 (d, 1H), 7.46 (m, 3H), 7.64 (m, 2H), 7.77 ( d, 2H), 8.02 (d, 2H), 11.73 (s, 1H)
<단계 3> 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1,2-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000078
Figure PCTKR2013007669-appb-I000078
5-(2-nitrophenyl)-1H-indole 대신 상기 5-(2-nitrophenyl)-2-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 얻었다.Except for using the 5- (2-nitrophenyl) -2-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1H-indole was carried out in the same manner as in <Step 3> of Preparation Example 5 -(2-nitrophenyl) -1,2-diphenyl-1H-indole was obtained.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)
<단계 4> IC-20의 합성Step 4 Synthesis of IC-20
Figure PCTKR2013007669-appb-I000079
Figure PCTKR2013007669-appb-I000079
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-20을 얻었다.<Step 4> of Preparation Example 1, except that 5- (2-nitrophenyl) -1,2-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole. IC-20 was obtained by performing the same procedure as in the following.
GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (Theoretical value: 358.15 g / mol, Measured value: 358 g / mol)
[준비예 21] IC-21의 합성Preparation Example 21 Synthesis of IC-21
<단계 1> 6-chloro-2-phenyl-1H-indole의 합성<Step 1> Synthesis of 6-chloro-2-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000080
Figure PCTKR2013007669-appb-I000080
5-bromo-1H-indole과 iodobenzene 대신 6-chloro-1H-indole과 bromobenzene을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 1>과 동일한 과정을 수행하여 6-chloro-2-phenyl-1H-indole을 얻었다.Except for using 6-chloro-1H-indole and bromobenzene instead of 5-bromo-1H-indole and iodobenzene 6-chloro-2-phenyl-1H was carried out in the same manner as in <Step 1> of Preparation Example 20 got -indole
1H-NMR: δ 6.92 (d, 1H), 7.02 (dd, 1H), 7.33 (t, 1H), 7.41 (s, 1H), 7.47 (t, 2H), 7.54 (d, 1H), 7.85 (d, 2H), 11.68 (s, 1H) 1 H-NMR: δ 6.92 (d, 1H), 7.02 (dd, 1H), 7.33 (t, 1H), 7.41 (s, 1H), 7.47 (t, 2H), 7.54 (d, 1H), 7.85 ( d, 2H), 11.68 (s, 1H)
<단계 2> 6-(2-nitrophenyl)-2-phenyl-1H-indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -2-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000081
Figure PCTKR2013007669-appb-I000081
5-bromo-2-phenyl-1H-indole 대신 상기 6-chloro-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-2-phenyl-1H-indole을 얻었다.Except for using the 6-chloro-2-phenyl-1H-indole instead of 5-bromo-2-phenyl-1H-indole was carried out the same process as in <Step 2> of Preparation Example 20 6- (2 -nitrophenyl) -2-phenyl-1H-indole was obtained.
1H-NMR: δ 6.91 (d, 1H), 7.03 (d, 1H), 7.31 (t, 1H), 7.42 (s, 1H), 7.48 (m, 3H), 7.53 (d, 1H), 7.76 (m, 3H), 8.01 (d, 2H), 11.66 (s, 1H) 1 H-NMR: δ 6.91 (d, 1H), 7.03 (d, 1H), 7.31 (t, 1H), 7.42 (s, 1H), 7.48 (m, 3H), 7.53 (d, 1H), 7.76 ( m, 3H), 8.01 (d, 2H), 11.66 (s, 1H)
<단계 3> 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole의 합성Step 3 Synthesis of 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000082
Figure PCTKR2013007669-appb-I000082
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-2-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 얻었다.Except for using 6- (2-nitrophenyl) -2-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1H-indole was carried out in the same manner as in <Step 3> of Preparation Example 6 -(2-nitrophenyl) -1,2-diphenyl-1H-indole was obtained.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)
<단계 4> IC-21의 합성Step 4 Synthesis of IC-21
Figure PCTKR2013007669-appb-I000083
Figure PCTKR2013007669-appb-I000083
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-21을 얻었다.<Step 4 of Preparation Example 1> except that 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-21 was obtained by performing the same procedure as in the following.
GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (Theoretical value: 358.15 g / mol, Measured value: 358 g / mol)
[준비예 22] IC-22의 합성Preparation Example 22 Synthesis of IC-22
<단계 1> 6-chloro-3-phenyl-1H-indole의 합성<Step 1> Synthesis of 6-chloro-3-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000084
Figure PCTKR2013007669-appb-I000084
질소 기류 하에서 6-chloro-1H-indole (25 g, 0.17 mol), bromobenzene (31.19 g, 0.20 mol), Pd(OAc)2 (1.86 g, 5 mol), Triphenylphosphine (2.17 g, 5 mol%), K2CO3 (68.64 g, 0.50 mol) 및 1,4-dioxane (300 ml)를 혼합하고 130℃에서 18시간 동안 교반하였다.6-chloro-1H-indole (25 g, 0.17 mol), bromobenzene (31.19 g, 0.20 mol), Pd (OAc) 2 (1.86 g, 5 mol), Triphenylphosphine (2.17 g, 5 mol%), under nitrogen stream K 2 CO 3 (68.64 g, 0.50 mol) and 1,4-dioxane (300 ml) were mixed and stirred at 130 ° C. for 18 hours.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 6-chloro-3-phenyl-1H-indole (24.5 g, 수율 65%)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate, followed by removing water with MgSO 4 , and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 6-chloro-3-phenyl-1H-indole ( 24.5 g, yield 65%) was obtained.
1H-NMR: δ 7.10 (dd, 1H), 7.25 (m, 1H), 7.43 (t, 2H), 7.49 (d, 1H), 7.67 (dd, 2H), 7.73 (d, 1H), 7.85 (d, 1H), 11.49 (s, 1H) 1 H-NMR: δ 7.10 (dd, 1H), 7.25 (m, 1H), 7.43 (t, 2H), 7.49 (d, 1H), 7.67 (dd, 2H), 7.73 (d, 1H), 7.85 ( d, 1 H), 11.49 (s, 1 H)
<단계 2> 6-(2-nitrophenyl)-3-phenyl-1H-indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -3-phenyl-1H-indole
Figure PCTKR2013007669-appb-I000085
Figure PCTKR2013007669-appb-I000085
5-bromo-2-phenyl-1H-indole 대신 상기 6-chloro-3-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-3-phenyl-1H-indole을 얻었다.Except for using the 6-chloro-3-phenyl-1H-indole instead of 5-bromo-2-phenyl-1H-indole was carried out the same procedure as in <Step 2> of Preparation Example 20 6- (2 -nitrophenyl) -3-phenyl-1H-indole was obtained.
1H-NMR: δ 7.11 (d, 1H), 7.26 (m, 1H), 7.44 (t, 2H), 7.48 (m, 2H), 7.55 (m, 3H), 7.61 (d, 1H), 7.73 (d, 1H), 8.00 (d, 2H), 11.48 (s, 1H) 1 H-NMR: δ 7.11 (d, 1H), 7.26 (m, 1H), 7.44 (t, 2H), 7.48 (m, 2H), 7.55 (m, 3H), 7.61 (d, 1H), 7.73 ( d, 1H), 8.00 (d, 2H), 11.48 (s, 1H)
<단계 3> 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000086
Figure PCTKR2013007669-appb-I000086
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-3-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole을 얻었다.Except for using 6- (2-nitrophenyl) -3-phenyl-1H-indole instead of 5- (2-nitrophenyl) -1H-indole was carried out in the same manner as in <Step 3> of Preparation Example 6 -(2-nitrophenyl) -1,3-diphenyl-1H-indole was obtained.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)
<단계 4> IC-22의 합성Step 4 Synthesis of IC-22
Figure PCTKR2013007669-appb-I000087
Figure PCTKR2013007669-appb-I000087
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-22를 얻었다.<Step 4> of Preparation Example 1, except that 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole. IC-22 was obtained by performing the same procedure as in the following.
GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (Theoretical value: 358.15 g / mol, Measured value: 358 g / mol)
[준비예 23] IC-23의 합성Preparation Example 23 Synthesis of IC-23
<단계 1> 5-bromo-2,3-diphenyl-1H-indole의 합성<Step 1> Synthesis of 5-bromo-2,3-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000088
Figure PCTKR2013007669-appb-I000088
6-chloro-1H-indole 대신 5-bromo-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 22의 <단계 1>과 동일한 과정을 수행하여 5-bromo-2,3-diphenyl-1H-indole을 얻었다.Except for using 5-bromo-2-phenyl-1H-indole instead of 6-chloro-1H-indole to perform the same process as in <Step 1> of Preparation Example 22 5-bromo-2,3-diphenyl -1 H-indole was obtained.
1H-NMR: δ 7.23 (d, 1H), 7.31 (t, 2H), 7.43 (m, 6H), 7.67 (d, 1H), 7.71 (d, 1H), 7.84 (d, 2H), 11.34 (s, 1H) 1 H-NMR: δ 7.23 (d, 1H), 7.31 (t, 2H), 7.43 (m, 6H), 7.67 (d, 1H), 7.71 (d, 1H), 7.84 (d, 2H), 11.34 ( s, 1 H)
<단계 2> 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -2,3-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000089
Figure PCTKR2013007669-appb-I000089
5-bromo-2-phenyl-1H-indole 대신 상기 5-bromo-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 얻었다.Except for using 5-bromo-2,3-diphenyl-1H-indole instead of 5-bromo-2-phenyl-1H-indole, the same procedure as in <Step 2> of Preparation Example 20 was performed. (2-nitrophenyl) -2,3-diphenyl-1H-indole was obtained.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)
<단계 3> 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole
Figure PCTKR2013007669-appb-I000090
Figure PCTKR2013007669-appb-I000090
5-(2-nitrophenyl)-1H-indole 대신 상기 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 얻었다.Except for using 5- (2-nitrophenyl) -2,3-diphenyl-1H-indole instead of 5- (2-nitrophenyl) -1H-indole, the same procedure as in <Step 3> of Preparation Example 1 was performed. 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole was obtained.
GC-Mass (이론치: 466.17 g/mol, 측정치: 466 g/mol)GC-Mass (Theoretical value: 466.17 g / mol, Measured value: 466 g / mol)
<단계 4> IC-23의 합성Step 4 Synthesis of IC-23
Figure PCTKR2013007669-appb-I000091
Figure PCTKR2013007669-appb-I000091
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-23을 얻었다.<Step of Preparation Example 1 except that 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole IC-23 was obtained by the same procedure as 4>.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (Theoretical value: 434.18 g / mol, Measured value: 434 g / mol)
[준비예 24] IC-24의 합성Preparation Example 24 Synthesis of IC-24
<단계 1> 6-chloro-2,3-diphenyl-1H-indole의 합성<Step 1> Synthesis of 6-chloro-2,3-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000092
Figure PCTKR2013007669-appb-I000092
6-chloro-1H-indole 대신 6-chloro-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 22의 <단계 1>과 동일한 과정을 수행하여 6-chloro-2,3-diphenyl-1H-indole을 얻었다.Except for using 6-chloro-2-phenyl-1H-indole instead of 6-chloro-1H-indole was carried out the same process as in <Step 1> of Preparation Example 22 6-chloro-2,3-diphenyl -1 H-indole was obtained.
1H-NMR: δ 7.18 (d, 1H), 7.29 (t, 2H), 7.50 (m, 6H), 7.62 (d, 1H), 7.75 (d, 1H), 7.89 (d, 2H), 11.35 (s, 1H) 1 H-NMR: δ 7.18 (d, 1H), 7.29 (t, 2H), 7.50 (m, 6H), 7.62 (d, 1H), 7.75 (d, 1H), 7.89 (d, 2H), 11.35 ( s, 1 H)
<단계 2> 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole
Figure PCTKR2013007669-appb-I000093
Figure PCTKR2013007669-appb-I000093
5-bromo-2-phenyl-1H-indole 대신 상기 6-chloro-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 얻었다.Except for using the 6-chloro-2,3-diphenyl-1H-indole instead of 5-bromo-2-phenyl-1H-indole to perform the same process as in <Step 2> of Preparation Example 20 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole was obtained.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)
<단계 3> 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole
Figure PCTKR2013007669-appb-I000094
Figure PCTKR2013007669-appb-I000094
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 얻었다.Except for using 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole instead of 5- (2-nitrophenyl) -1H-indole, the same procedure as in <Step 3> of Preparation Example 1 was performed. To 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole.
GC-Mass (이론치: 466.17 g/mol, 측정치: 466 g/mol)GC-Mass (Theoretical value: 466.17 g / mol, Measured value: 466 g / mol)
<단계 4> IC-24의 합성Step 4 Synthesis of IC-24
Figure PCTKR2013007669-appb-I000095
Figure PCTKR2013007669-appb-I000095
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-24을 얻었다.<Step of Preparation Example 1 except that 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole. IC-24 was obtained by following the same procedure as 4>.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (Theoretical value: 434.18 g / mol, Measured value: 434 g / mol)
[준비예 25] IC-25의 합성Preparation Example 25 Synthesis of IC-25
<단계 1> 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000096
Figure PCTKR2013007669-appb-I000096
질소 기류 하에서 6-(2-nitrophenyl)-1H-indole (10 g, 41.97 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (17.32 g, 50.37 mmol), Pd(OAc)2 (0.47 g, 5 mol%), NaO(t-bu) (8.07 g, 83.95 mmol), P(t-bu)3 (0.85 g, 4.19 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.6- (2-nitrophenyl) -1H-indole (10 g, 41.97 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (17.32 g, 50.37 mmol) under nitrogen stream , Pd (OAc) 2 (0.47 g, 5 mol%), NaO (t-bu) (8.07 g, 83.95 mmol), P (t-bu) 3 (0.85 g, 4.19 mmol) and Toluene (100 ml) Mix and stir at 110 ° C. for 12 h.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole (15.8 g, 수율 69%)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 3: 1 (v / v)), and purified by 1- (3- (4,6-diphenyl-). 1,3,5-triazin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-indole (15.8 g, yield 69%) was obtained.
GC-Mass (이론치: 545.19 g/mol, 측정치: 545 g/mol)GC-Mass (Theoretical value: 545.19 g / mol, Measured value: 545 g / mol)
<단계 2> IC-25의 합성<Step 2> Synthesis of IC-25
Figure PCTKR2013007669-appb-I000097
Figure PCTKR2013007669-appb-I000097
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-25을 얻었다.5- (2-nitrophenyl) -1-phenyl-1H-indole instead of 1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -6- (2-nitrophenyl Except for using) -1H-indole was carried out the same procedure as in <Step 4> of Preparation Example 1 to obtain an IC-25.
GC-Mass (이론치: 513.20 g/mol, 측정치: 513 g/mol)GC-Mass (Theoretical value: 513.20 g / mol, Measured value: 513 g / mol)
[준비예 26] IC-26의 합성Preparation 26 Synthesis of IC-26
<단계 1> 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole의 합성 <Step 1> Synthesis of 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl) -6- (2-nitrophenyl) -1H- indole
Figure PCTKR2013007669-appb-I000098
Figure PCTKR2013007669-appb-I000098
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chloro phenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 준비예 25의 <단계 1>과 동일한 과정을 수행하여 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole을 얻었다.<Step of Preparation Example 25 except that 2- (3-chlorophenyl) -4,6-diphenylpyrimidine was used instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine. 1> was carried out in the same manner to obtain 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-indole.
GC-Mass (이론치: 544.19 g/mol, 측정치: 544 g/mol)GC-Mass (Theoretical value: 544.19 g / mol, Measured value: 544 g / mol)
<단계 2> IC-26의 합성<Step 2> Synthesis of IC-26
Figure PCTKR2013007669-appb-I000099
Figure PCTKR2013007669-appb-I000099
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-26을 얻었다.Using 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole Except for the same procedure as in <Step 4> of Preparation Example 1 to obtain an IC-26.
GC-Mass (이론치: 512.20 g/mol, 측정치: 512 g/mol)GC-Mass (Theoretical value: 512.20 g / mol, Measured value: 512 g / mol)
[준비예 27] IC-27의 합성Preparation 27 Synthesis of IC-27
<단계 1> 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole의 합성 <Step 1> Synthesis of 1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -5- (2- nitrophenyl) -1H-indole
Figure PCTKR2013007669-appb-I000100
Figure PCTKR2013007669-appb-I000100
6-(2-nitrophenyl)-1H-indole 대신 5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 25의 <단계 1>과 동일한 과정을 수행하여 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole을 얻었다.Except for using 5- (2-nitrophenyl) -1H-indole instead of 6- (2-nitrophenyl) -1H-indole, 1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -5- (2-nitrophenyl) -1H-indole was obtained.
GC-Mass (이론치: 545.19 g/mol, 측정치: 545 g/mol)GC-Mass (Theoretical value: 545.19 g / mol, Measured value: 545 g / mol)
<단계 2> IC-27의 합성<Step 2> Synthesis of IC-27
Figure PCTKR2013007669-appb-I000101
Figure PCTKR2013007669-appb-I000101
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-27을 얻었다.5- (2-nitrophenyl) -1-phenyl-1H-indole instead of 1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -5- (2-nitrophenyl Except for using) -1H-indole was carried out the same procedure as in <Step 4> of Preparation Example 1 to obtain an IC-27.
GC-Mass (이론치: 513.20 g/mol, 측정치: 513 g/mol)GC-Mass (Theoretical value: 513.20 g / mol, Measured value: 513 g / mol)
[준비예 28] IC-28의 합성Preparation Example 28 Synthesis of IC-28
<단계 1> 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole의 합성 <Step 1> Synthesis of 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl) -5- (2-nitrophenyl) -1H- indole
Figure PCTKR2013007669-appb-I000102
Figure PCTKR2013007669-appb-I000102
6-(2-nitrophenyl)-1H-indole과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 5-(2-nitrophenyl)-1H-indole과 2-(3-chlorophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 준비예 25의 <단계 1>과 동일한 과정을 수행하여 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole을 얻었다.6- (2-nitrophenyl) -1H-indole and 2- (3 instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl)-was subjected to the same process as in <Step 1> of Preparation Example 25, except that -chlorophenyl) -4,6-diphenylpyrimidine was used. 5- (2-nitrophenyl) -1H-indole was obtained.
GC-Mass (이론치: 544.19 g/mol, 측정치: 544 g/mol)GC-Mass (Theoretical value: 544.19 g / mol, Measured value: 544 g / mol)
<단계 2> IC-28의 합성<Step 2> Synthesis of IC-28
Figure PCTKR2013007669-appb-I000103
Figure PCTKR2013007669-appb-I000103
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-28을 얻었다.Using 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl) -5- (2-nitrophenyl) -1H-indole instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole Except for the same procedure as in <Step 4> of Preparation Example 1 to obtain an IC-28.
GC-Mass (이론치: 512.20 g/mol, 측정치: 512 g/mol)GC-Mass (Theoretical value: 512.20 g / mol, Measured value: 512 g / mol)
[준비예 29] IC-29a 및 IC-29b의 합성 Preparation Example 29 Synthesis of IC-29a and IC-29b
<단계 1> 2-(benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성 Step 1 Synthesis of 2- (benzo [b] thiophen-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Figure PCTKR2013007669-appb-I000104
Figure PCTKR2013007669-appb-I000104
5-bromo-1H-indole 대신 5-bromobenzo[b]thiophene를 사용하는 것을 제외하고는 준비예 1의 <단계 1>과 동일한 과정을 수행하여 2-(benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.Except for using 5-bromobenzo [b] thiophene instead of 5-bromo-1H-indole, 2- (benzo [b] thiophen-5-yl)-was carried out in the same manner as in <Step 1> of Preparation Example 1 4,4,5,5-tetramethyl-1,3,2-dioxaborolane was obtained.
1H NMR: δ 1.24 (s, 12H), 7.65 (d, 1H), 7.85 (d, 1H), 7.98 (d, 1H), 8.07 (d, 1H), 8.12 (s, 1H) 1 H NMR: δ 1.24 (s, 12H), 7.65 (d, 1H), 7.85 (d, 1H), 7.98 (d, 1H), 8.07 (d, 1H), 8.12 (s, 1H)
<단계 2> 5-(2-nitrophenyl)benzo[b]thiophene의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) benzo [b] thiophene
Figure PCTKR2013007669-appb-I000105
Figure PCTKR2013007669-appb-I000105
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 2-(benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)benzo[b]thiophene을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 2- (benzo [b] thiophen-5-yl) -4,4,5 A 5- (2-nitrophenyl) benzo [b] thiophene was obtained in the same manner as in <Step 2> of Preparation Example 1, except that, 5-tetramethyl-1,3,2-dioxaborolane was used.
1H NMR: δ 7.67 (m, 2H), 7.88 (m, 2H), 7.98 (d, 1H), 8.00 (d, 1H), 8.07 (m, 2H), 8.13 (s, 1H) 1 H NMR: δ 7.67 (m, 2H), 7.88 (m, 2H), 7.98 (d, 1H), 8.00 (d, 1H), 8.07 (m, 2H), 8.13 (s, 1H)
<단계 3> IC-29a 및 IC-29b의 합성Step 3 Synthesis of IC-29a and IC-29b
Figure PCTKR2013007669-appb-I000106
Figure PCTKR2013007669-appb-I000106
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)benzo[b]thiophene을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-29a 1.70 g (7.60 mmol, yield : 35 %)과 IC-29b 1.89 g (8.46 mmol, yield : 39%)을 얻었다.The same procedure as in <Step 4> of Preparation Example 1 was performed except that 5- (2-nitrophenyl) benzo [b] thiophene was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole. 1.70 g (7.60 mmol, yield: 35%) of IC-29a and 1.89 g (8.46 mmol, yield: 39%) of IC-29b were obtained.
IC-29a의 1H-NMR : δ 7.29 (t, 1H), 7.59 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.26 (s, 1H) 1 H-NMR of IC-29a: δ 7.29 (t, 1H), 7.59 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.26 (s, 1H)
IC-29b의 1H-NMR : δ 7.29 (t, 1H), 7.53 (m, 2H), 7.81 (m, 3H), 8.12 (m, 2H), 8.25 (s, 1H) 1 H-NMR of IC-29b: δ 7.29 (t, 1H), 7.53 (m, 2H), 7.81 (m, 3H), 8.12 (m, 2H), 8.25 (s, 1H)
[준비예 30] IC-30 의 합성 Preparation Example 30 Synthesis of IC-30
<단계 1> 7-(2-nitrophenyl)benzo[b]thiophene의 합성Step 1 Synthesis of 7- (2-nitrophenyl) benzo [b] thiophene
Figure PCTKR2013007669-appb-I000107
Figure PCTKR2013007669-appb-I000107
질소 기류 하에서 12.2 g (35.2 mmol)의 7-bromobenzo[b]thiophene, 6.44 g (38.7 mmol)의 2-nitrophenylboronic acid, 4.22 g (105.6 mmol)의 NaOH과 300 ml/150 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 2.03 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 7-(2-nitrophenyl)benzo[b]thiophene 7.38 g (28.9 mmol, yield 82 %)을 얻었다.12.2 g (35.2 mmol) of 7-bromobenzo [b] thiophene, 6.44 g (38.7 mmol) of 2-nitrophenylboronic acid, 4.22 g (105.6 mmol) of NaOH and 300 ml / 150 ml of THF / H 2 O under a nitrogen stream Was added and stirred. 2.03 g (5 mol%) of Pd (PPh 3 ) 4 was added at 40 ° C. and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. After removing the solvent of the organic layer was filtered using column chromatography to obtain 7.38 g (28.9 mmol, yield 82%) of 7- (2-nitrophenyl) benzo [b] thiophene.
1H-NMR : δ 7.63 (m, 5H), 7.96 (m, 3H), 8.21 (d, 1H) 1 H-NMR: δ 7.63 (m, 5H), 7.96 (m, 3H), 8.21 (d, 1H)
<단계 2> IC-30 의 합성<Step 2> Synthesis of IC-30
Figure PCTKR2013007669-appb-I000108
Figure PCTKR2013007669-appb-I000108
질소 기류 하에서 상기 7-(2-nitrophenyl)benzo[b]thiophene 5.53 g (21.7 mmol)과 triphenylphosphine 14.2 g (54.2 mmol), 1,2-dichlorobenzene 100 ml를 넣은 후 12시간 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 추출된 유기층은 MgSO4로 물을 제거하고, 컬럼크로마토그래피를 이용하여 IC-30 3.29 g, (14.8 mmol, yield : 68 %)을 얻었다.Under nitrogen stream, 5.53 g (21.7 mmol) of 7- (2-nitrophenyl) benzo [b] thiophene, 14.2 g (54.2 mmol) of triphenylphosphine, and 100 ml of 1,2-dichlorobenzene were added thereto, followed by stirring for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed and extracted with dichloromethane. The extracted organic layer was removed with water with MgSO 4 , and obtained 3.29 g, (14.8 mmol, yield: 68%) of IC-30 by column chromatography.
1H-NMR : δ 7.37 (t, 1H), 7.46 (m, 5H), 7.87 (d, 1H), 8.20 (d, 1H), 8.24 (s, 1H) 1 H-NMR: δ 7.37 (t, 1H), 7.46 (m, 5H), 7.87 (d, 1H), 8.20 (d, 1H), 8.24 (s, 1H)
[준비예 31] IC-31a 및 IC-31b의 합성 Preparation Example 31 Synthesis of IC-31a and IC-31b
<단계 1> 6-(2-nitrophenyl)benzo[b]thiophene의 합성Step 1 Synthesis of 6- (2-nitrophenyl) benzo [b] thiophene
Figure PCTKR2013007669-appb-I000109
Figure PCTKR2013007669-appb-I000109
7-bromobenzo[b]thiophene 대신 6-bromobenzo[b]thiophene 12.2 g (35.2 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 1>과 동일한 과정을 수행하여 6-(2-nitrophenyl)benzo[b]thiophene 7.01 g (27.5 mmol, yield : 78%)을 얻었다.Except for using 12.2 g (35.2 mmol) of 6-bromobenzo [b] thiophene instead of 7-bromobenzo [b] thiophene, 6- (2-nitrophenyl) benzo was prepared in the same manner as in <Step 1> of Preparation Example 30. 7.01 g of [b] thiophene were obtained (27.5 mmol, yield: 78%).
1H-NMR : δ 7.68 (m, 3H), 7.98 (m, 6H) 1 H-NMR: δ 7.68 (m, 3H), 7.98 (m, 6H)
<단계 2> IC-31a과 IC-31b의 합성Step 2 Synthesis of IC-31a and IC-31b
Figure PCTKR2013007669-appb-I000110
Figure PCTKR2013007669-appb-I000110
7-(2-nitrophenyl)benzo[b]thiophene 대신 상기 6-(2-nitrophenyl)benzo[b]thiophene 5.53 g (21.7 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 2>와 동일한 과정을 수행하여 IC-31a 1.60 g (7.16 mmol, yield : 33 %) 과 IC-31b 1.79 g (8.03 mmol, yield : 37%)을 얻었다. The same procedure as in <Step 2> of Preparation Example 30, except that 5.53 g (21.7 mmol) of 6- (2-nitrophenyl) benzo [b] thiophene was used instead of 7- (2-nitrophenyl) benzo [b] thiophene. 1.60 g (7.16 mmol, yield: 33%) of IC-31a and 1.79 g (8.03 mmol, yield: 37%) of IC-31b were obtained.
IC-31a 의 1H-NMR : δ 7.27 (t, 1H), 7.53 (m, 4H), 7.78 (d, 1H), 7.92 (d, 1H), 8.10 (d, 1H), 8.25 (s, 1H) 1 H-NMR of IC-31a: δ 7.27 (t, 1H), 7.53 (m, 4H), 7.78 (d, 1H), 7.92 (d, 1H), 8.10 (d, 1H), 8.25 (s, 1H )
IC-31b 의 1H-NMR : δ 7.29 (t, 1H), 7.63 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.25 (s, 1H) 1 H-NMR of IC-31b: δ 7.29 (t, 1H), 7.63 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.25 (s, 1H)
[준비예 32] IC-32의 합성 Preparation Example 32 Synthesis of IC-32
<단계 1> 4-(2-nitrophenyl)benzo[b]thiophene의 합성<Step 1> Synthesis of 4- (2-nitrophenyl) benzo [b] thiophene
Figure PCTKR2013007669-appb-I000111
Figure PCTKR2013007669-appb-I000111
7-bromobenzo[b]thiophene 대신 4-bromobenzo[b]thiophene 12.2 g (35.2 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 1>과 동일한 과정을 수행하여 4-(2-nitrophenyl)benzo[b]thiophene 7.28 g (28.5 mmol, yield : 81%)을 얻었다.Except for using 12.2 g (35.2 mmol) of 4-bromobenzo [b] thiophene instead of 7-bromobenzo [b] thiophene, 4- (2-nitrophenyl) benzo was subjected to the same procedure as in <Step 1> of Preparation Example 30. 7.28 g (28.5 mmol, yield: 81%) of [b] thiophene were obtained.
1H-NMR : δ 7.68 (m, 4H), 7.89 (m, 3H), 8.01 (m, 2H) 1 H-NMR: δ 7.68 (m, 4H), 7.89 (m, 3H), 8.01 (m, 2H)
<단계 2> IC-32 의 합성<Step 2> Synthesis of IC-32
Figure PCTKR2013007669-appb-I000112
Figure PCTKR2013007669-appb-I000112
7-(2-nitrophenyl)benzo[b]thiophene 대신 상기 4-(2-nitrophenyl)benzo[b]thiophene 5.53 g (21.7 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 2>와 동일한 과정을 수행하여 IC-32 3.05 g (13.7 mmol, yield : 63 %)을 얻었다. The same procedure as in <Step 2> of Preparation Example 30, except that 5.53 g (21.7 mmol) of 4- (2-nitrophenyl) benzo [b] thiophene was used instead of 7- (2-nitrophenyl) benzo [b] thiophene. This yielded 3.05 g (13.7 mmol, yield: 63%) of IC-32.
1H-NMR : δ 7.31 (m, 2H), 7.73 (m, 4H), 7.96 (d, 1H), 8.10 (d, 1H), 8.26 (s, 1H) 1 H-NMR: δ 7.31 (m, 2H), 7.73 (m, 4H), 7.96 (d, 1H), 8.10 (d, 1H), 8.26 (s, 1H)
[준비예 33] IC-33의 합성Preparation 33 Synthesis of IC-33
<단계 1> 4-(2-isopropylphenyl)-1H-indole의 합성<Step 1> Synthesis of 4- (2-isopropylphenyl) -1H-indole
Figure PCTKR2013007669-appb-I000113
Figure PCTKR2013007669-appb-I000113
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하고 1-bromo-2-nitrobenzene 대신 1-bromo-2-isopropylbenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-isopropylphenyl)-1H-indole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan Except for using 2-yl) -1H-indole and using 1-bromo-2-isopropylbenzene instead of 1-bromo-2-nitrobenzene, the same procedure as in <Step 2> of Preparation Example 1 was performed. (2-isopropylphenyl) -1H-indole was obtained.
1H NMR: δ 1.21 (s, 6H), 2.87 (m, 1H), 6.43 (d, 1H), 7.26 (t, 1H), 7.35 (m, 3H), 7.48 (d, 1H), 7.74 (m, 2H), 7.85 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 1.21 (s, 6H), 2.87 (m, 1H), 6.43 (d, 1H), 7.26 (t, 1H), 7.35 (m, 3H), 7.48 (d, 1H), 7.74 (m , 2H), 7.85 (d, 1H), 8.23 (s, 1H)
<단계 2> IC-33의 합성<Step 2> Synthesis of IC-33
Figure PCTKR2013007669-appb-I000114
Figure PCTKR2013007669-appb-I000114
질소 기류 하에서 상기 4-(2-isopropylphenyl)-1H-indole(5 g, 21.25 mmol)과 RhCl(PPh3)3(98.3 mg, 0.5 mol%)를 1,4-dioxane 50 ml에 녹인 다음 135℃에서 1시간 동안 교반하였다. Dissolve the 4- (2-isopropylphenyl) -1H-indole (5 g, 21.25 mmol) and RhCl (PPh 3 ) 3 (98.3 mg, 0.5 mol%) in 50 ml of 1,4-dioxane under nitrogen stream, and then 135 ° C. Stirred for 1 h.
반응 종결 후 용매를 제거하고 컬럼크로마토그래피 (Hexane:MC = 3:1 (v:v))로 정제하여 IC-33 (4 g, 수율 81%)을 얻었다.After completion of the reaction, the solvent was removed and purified by column chromatography (Hexane: MC = 3: 1 (v: v)) to obtain IC-33 (4 g, 81% yield).
1H NMR: δ 1.20 (s, 6H), 6.45 (d, 1H), 7.25 (d, 1H), 7.37 (m, 3H), 7.49 (d, 1H), 7.75 (d, 1H), 7.86 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 1.20 (s, 6H), 6.45 (d, 1H), 7.25 (d, 1H), 7.37 (m, 3H), 7.49 (d, 1H), 7.75 (d, 1H), 7.86 (d , 1H), 8.22 (s, 1H)
[준비예 34] IC-34의 합성Preparation 34 Synthesis of IC-34
<단계 1> 4-(2-benzhydrylphenyl)-1H-indole의 합성<Step 1> Synthesis of 4- (2-benzhydrylphenyl) -1H-indole
Figure PCTKR2013007669-appb-I000115
Figure PCTKR2013007669-appb-I000115
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하고 1-bromo-2-nitrobenzene 대신 (2-bromophenyl)methylene)dibenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-benzhydrylphenyl)-1H-indole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan Except for using 2-yl) -1H-indole and using (2-bromophenyl) methylene) dibenzene instead of 1-bromo-2-nitrobenzene, the same procedure as in <Step 2> of Preparation Example 1 was performed. -(2-benzhydrylphenyl) -1H-indole was obtained.
1H NMR: δ 2.88 (m, 1H), 6.44 (d, 1H), 7.27 (m, 6H), 7.34 (m, 8H), 7.47 (d, 1H), 7.75 (m, 2H), 7.86 (d, 1H), 8.21 (s, 1H) 1 H NMR: δ 2.88 (m, 1H), 6.44 (d, 1H), 7.27 (m, 6H), 7.34 (m, 8H), 7.47 (d, 1H), 7.75 (m, 2H), 7.86 (d , 1H), 8.21 (s, 1H)
<단계 2> IC-34의 합성<Step 2> Synthesis of IC-34
Figure PCTKR2013007669-appb-I000116
Figure PCTKR2013007669-appb-I000116
4-(2-isopropylphenyl)-1H-indole 대신 상기 4-(2-benzhydrylphenyl)-1H-indole을 사용하여 준비예 33의 <단계 2>와 동일한 과정을 수행하여 IC-34을 얻었다.IC-34 was obtained by the same procedure as in <Step 2> of Preparation Example 33 using the 4- (2-benzhydrylphenyl) -1H-indole instead of 4- (2-isopropylphenyl) -1H-indole.
1H NMR: δ 6.43 (d, 1H), 7.26 (m, 5H), 7.34 (m, 8H), 7.46 (d, 1H), 7.76 (m, 2H), 7.85 (d, 1H), 8.20 (s, 1H) 1 H NMR: δ 6.43 (d, 1H), 7.26 (m, 5H), 7.34 (m, 8H), 7.46 (d, 1H), 7.76 (m, 2H), 7.85 (d, 1H), 8.20 (s , 1H)
[준비예 35] IC-35 의 합성Preparation 35 Synthesis of IC-35
<단계 1> 6-(2-bromophenyl)-7-chloro-1H-indole의 합성Step 1 Synthesis of 6- (2-bromophenyl) -7-chloro-1H-indole
Figure PCTKR2013007669-appb-I000117
Figure PCTKR2013007669-appb-I000117
질소 기류 하에서 9.13 g (39.6 mmol)의 6-bromo-7-chloro-1H-indole, 9.54 g (47.5 mmol)의 2-bromophenylboronic acid, 4.75 g (118.8 mmol)의 NaOH과 200 ml/100 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 2.29 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 6-(2-bromophenyl)-7-chloro-1H-indole 8.86 g (28.9 mmol, yield: 73 %)을 얻었다.9.13 g (39.6 mmol) of 6-bromo-7-chloro-1H-indole, 9.54 g (47.5 mmol) of 2-bromophenylboronic acid, 4.75 g (118.8 mmol) of NaOH and 200 ml / 100 ml of THF under nitrogen stream / H 2 O was added and stirred. 2.29 g (5 mol%) of Pd (PPh 3 ) 4 was added at 40 ° C. and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give 8.86 g (28.9 mmol, yield: 73%) of 6- (2-bromophenyl) -7-chloro-1H-indole.
1H-NMR : δ 6.45 (d, 1H), 7.35 (m, 3H), 7.74 (m, 3H), 8.06 (d, 1H), 8.64 (s, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.35 (m, 3H), 7.74 (m, 3H), 8.06 (d, 1H), 8.64 (s, 1H)
<단계 2> ethyl 3-(2-(7-chloro-1H-indol-6-yl)phenylthio)propanoate의 합성<Step 2> Synthesis of ethyl 3- (2- (7-chloro-1H-indol-6-yl) phenylthio) propanoate
Figure PCTKR2013007669-appb-I000118
Figure PCTKR2013007669-appb-I000118
질소 기류 하에서 7.45 g (24.3 mmol)의 6-(2-bromophenyl)-7-chloro-1H-indole, 3.59 g (26.77 mmol)의 ethyl 3-mercaptopropanoate, 167 mg (0.18 mmol)의 Pd2dba3, 197 mg (0.37 mmol)의 dpephos, 8.4 g (61 mmol)의 K2CO3를 100 ml의 Toluene에 넣고 110℃에서 15시간 교반하였다.7.45 g (24.3 mmol) of 6- (2-bromophenyl) -7-chloro-1H-indole, 3.59 g (26.77 mmol) of ethyl 3-mercaptopropanoate, 167 mg (0.18 mmol) of Pd 2 dba 3 , under a nitrogen stream 197 mg (0.37 mmol) of dpephos and 8.4 g (61 mmol) of K 2 CO 3 were added to 100 ml of Toluene and stirred at 110 ° C. for 15 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 ethyl 3-(2-(7-chloro-1H-indol-6-yl)phenylthio)propanoate 6.38 g (17.7 mmol, yield: 72 %)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer, 6.38 g (17.7 mmol, yield: 72%) of ethyl 3- (2- (7-chloro-1H-indol-6-yl) phenylthio) propanoate was obtained by column chromatography.
1H-NMR : δ 1.29 (t, 3H), 2.58 (t, 2H), 3.12 (t, 2H), 4.12 (q, 2H), 6.25 (d, 1H), 7.37 (m, 4H), 7.70 (m, 2H), 8.06 (d, 1H), 8.60 (s, 1H) 1 H-NMR: δ 1.29 (t, 3H), 2.58 (t, 2H), 3.12 (t, 2H), 4.12 (q, 2H), 6.25 (d, 1H), 7.37 (m, 4H), 7.70 ( m, 2H), 8.06 (d, 1H), 8.60 (s, 1H)
<단계 3> IC-35의 합성<Step 3> Synthesis of IC-35
Figure PCTKR2013007669-appb-I000119
Figure PCTKR2013007669-appb-I000119
질소 기류 하에서 6.34 g (15.4 mmol)의 ethyl 3-(2-(7-chloro-1H-indol-6-yl)phenylthio)propanoate, 2.60 g (23.2 mmol)의 potassium tert-butoxide를 100 ml의 THF에 넣고 50℃에서 8시간 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 IC-35 2.30 g (10.3 mmol, yield: 67 %)을 얻었다.Under nitrogen stream, 6.34 g (15.4 mmol) ethyl 3- (2- (7-chloro-1H-indol-6-yl) phenylthio) propanoate, 2.60 g (23.2 mmol) potassium tert-butoxide were added to 100 ml THF. The mixture was stirred at 50 ° C. for 8 hours. After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using a column chromatography to obtain 2.30 g (10.3 mmol, yield: 67%) IC-35.
1H-NMR : δ 6.44 (d, 1H), 7.25 (d, 1H), 7.51 (m, 3H), 8.00 (m, 2H), 8.40 (d, 1H), 8.63 (s, 1H) 1 H-NMR: δ 6.44 (d, 1H), 7.25 (d, 1H), 7.51 (m, 3H), 8.00 (m, 2H), 8.40 (d, 1H), 8.63 (s, 1H)
[준비예 36] IC-36의 합성Preparation 36 Synthesis of IC-36
<단계 1> 2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성Step 1 Synthesis of 2- (benzofuran-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Figure PCTKR2013007669-appb-I000120
Figure PCTKR2013007669-appb-I000120
질소 기류 하에서 5-bromobenzofuran (25 g, 0.126 mol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (38.67 g, 0.152 mol), Pd(dppf)Cl2 (3.11 g, 3 mol%), KOAc (37.36 g, 0.381 mol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.5-bromobenzofuran (25 g, 0.126 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane under nitrogen stream ) (38.67 g, 0.152 mol), Pd (dppf) Cl 2 (3.11 g, 3 mol%), KOAc (37.36 g, 0.381 mol) and 1,4-dioxane (500 ml) were mixed and 12 hours at 130 ° C. Was stirred.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (23.23 g, 수율 75%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to give 2- (benzofuran-5-yl) -4, 4,5,5-tetramethyl-1,3,2-dioxaborolane (23.23 g, yield 75%) was obtained.
1H-NMR: δ 1.25 (s, 12H), 6.46 (d, 1H), 7.28 (d, 1H), 7.43 (d, 1H), 7.53 (d, 1H), 7.98 (s, 1H) 1 H-NMR: δ 1.25 (s, 12H), 6.46 (d, 1H), 7.28 (d, 1H), 7.43 (d, 1H), 7.53 (d, 1H), 7.98 (s, 1H)
<단계 2> 5-(2-nitrophenyl)benzofuran의 합성Step 2 Synthesis of 5- (2-nitrophenyl) benzofuran
Figure PCTKR2013007669-appb-I000121
Figure PCTKR2013007669-appb-I000121
질소 기류 하에서 1-bromo-2-nitrobenzene (15.86 g, 78.52 mmol)과 상기 2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (23 g, 94.23 mmol), K2CO3 (32.56 g, 235.57 mmol) 및 1,4-dioxane/H2O(400 ml/200 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(4.54 g, 5 mol%)를 넣고 110℃에서 12시간 동안 교반하였다. 1-bromo-2-nitrobenzene (15.86 g, 78.52 mmol) and 2- (benzofuran-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (23 g, 94.23 mmol), K 2 CO 3 (32.56 g, 235.57 mmol) and 1,4-dioxane / H 2 O (400 ml / 200 ml) were mixed and then Pd (PPh 3 ) 4 (4.54 g, 5 mol%) was added and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)benzofuran (12.40 g, 수율 66%)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the organic layer obtained was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to give 5- (2-nitrophenyl) benzofuran (12.40 g, 66% yield).
1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 (s, 1H), 8.01 (d, 1H), 8.06 (t, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 ( s, 1H), 8.01 (d, 1H), 8.06 (t, 1H)
<단계 3> IC-36의 합성Step 3 Synthesis of IC-36
Figure PCTKR2013007669-appb-I000122
Figure PCTKR2013007669-appb-I000122
질소 기류 하에서 상기 5-(2-nitrophenyl)benzofuran (10 g, 41.80 mmol), triphenylphosphine (27.41 g, 104.50 mmol) 및 1,2-dichlorobenzene (150 ml)를 혼합하고 12시간 동안 교반하였다.The 5- (2-nitrophenyl) benzofuran (10 g, 41.80 mmol), triphenylphosphine (27.41 g, 104.50 mmol) and 1,2-dichlorobenzene (150 ml) were mixed and stirred for 12 hours under a nitrogen stream.
반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane:MC=3:1 (v/v))로 정제하여 IC-36 (4.76 g, 수율 55%)을 얻었다.After the reaction was completed, 1,2-dichlorobenzene was removed and extracted with dichloromethane. Water was removed with MgSO 4, and the organic layer was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain IC-36 (4.76 g, 55% yield).
1H-NMR: δ 6.51 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 (d, 1H), 8.05 (t, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.51 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 ( d, 1H), 8.05 (t, 1H), 10.58 (s, 1H)
[준비예 37] IC-37의 합성Preparation Example 37 Synthesis of IC-37
<단계 1> 2-(benzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성 Step 1 Synthesis of 2- (benzofuran-6-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Figure PCTKR2013007669-appb-I000123
Figure PCTKR2013007669-appb-I000123
5-bromobenzofuran 대신 6-bromobenzofuran을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 2-(benzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.Except for using 6-bromobenzofuran instead of 5-bromobenzofuran was carried out the same process as in <Step 1> of Preparation Example 1 2- (benzofuran-6-yl) -4,4,5,5-tetramethyl-1 , 3,2-dioxaborolane was obtained.
1H-NMR: δ 1.25 (s, 12H), 6.46 (d, 1H), 7.28 (d, 1H), 7.43 (d, 1H), 7.53 (d, 1H), 7.98 (s, 1H) 1 H-NMR: δ 1.25 (s, 12H), 6.46 (d, 1H), 7.28 (d, 1H), 7.43 (d, 1H), 7.53 (d, 1H), 7.98 (s, 1H)
<단계 2> 6-(2-nitrophenyl)benzofuran의 합성Step 2 Synthesis of 6- (2-nitrophenyl) benzofuran
Figure PCTKR2013007669-appb-I000124
Figure PCTKR2013007669-appb-I000124
2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 상기 2-(benzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)benzofuran을 얻었다.2- (benzofuran-6-yl) -4,4,5,5-tetramethyl-1 instead of 2- (benzofuran-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane A 6- (2-nitrophenyl) benzofuran was obtained in the same manner as in <Step 2> of Preparation Example 36, except that 3,2-dioxaborolane was used.
1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 (s, 1H), 8.01 (d, 1H), 8.06 (t, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 ( s, 1H), 8.01 (d, 1H), 8.06 (t, 1H)
<단계 3> IC-37의 합성Step 3 Synthesis of IC-37
Figure PCTKR2013007669-appb-I000125
Figure PCTKR2013007669-appb-I000125
5-(2-nitrophenyl)benzofuran 대신 6-(2-nitrophenyl)benzofuran을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 3>과 동일한 과정을 수행하여 IC-37를 얻었다.IC-37 was obtained by the same procedure as <Step 3> of Preparation Example 36, except that 6- (2-nitrophenyl) benzofuran was used instead of 5- (2-nitrophenyl) benzofuran.
1H-NMR: δ 6.51 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 (d, 1H), 8.05 (t, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.51 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 ( d, 1H), 8.05 (t, 1H), 10.58 (s, 1H)
[준비예 38] IC-38의 합성Preparation 38 Synthesis of IC-38
<단계 1> dibenzo[b,d]furan-3-amine의 합성<Step 1> Synthesis of dibenzo [b, d] furan-3-amine
Figure PCTKR2013007669-appb-I000126
Figure PCTKR2013007669-appb-I000126
질소 기류 하에서 3-bromodibenzo[b,d]furan (7.41 g, 30.0 mmol)을 THF 100 ml 에 녹인 후, 28 % aqueous ammonia (10.2 ml, 150 mmol) 과 Cu (0.10 g, 5 mol%)를 넣고, 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA=10:1 (v/v))로 정제하여 dibenzo[b,d]furan-3-amine 4.45 g (yield : 81%)을 얻었다.Dissolve 3-bromodibenzo [b, d] furan (7.41 g, 30.0 mmol) in THF 100 ml under nitrogen stream, add 28% aqueous ammonia (10.2 ml, 150 mmol) and Cu (0.10 g, 5 mol%). And stirred at 110 ° C. for 12 h. After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. The solvent of the filtered organic layer was removed and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 4.45 g (yield: 81%) of dibenzo [b, d] furan-3-amine.
1H-NMR: δ 5.32 (s, 2H), 6.33 (d, 1H), 7.34 (m, 2H), 7.43 (s, 1H), 7.65 (d, 2H), 7.89 (d, 1H) 1 H-NMR: δ 5.32 (s, 2H), 6.33 (d, 1H), 7.34 (m, 2H), 7.43 (s, 1H), 7.65 (d, 2H), 7.89 (d, 1H)
<단계 2> IC-38의 합성Step 2 Synthesis of IC-38
Figure PCTKR2013007669-appb-I000127
Figure PCTKR2013007669-appb-I000127
질소 기류 하에서 dibenzo[b,d]furan-3-amine (4.45 g, 24.29 mmol)을 H2O/dioxane (10 ml / 90 ml) 에 녹인 후, triethanolammonium chloride (0.45 g, 2.43 mmol) 과 RuCl3`H2O (0.055 g, 0.2 mmol)과 PPh3 (0.191 g, 0.7 mmol), SnCl2`2H2O (0.548 g, 2.43 mmol)을 넣고, 180℃에서 20시간 동안 교반하였다. 반응 종결 후 aqueous 5% HCl 에 반응물을 붓고, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피(Hexane:MC=1:1 (v/v))로 정제하여 IC-38 2.7 g (yield : 53%)을 얻었다.Dibenzo [b, d] furan-3-amine (4.45 g, 24.29 mmol) was dissolved in H 2 O / dioxane (10 ml / 90 ml) under a stream of nitrogen, followed by triethanolammonium chloride (0.45 g, 2.43 mmol) and RuCl 3 ` H 2 O (0.055 g, 0.2 mmol), PPh 3 (0.191 g, 0.7 mmol) and SnCl 2` 2H 2 O (0.548 g, 2.43 mmol) were added thereto, followed by stirring at 180 ° C. for 20 hours. After completion of the reaction, the reaction mixture was poured into aqueous 5% HCl, extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to give 2.7 g (yield: 53%) of IC-38.
1H-NMR: δ 6.45 (d, 1H), 7.13 (d, 1H), 7.27 (d, 1H), 7.35 (m, 2H), 7.66 (d, 1H), 7.88 (d, 2H), 10.46 (s, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.13 (d, 1H), 7.27 (d, 1H), 7.35 (m, 2H), 7.66 (d, 1H), 7.88 (d, 2H), 10.46 ( s, 1 H)
[준비예 39] IC-39의 합성Preparation 39 Synthesis of IC-39
<단계 1> 5,5-dimethyl-5H-dibenzo[b,d]silol-3-amine의 합성Step 1 Synthesis of 5,5-dimethyl-5H-dibenzo [b, d] silol-3-amine
Figure PCTKR2013007669-appb-I000128
Figure PCTKR2013007669-appb-I000128
3-bromodibenzo[b,d]furan 대신 3-bromo-5,5-dimethyl-5H-dibenzo[b,d] silole을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 1>과 동일한 과정을 수행하여 5,5-dimethyl-5H-dibenzo[b,d]silol-3-amine을 얻었다.The same procedure as in <Step 1> of Preparation Example 38 was performed except that 3-bromo-5,5-dimethyl-5H-dibenzo [b, d] silole was used instead of 3-bromodibenzo [b, d] furan. To 5,5-dimethyl-5H-dibenzo [b, d] silol-3-amine.
1H-NMR: δ 0.68 (s, 6H), 5.31 (s, 2H), 6.68 (d, 1H), 6.80 (s, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 (t, 1H), 7.64 (d, 1H), 7.91 (d, 1H) 1 H-NMR: δ 0.68 (s, 6H), 5.31 (s, 2H), 6.68 (d, 1H), 6.80 (s, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 ( t, 1H), 7.64 (d, 1H), 7.91 (d, 1H)
<단계 2> IC-39의 합성<Step 2> Synthesis of IC-39
Figure PCTKR2013007669-appb-I000129
Figure PCTKR2013007669-appb-I000129
dibenzo[b,d]furan-3-amine 대신 상기 5,5-dimethyl-5H-dibenzo[b,d]silol-3-amine을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 2>과 동일한 과정을 수행하여 IC-39를 얻었다.Except for using 5,5-dimethyl-5H-dibenzo [b, d] silol-3-amine instead of dibenzo [b, d] furan-3-amine, the same as in <Step 2> of Preparation Example 38 The procedure was followed to obtain IC-39.
1H-NMR: δ0.66 (s, 6H), 6.45 (d, 1H), 7.27 (d, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 (t, 1H), 7.79 (d, 1H), 7.89 (d, 1H), 7.97 (d, 1H), 10.42 (s, 1H) 1 H-NMR: δ 0.66 (s, 6H), 6.45 (d, 1H), 7.27 (d, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 (t, 1H), 7.79 (d, 1H), 7.89 (d, 1H), 7.97 (d, 1H), 10.42 (s, 1H)
[준비예 40] IC-40의 합성Preparation 40 Synthesis of IC-40
<단계 1> 5,5-diphenyl-5H-dibenzo[b,d]silol-3-amine의 합성Step 1 Synthesis of 5,5-diphenyl-5H-dibenzo [b, d] silol-3-amine
Figure PCTKR2013007669-appb-I000130
Figure PCTKR2013007669-appb-I000130
3-bromodibenzo[b,d]furan 대신 3-bromo-5,5-diphenyl-5H-dibenzo[b,d] silole을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 1>과 동일한 과정을 수행하여 5,5-diphenyl-5H-dibenzo[b,d]silol-3-amine을 얻었다.The same procedure as in <Step 1> of Preparation Example 38 was performed except that 3-bromo-5,5-diphenyl-5H-dibenzo [b, d] silole was used instead of 3-bromodibenzo [b, d] furan. To 5,5-diphenyl-5H-dibenzo [b, d] silol-3-amine.
1H-NMR: δ 5.33 (s, 2H), 6.67 (d, 1H), 6.81 (s, 1H), 7.31 (t, 1H), 7.37 (m, 4H), 7.46 (m, 4H), 7.54 (m, 3H), 7.62 (t, 1H), 7.66 (d, 1H), 7.92 (d, 1H) 1 H-NMR: δ 5.33 (s, 2H), 6.67 (d, 1H), 6.81 (s, 1H), 7.31 (t, 1H), 7.37 (m, 4H), 7.46 (m, 4H), 7.54 ( m, 3H), 7.62 (t, 1H), 7.66 (d, 1H), 7.92 (d, 1H)
<단계 2> IC-40의 합성<Step 2> Synthesis of IC-40
Figure PCTKR2013007669-appb-I000131
Figure PCTKR2013007669-appb-I000131
dibenzo[b,d]furan-3-amine 대신 상기 5,5-diphenyl-5H-dibenzo[b,d]silol-3-amine을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 2>과 동일한 과정을 수행하여 IC-40을 얻었다.Except for using the 5,5-diphenyl-5H-dibenzo [b, d] silol-3-amine instead of dibenzo [b, d] furan-3-amine, the same as in <Step 2> of Preparation Example 38 The procedure was followed to obtain IC-40.
1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.35 (m, 5H), 7.47 (m, 4H), 7.53 (m, 3H), 7.62 (t, 1H), 7.78 (d, 1H), 7.90 (d, 1H), 7.96 (d, 1H), 10.41 (s, 1H) 1 H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.35 (m, 5H), 7.47 (m, 4H), 7.53 (m, 3H), 7.62 (t, 1H), 7.78 ( d, 1H), 7.90 (d, 1H), 7.96 (d, 1H), 10.41 (s, 1H)
[준비예 41] IC-41의 합성Preparation Example 41 Synthesis of IC-41
Figure PCTKR2013007669-appb-I000132
Figure PCTKR2013007669-appb-I000132
dibenzo[b,d]furan-3-amine 대신 dibenzo[b,d]selenophen-3-amine을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 2>과 동일한 과정을 수행하여 IC-41을 얻었다.Except for using dibenzo [b, d] selenophen-3-amine instead of dibenzo [b, d] furan-3-amine, IC-41 was obtained by the same procedure as in <Step 2> of Preparation Example 38 above. .
1H-NMR: δ 6.47 (d, 1H), 7.15 (d, 1H), 7.26 (d, 1H), 7.36 (m, 2H), 7.67 (d, 1H), 7.89 (d, 2H), 10.45 (s, 1H) 1 H-NMR: δ 6.47 (d, 1H), 7.15 (d, 1H), 7.26 (d, 1H), 7.36 (m, 2H), 7.67 (d, 1H), 7.89 (d, 2H), 10.45 ( s, 1 H)
[준비예 42] IC-42의 합성Preparation Example 42 Synthesis of IC-42
<단계 1> 2-(benzo[b]selenophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성Step 1 Synthesis of 2- (benzo [b] selenophen-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Figure PCTKR2013007669-appb-I000133
Figure PCTKR2013007669-appb-I000133
5-bromobenzofuran 대신 5-bromobenzo[b]selenophene을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 1>과 동일한 과정을 수행하여 2-(benzo[b]selenophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.Except for using 5-bromobenzo [b] selenophene instead of 5-bromobenzofuran, the same procedure as in <Step 1> of Preparation Example 36 was carried out to give 2- (benzo [b] selenophen-5-yl) -4,4 , 5,5-tetramethyl-1,3,2-dioxaborolane was obtained.
1H-NMR: δ 1.26 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 8.00 (s, 1H) 1 H-NMR: δ 1.26 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 8.00 (s, 1H)
<단계 2> 5-(2-nitrophenyl)benzo[b]selenophene의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) benzo [b] selenophene
Figure PCTKR2013007669-appb-I000134
Figure PCTKR2013007669-appb-I000134
2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 상기 2-(benzo[b]selenophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)benzo[b]selenophene을 얻었다.2- (benzo [b] selenophen-5-yl) -4,4,5,5 instead of 2- (benzofuran-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane A 5- (2-nitrophenyl) benzo [b] selenophene was obtained by following the same procedure as in <Step 2> of Preparation Example 36, except that -tetramethyl-1,3,2-dioxaborolane was used.
1H-NMR: δ 6.44 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.51 (d, 1H), 7.65 (t, 1H), 7.84 (t, 1H), 7.94 (s, 1H), 8.00 (d, 1H), 8.05 (t, 1H) 1 H-NMR: δ 6.44 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.51 (d, 1H), 7.65 (t, 1H), 7.84 (t, 1H), 7.94 ( s, 1H), 8.00 (d, 1H), 8.05 (t, 1H)
<단계 3> IC-42의 합성Step 3 Synthesis of IC-42
Figure PCTKR2013007669-appb-I000135
Figure PCTKR2013007669-appb-I000135
5-(2-nitrophenyl)benzofuran 대신 5-(2-nitrophenyl)benzo[b]selenophene 을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 3>과 동일한 과정을 수행하여 IC-42를 얻었다.IC-42 was obtained by the same procedure as <Step 3> of Preparation Example 36, except that 5- (2-nitrophenyl) benzo [b] selenophene was used instead of 5- (2-nitrophenyl) benzofuran.
1H-NMR: δ 6.52 (d, 1H), 7.26 (d, 1H), 7.44 (d, 1H), 7.55 (d, 1H), 7.69 (t, 1H), 7.85 (t, 1H), 7.96 (d, 1H), 8.03 (t, 1H), 10.56 (s, 1H) 1 H-NMR: δ 6.52 (d, 1H), 7.26 (d, 1H), 7.44 (d, 1H), 7.55 (d, 1H), 7.69 (t, 1H), 7.85 (t, 1H), 7.96 ( d, 1H), 8.03 (t, 1H), 10.56 (s, 1H)
[준비예 43] IC-43의 합성Preparation Example 43 Synthesis of IC-43
<단계 1> 2-(benzo[b]selenophen-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성Step 1 Synthesis of 2- (benzo [b] selenophen-6-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Figure PCTKR2013007669-appb-I000136
Figure PCTKR2013007669-appb-I000136
5-bromobenzofuran 대신 6-bromobenzo[b]selenophene을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 1>과 동일한 과정을 수행하여 2-(benzo[b]selenophen-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.Except for using 6-bromobenzo [b] selenophene instead of 5-bromobenzofuran, the same procedure as in <Step 1> of Preparation Example 36 was carried out to give 2- (benzo [b] selenophen-6-yl) -4,4 , 5,5-tetramethyl-1,3,2-dioxaborolane was obtained.
1H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.28 (d, 1H), 7.44 (d, 1H), 7.57 (d, 1H), 7.96 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.28 (d, 1H), 7.44 (d, 1H), 7.57 (d, 1H), 7.96 (s, 1H)
<단계 2> 6-(2-nitrophenyl)benzo[b]selenophene의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) benzo [b] selenophene
Figure PCTKR2013007669-appb-I000137
Figure PCTKR2013007669-appb-I000137
2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 2-(benzo[b]selenophen-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)benzo[b]selenophene을 얻었다.2- (benzo [b] selenophen-6-yl) -4,4,5,5- instead of 2- (benzofuran-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane A 6- (2-nitrophenyl) benzo [b] selenophene was obtained by following the same procedure as in <Step 2> of Preparation Example 36, except that tetramethyl-1,3,2-dioxaborolane was used.
1H-NMR: δ 6.46 (d, 1H), 7.26 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.67 (t, 1H), 7.86 (t, 1H), 7.93 (s, 1H), 8.02 (d, 1H), 8.08 (t, 1H) 1 H-NMR: δ 6.46 (d, 1H), 7.26 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.67 (t, 1H), 7.86 (t, 1H), 7.93 ( s, 1H), 8.02 (d, 1H), 8.08 (t, 1H)
<단계 3> IC-43의 합성Step 3 Synthesis of IC-43
Figure PCTKR2013007669-appb-I000138
Figure PCTKR2013007669-appb-I000138
5-(2-nitrophenyl)benzofuran 대신 6-(2-nitrophenyl)benzo[b]selenophene 을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 3>과 동일한 과정을 수행하여 IC-43를 얻었다.Except for using 6- (2-nitrophenyl) benzo [b] selenophene instead of 5- (2-nitrophenyl) benzofuran IC-43 was obtained by the same procedure as in <Step 3> of Preparation Example 36.
1H-NMR: δ 6.52 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.52 (d, 1H), 7.67 (t, 1H), 7.85 (t, 1H), 8.01 (d, 1H), 8.09 (t, 1H), 10.55 (s, 1H) 1 H-NMR: δ 6.52 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.52 (d, 1H), 7.67 (t, 1H), 7.85 (t, 1H), 8.01 ( d, 1H), 8.09 (t, 1H), 10.55 (s, 1H)
[합성예 1] Inv-1의 합성Synthesis Example 1 Synthesis of Inv-1
Figure PCTKR2013007669-appb-I000139
Figure PCTKR2013007669-appb-I000139
질소 기류 하에서 IC-1 (3 g, 10.63 mmol), 3-bromobiphenyl (3.72 g, 15.94 mmol), Cu powder (0.07 g, 1.06 mmol), K2CO3 (1.47 g, 10.63 mmol), Na2SO4 (1.51 g, 10.63 mmol), nitrobenzene (100 ml)를 혼합하고 200℃에서 24시간 동안 교반하였다. IC-1 (3 g, 10.63 mmol), 3-bromobiphenyl (3.72 g, 15.94 mmol), Cu powder (0.07 g, 1.06 mmol), K 2 CO 3 (1.47 g, 10.63 mmol), Na 2 SO under a nitrogen stream. 4 (1.51 g, 10.63 mmol) and nitrobenzene (100 ml) were mixed and stirred at 200 ° C. for 24 hours.
반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 1:1 (v/v))로 정제하여 목적 화합물인 Inv-1 (2.26 g, 수율 49 %)을 얻었다. After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removing the solvent in the organic layer was removed from water and purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to give the title compound Inv-1 (2.26 g, yield 49%).
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (Theoretical value: 434.18 g / mol, Measured value: 434 g / mol)
[합성예 2] Inv-2의 합성Synthesis Example 2 Synthesis of Inv-2
Figure PCTKR2013007669-appb-I000140
Figure PCTKR2013007669-appb-I000140
3-bromobiphenyl 대신 3-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-2 (2.13 g, 46 %)를 얻었다.Inv-2 (2.13 g, 46%) was obtained by the same procedure as in Synthesis Example 1, except that 3- (4-bromophenyl) pyridine was used instead of 3-bromobiphenyl.
GC-Mass (이론치: 435.17 g/mol, 측정치: 435.17 g/mol)GC-Mass (Theoretical value: 435.17 g / mol, Measured value: 435.17 g / mol)
[합성예 3] Inv-3의 합성Synthesis Example 3 Synthesis of Inv-3
Figure PCTKR2013007669-appb-I000141
Figure PCTKR2013007669-appb-I000141
질소 기류 하에서 IC-1 (3 g, 10.63 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.38 g, 12.75 mmol), Pd(OAc)2 (0.12 g, 5 mol%), NaO(t-bu) (2.04 g, 21.25 mmol), P(t-bu)3 (0.21 g, 1.06 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.IC-1 (3 g, 10.63 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.38 g, 12.75 mmol), Pd (OAc) 2 (0.12) under nitrogen stream g, 5 mol%), NaO (t-bu) (2.04 g, 21.25 mmol), P (t-bu) 3 (0.21 g, 1.06 mmol) and Toluene (100 ml) were mixed and stirred at 110 ° C. for 12 hours. Stirred.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 목적 화합물인 Inv-3 (4.89 g, 수율 78 %)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , and purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain Inv-3 (4.89 g, yield 78). %) Was obtained.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 4] Inv-4의 합성Synthesis Example 4 Synthesis of Inv-4
Figure PCTKR2013007669-appb-I000142
Figure PCTKR2013007669-appb-I000142
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-4 (4.97 g, 79 %)를 얻었다.2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) -1,3,5-triazine instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using the same procedure as in Synthesis Example 3 to obtain the title compound Inv-4 (4.97 g, 79%).
GC-Mass (이론치: 591.22 g/mol, 측정치: 591 g/mol)GC-Mass (Theoretical value: 591.22 g / mol, Measured value: 591 g / mol)
[합성예 5] Inv-5의 합성Synthesis Example 5 Synthesis of Inv-5
Figure PCTKR2013007669-appb-I000143
Figure PCTKR2013007669-appb-I000143
3-bromobiphenyl 대신 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-5 (3.21 g, 50 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine was used instead of 3-bromobiphenyl. -5 (3.21 g, 50%) was obtained.
GC-Mass (이론치: 603.24 g/mol, 측정치: 603 g/mol)GC-Mass (Theoretical value: 603.24 g / mol, Measured value: 603 g / mol)
[합성예 6] Inv-6의 합성Synthesis Example 6 Synthesis of Inv-6
Figure PCTKR2013007669-appb-I000144
Figure PCTKR2013007669-appb-I000144
3-bromobiphenyl 대신 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-6 (3.47 g, 49 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine was used instead of 3-bromobiphenyl. -6 (3.47 g, 49%) was obtained.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 7] Inv-7의 합성Synthesis Example 7 Synthesis of Inv-7
Figure PCTKR2013007669-appb-I000145
Figure PCTKR2013007669-appb-I000145
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-7 (5.38 g,76 %)를 얻었다.2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -1,3,5-triazine instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using the same process as in Synthesis Example 3 to obtain the title compound Inv-7 (5.38 g, 76%).
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 8] Inv-8의 합성Synthesis Example 8 Synthesis of Inv-8
Figure PCTKR2013007669-appb-I000146
Figure PCTKR2013007669-appb-I000146
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chlorophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-8 (4.63 g, 74 %)를 얻었다.The same procedure as in Synthesis Example 3 was repeated except that 2- (3-chlorophenyl) -4,6-diphenylpyrimidine was used instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine. The resulting compound, Inv-8 (4.63 g, 74%) was obtained.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 9] Inv-9의 합성Synthesis Example 9 Synthesis of Inv-9
Figure PCTKR2013007669-appb-I000147
Figure PCTKR2013007669-appb-I000147
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)pyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-9 (4.83 g, 77 %)를 얻었다.Except for using 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) pyrimidine instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Inv-9 (4.83 g, 77%) was obtained by the same procedure as in Synthesis Example 3.
GC-Mass (이론치: 590.22 g/mol, 측정치: 590 g/mol)GC-Mass (Theoretical value: 590.22 g / mol, Measured value: 590 g / mol)
[합성예 10] Inv-10의 합성Synthesis Example 10 Synthesis of Inv-10
Figure PCTKR2013007669-appb-I000148
Figure PCTKR2013007669-appb-I000148
3-bromobiphenyl 대신 4-(5-bromobiphenyl-3-yl)-2,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-10 (3.53 g, 50 %)를 얻었다.Inv-10 (3.53 g, 50%) was carried out in the same manner as in Synthesis Example 1, except that 4- (5-bromobiphenyl-3-yl) -2,6-diphenylpyrimidine was used instead of 3-bromobiphenyl. )
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (Theoretical value: 664.26 g / mol, Measured value: 664 g / mol)
[합성예 11] Inv-11의 합성Synthesis Example 11 Synthesis of Inv-11
Figure PCTKR2013007669-appb-I000149
Figure PCTKR2013007669-appb-I000149
3-bromobiphenyl 대신 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-11 (3.39 g, 47 %)를 얻었다.The same procedure as in Synthesis Example 1 was conducted except that 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole was used instead of 3-bromobiphenyl. Inv-11 (3.39 g, 47%) was obtained as the target compound.
GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)GC-Mass (Theoretical value: 678.25 g / mol, Measured value: 678 g / mol)
[합성예 12] Inv-12의 합성Synthesis Example 12 Synthesis of Inv-12
Figure PCTKR2013007669-appb-I000150
Figure PCTKR2013007669-appb-I000150
3-bromobiphenyl 대신 (4-bromophenyl)diphenylborane을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-12 (2.44 g, 44 %)를 얻었다.Except for using (4-bromophenyl) diphenylborane instead of 3-bromobiphenyl was carried out in the same manner as in Synthesis Example 1 to obtain the target compound Inv-12 (2.44 g, 44%).
GC-Mass (이론치: 522.23 g/mol, 측정치: 522 g/mol)GC-Mass (Theoretical value: 522.23 g / mol, Measured value: 522 g / mol)
[합성예 13] Inv-13의 합성Synthesis Example 13 Synthesis of Inv-13
Figure PCTKR2013007669-appb-I000151
Figure PCTKR2013007669-appb-I000151
3-bromobiphenyl 대신 (4-bromophenyl)diphenylphosphine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-13 (2.59 g, 45 %)를 얻었다.Except for using (4-bromophenyl) diphenylphosphine instead of 3-bromobiphenyl was carried out in the same manner as in Synthesis Example 1 to obtain the target compound Inv-13 (2.59 g, 45%).
GC-Mass (이론치: 542.19 g/mol, 측정치: 542 g/mol)GC-Mass (Theoretical value: 542.19 g / mol, Measured value: 542 g / mol)
[합성예 14] Inv-14의 합성Synthesis Example 14 Synthesis of Inv-14
Figure PCTKR2013007669-appb-I000152
Figure PCTKR2013007669-appb-I000152
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 (4-chlorophenyl)triphenylsilane을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-14 (4.92 g, 75 %)를 얻었다.Inv-, the target compound, was prepared in the same manner as in Synthesis Example 3, except that (4-chlorophenyl) triphenylsilane was used instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine. 14 (4.92 g, 75%) was obtained.
GC-Mass (이론치: 616.23 g/mol, 측정치: 616 g/mol)GC-Mass (Theoretical value: 616.23 g / mol, Measured value: 616 g / mol)
[합성예 15] Inv-15의 합성Synthesis Example 15 Synthesis of Inv-15
Figure PCTKR2013007669-appb-I000153
Figure PCTKR2013007669-appb-I000153
IC-1 대신 IC-2를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-15 (4.51 g, 72 %)를 얻었다.Exc-15 (4.51 g, 72%) was obtained by the same procedure as in Synthesis Example 3, except that IC-2 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 16] Inv-16의 합성Synthesis Example 16 Synthesis of Inv-16
Figure PCTKR2013007669-appb-I000154
Figure PCTKR2013007669-appb-I000154
IC-1 대신 IC-3을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-16 (2.35 g, 51 %)를 얻었다.Exc-16 (2.35 g, 51%) was obtained by the same procedure as in Synthesis Example 1, except that IC-3 was used instead of IC-1.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (Theoretical value: 434.18 g / mol, Measured value: 434 g / mol)
[합성예 17] Inv-17의 합성Synthesis Example 17 Synthesis of Inv-17
Figure PCTKR2013007669-appb-I000155
Figure PCTKR2013007669-appb-I000155
IC-1과 3-bromobiphenyl 대신 IC-3과 3-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-17 (2.45 g, 53 %)를 얻었다.Inv-17 (2.45 g, 53%) was prepared by the same procedure as in Synthesis Example 1, except that IC-3 and 3- (4-bromophenyl) pyridine were used instead of IC-1 and 3-bromobiphenyl. Got.
GC-Mass (이론치: 435.17 g/mol, 측정치: 435 g/mol)GC-Mass (Theoretical value: 435.17 g / mol, Measured value: 435 g / mol)
[합성예 18] Inv-18의 합성Synthesis Example 18 Synthesis of Inv-18
Figure PCTKR2013007669-appb-I000156
Figure PCTKR2013007669-appb-I000156
IC-1 대신 IC-3을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-18 (4.32 g, 69 %)를 얻었다.Exc-18 (4.32 g, 69%) was obtained by the same procedure as in Synthesis Example 3, except that IC-3 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 19] Inv-19의 합성Synthesis Example 19 Synthesis of Inv-19
Figure PCTKR2013007669-appb-I000157
Figure PCTKR2013007669-appb-I000157
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-19 (4.53 g, 72 %)를 얻었다.IC-3 and 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using -1,3,5-triazine was carried out in the same manner as in Synthesis Example 3 to obtain the title compound Inv-19 (4.53 g, 72%).
GC-Mass (이론치: 591.22 g/mol, 측정치: 591 g/mol)GC-Mass (Theoretical value: 591.22 g / mol, Measured value: 591 g / mol)
[합성예 20] Inv-20의 합성Synthesis Example 20 Synthesis of Inv-20
Figure PCTKR2013007669-appb-I000158
Figure PCTKR2013007669-appb-I000158
IC-1과 3-bromobiphenyl 대신 IC-3과 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-20 (2.95 g, 46 %)를 얻었다.The same as in Synthesis Example 1 except for using IC-3 and 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine instead of IC-1 and 3-bromobiphenyl The procedure was followed to obtain Inv-20 (2.95 g, 46%) as the target compound.
GC-Mass (이론치: 603.24 g/mol, 측정치: 603 g/mol)GC-Mass (Theoretical value: 603.24 g / mol, Measured value: 603 g / mol)
[합성예 21] Inv-21의 합성Synthesis Example 21 Synthesis of Inv-21
Figure PCTKR2013007669-appb-I000159
Figure PCTKR2013007669-appb-I000159
IC-1과 3-bromobiphenyl 대신 IC-3과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-21 (3.18 g, 45 %)를 얻었다.The same as in Synthesis Example 1 except for using IC-3 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine instead of IC-1 and 3-bromobiphenyl The procedure was followed to obtain the target compound Inv-21 (3.18 g, 45%).
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 22] Inv-22의 합성Synthesis Example 22 Synthesis of Inv-22
Figure PCTKR2013007669-appb-I000160
Figure PCTKR2013007669-appb-I000160
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-22 (6.07 g, 77 %)를 얻었다.IC-3 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Exc-22 (6.07 g, 77%) was obtained by the same procedure as in Synthesis Example 3, except that -1,3,5-triazine was used.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 23] Inv-23의 합성Synthesis Example 23 Synthesis of Inv-23
Figure PCTKR2013007669-appb-I000161
Figure PCTKR2013007669-appb-I000161
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2-(3-chlorophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-23 (4.69 g, 75 %)를 얻었다.Except for using IC-3 and 2- (3-chlorophenyl) -4,6-diphenylpyrimidine instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Inv-23 (4.69 g, 75%) was obtained by the same procedure as in Synthesis Example 3.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 24] Inv-24의 합성Synthesis Example 24 Synthesis of Inv-24
Figure PCTKR2013007669-appb-I000162
Figure PCTKR2013007669-appb-I000162
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)pyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-24 (4.46 g, 71 %)를 얻었다.IC-3 and 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using pyrimidine was carried out the same procedure as in Synthesis Example 3 to obtain the target compound Inv-24 (4.46 g, 71%).
GC-Mass (이론치: 590.22 g/mol, 측정치: 590 g/mol)GC-Mass (Theoretical value: 590.22 g / mol, Measured value: 590 g / mol)
[합성예 25] Inv-25의 합성Synthesis Example 25 Synthesis of Inv-25
Figure PCTKR2013007669-appb-I000163
Figure PCTKR2013007669-appb-I000163
IC-1과 3-bromobiphenyl 대신 IC-3과 4-(5-bromobiphenyl-3-yl)-2,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-25 (3.04 g, 43 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that IC-3 and 4- (5-bromobiphenyl-3-yl) -2,6-diphenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl. -25 (3.04 g, 43%) was obtained.
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (Theoretical value: 664.26 g / mol, Measured value: 664 g / mol)
[합성예 26] Inv-26의 합성Synthesis Example 26 Synthesis of Inv-26
Figure PCTKR2013007669-appb-I000164
Figure PCTKR2013007669-appb-I000164
IC-1과 3-bromobiphenyl 대신 IC-3과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-26 (2.96 g, 41 %)를 얻었다.The above synthesis except for using IC-3 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole instead of IC-1 and 3-bromobiphenyl Inv-26 (2.96 g, 41%) was obtained by the same procedure as in Example 1.
GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)GC-Mass (Theoretical value: 678.25 g / mol, Measured value: 678 g / mol)
[합성예 27] Inv-27의 합성Synthesis Example 27 Synthesis of Inv-27
Figure PCTKR2013007669-appb-I000165
Figure PCTKR2013007669-appb-I000165
IC-1과 3-bromobiphenyl 대신 IC-3과 (4-bromophenyl)diphenylborane을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-27 (2.66 g, 48 %)를 얻었다.Inv-27 (2.66 g, 48%) was obtained by the same procedure as in Synthesis Example 1, except that IC-3 and (4-bromophenyl) diphenylborane were used instead of IC-1 and 3-bromobiphenyl. .
GC-Mass (이론치: 522.23 g/mol, 측정치: 522 g/mol)GC-Mass (Theoretical value: 522.23 g / mol, Measured value: 522 g / mol)
[합성예 28] Inv-28의 합성Synthesis Example 28 Synthesis of Inv-28
Figure PCTKR2013007669-appb-I000166
Figure PCTKR2013007669-appb-I000166
IC-1과 3-bromobiphenyl 대신 IC-3과 (4-bromophenyl) diphenylphosphine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-28 (2.54 g, 44 %)를 얻었다.Inv-28 (2.54 g, 44%) was obtained by the same procedure as in Synthesis Example 1, except that IC-3 and (4-bromophenyl) diphenylphosphine were used instead of IC-1 and 3-bromobiphenyl. .
GC-Mass (이론치: 542.19 g/mol, 측정치: 542 g/mol)GC-Mass (Theoretical value: 542.19 g / mol, Measured value: 542 g / mol)
[합성예 29] Inv-29의 합성Synthesis Example 29 Synthesis of Inv-29
Figure PCTKR2013007669-appb-I000167
Figure PCTKR2013007669-appb-I000167
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 (4-chlorophenyl)triphenylsilane을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-29 (4.65 g, 71 %)를 얻었다.The same procedure as in Synthesis Example 3 except for using IC-3 and (4-chlorophenyl) triphenylsilane instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine To give the target compound Inv-29 (4.65 g, 71%).
GC-Mass (이론치: 616.23 g/mol, 측정치: 616 g/mol)GC-Mass (Theoretical value: 616.23 g / mol, Measured value: 616 g / mol)
[합성예 30] Inv-30의 합성Synthesis Example 30 Synthesis of Inv-30
Figure PCTKR2013007669-appb-I000168
Figure PCTKR2013007669-appb-I000168
IC-1 대신 IC-4를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-30 (4.70 g, 75 %)를 얻었다.Exc-30 (4.70 g, 75%) was obtained by the same procedure as in Synthesis Example 3, except that IC-4 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 31] Inv-31의 합성Synthesis Example 31 Synthesis of Inv-31
Figure PCTKR2013007669-appb-I000169
Figure PCTKR2013007669-appb-I000169
IC-1 대신 IC-5를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-31 (4.57 g, 73 %)를 얻었다.Exc-31 (4.57 g, 73%) was obtained by the same procedure as in Synthesis Example 3, except that IC-5 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 32] Inv-32의 합성Synthesis Example 32 Synthesis of Inv-32
Figure PCTKR2013007669-appb-I000170
Figure PCTKR2013007669-appb-I000170
IC-1 대신 IC-6을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-32 (4.82 g, 77 %)를 얻었다.Exc-32 (4.82 g, 77%) was obtained by the same procedure as in Synthesis Example 3, except that IC-6 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 33] Inv-33의 합성Synthesis Example 33 Synthesis of Inv-33
Figure PCTKR2013007669-appb-I000171
Figure PCTKR2013007669-appb-I000171
질소 기류 하에서 IC-7 (5 g, 13.84 mmol)과 phenylboronic acid (2.03 g, 16.61 mmol), NaOH (1.66 g, 41.52 mmol) 및 THF/H2O(100 ml/500 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(0.80 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. Under a stream of nitrogen, IC-7 (5 g, 13.84 mmol) and phenylboronic acid (2.03 g, 16.61 mmol), NaOH (1.66 g, 41.52 mmol) and THF / H 2 O (100 ml / 500 ml) were mixed, Pd (PPh 3 ) 4 (0.80 g, 5 mol%) was added at 40 ° C. and stirred at 80 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 3,7-diphenyl-3,10-dihydropyrrolo[3,2-a]carbazole을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 3,7-diphenyl-3,10-dihydropyrrolo [3,2-a] carbazole.
상기 3,7-diphenyl-3,10-dihydropyrrolo[3,2-a]carbazole을 IC-1 대신 사용하여 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-33 (6.27 g, 68 %)를 얻었다.Using the 3,7-diphenyl-3,10-dihydropyrrolo [3,2-a] carbazole in place of IC-1, the same procedure as in Synthesis Example 3 was carried out, thereby Inv-33 (6.27 g, 68%) was the target compound. Got.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 34] Inv-34의 합성Synthesis Example 34 Synthesis of Inv-34
Figure PCTKR2013007669-appb-I000172
Figure PCTKR2013007669-appb-I000172
phenylboronic acid 대신 9-phenyl-9H-carbazol-3-ylboronic acid을 사용하는 것을 제외하고는 상기 합성예 33과 동일한 과정을 수행하여 목적 화합물인 Inv-34 (7.94 g, 69 %)를 얻었다.Except for using 9-phenyl-9H-carbazol-3-ylboronic acid instead of phenylboronic acid was carried out in the same manner as in Synthesis Example 33 to obtain the target compound Inv-34 (7.94 g, 69%).
GC-Mass (이론치: 830.32 g/mol, 측정치: 830 g/mol)GC-Mass (Theoretical value: 830.32 g / mol, Measured value: 830 g / mol)
[합성예 35] Inv-35의 합성Synthesis Example 35 Synthesis of Inv-35
Figure PCTKR2013007669-appb-I000173
Figure PCTKR2013007669-appb-I000173
IC-7 대신 IC-8을 사용하는 것을 제외하고는 상기 합성예 33과 동일한 과정을 수행하여 목적 화합물인 Inv-35 (6.64 g, 72 %)를 얻었다.Exc-35 (6.64 g, 72%) was obtained by the same procedure as in Synthesis Example 33, except that IC-8 was used instead of IC-7.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 36] Inv-36의 합성Synthesis Example 36 Synthesis of Inv-36
IC-7과 phenylboronic acid 대신 IC-8과 9-(4,6-diphenylpyridin-2-yl)-9H-carbazol-3-ylboronic acid을 사용하는 것을 제외하고는 상기 합성예 33과 동일한 과정을 수행하여 목적 화합물인 Inv-36 (10.22 g, 75 %)를 얻었다.The same procedure as in Synthesis Example 33 was carried out except that IC-8 and 9- (4,6-diphenylpyridin-2-yl) -9H-carbazol-3-ylboronic acid were used instead of IC-7 and phenylboronic acid. Inv-36 (10.22 g, 75%) was obtained as the target compound.
GC-Mass (이론치: 983.37 g/mol, 측정치: 983 g/mol)GC-Mass (Theoretical value: 983.37 g / mol, Measured value: 983 g / mol)
[합성예 37] Inv-37의 합성Synthesis Example 37 Synthesis of Inv-37
Figure PCTKR2013007669-appb-I000175
Figure PCTKR2013007669-appb-I000175
IC-1 대신 IC-9를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-37 (4.34 g, 71 %)를 얻었다.Exc-37 (4.34 g, 71%) was obtained by the same procedure as in Synthesis Example 3, except that IC-9 was used instead of IC-1.
GC-Mass (이론치: 603.24 g/mol, 측정치: 603 g/mol)GC-Mass (Theoretical value: 603.24 g / mol, Measured value: 603 g / mol)
[합성예 38] Inv-38의 합성Synthesis Example 38 Synthesis of Inv-38
Figure PCTKR2013007669-appb-I000176
Figure PCTKR2013007669-appb-I000176
IC-1과 3-bromobiphenyl 대신 IC-9와 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-38 (3.58 g, 52 %)를 얻었다.The same as in Synthesis Example 1 except that IC-9 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine are used instead of IC-1 and 3-bromobiphenyl. The procedure was followed to obtain Inv-38 (3.58 g, 52%) as the target compound.
GC-Mass (이론치: 679.27 g/mol, 측정치: 679 g/mol)GC-Mass (Theoretical value: 679.27 g / mol, Measured value: 679 g / mol)
[합성예 39] Inv-39의 합성Synthesis Example 39 Synthesis of Inv-39
Figure PCTKR2013007669-appb-I000177
Figure PCTKR2013007669-appb-I000177
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-9와 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-39 (5.20 g, 68 %)를 얻었다.IC-9 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using -1,3,5-triazine was carried out in the same manner as in Synthesis Example 3 to obtain the target compound Inv-39 (5.20 g, 68%).
GC-Mass (이론치: 775.30 g/mol, 측정치: 775 g/mol)GC-Mass (Theoretical value: 775.30 g / mol, Measured value: 775 g / mol)
[합성예 40] Inv-40의 합성Synthesis Example 40 Synthesis of Inv-40
Figure PCTKR2013007669-appb-I000178
Figure PCTKR2013007669-appb-I000178
IC-1 대신 IC-10을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-40 (3.90 g, 70 %)를 얻었다.Exc 40 (3.90 g, 70%) was obtained by the same procedure as in Synthesis Example 3, except that IC-10 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 41] Inv-41의 합성Synthesis Example 41 Synthesis of Inv-41
Figure PCTKR2013007669-appb-I000179
Figure PCTKR2013007669-appb-I000179
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-10과 2-(4-bromophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-41 (2.67 g, 48 %)를 얻었다.Except for using IC-10 and 2- (4-bromophenyl) -4,6-diphenylpyrimidine instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Inv-41 (2.67 g, 48%) was obtained by the same procedure as in Synthesis Example 1.
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (Theoretical value: 664.26 g / mol, Measured value: 664 g / mol)
[합성예 42] Inv-42의 합성Synthesis Example 42 Synthesis of Inv-42
Figure PCTKR2013007669-appb-I000180
Figure PCTKR2013007669-appb-I000180
IC-1 대신 IC-11을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-42 (3.74 g, 73 %)를 얻었다.Exc-42 (3.74 g, 73%) was obtained by the same procedure as in Synthesis Example 3, except that IC-11 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 43] Inv-43의 합성Synthesis Example 43 Synthesis of Inv-43
Figure PCTKR2013007669-appb-I000181
Figure PCTKR2013007669-appb-I000181
IC-1과 3-bromobiphenyl 대신 IC-11과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-43 (2.94 g, 52 %)를 얻었다.The same as in Synthesis Example 1 except for using IC-11 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine instead of IC-1 and 3-bromobiphenyl The procedure was followed to obtain the target compound Inv-43 (2.94 g, 52%).
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (Theoretical value: 817.32 g / mol, Measured value: 817 g / mol)
[합성예 44] Inv-44의 합성Synthesis Example 44 Synthesis of Inv-44
Figure PCTKR2013007669-appb-I000182
Figure PCTKR2013007669-appb-I000182
IC-1과 3-bromobiphenyl 대신 IC-11과 3,3'-(5-bromo-1,3-phenylene)dipyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-44 (2.34 g, 51 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that IC-11 and 3,3 '-(5-bromo-1,3-phenylene) dipyridine were used instead of IC-1 and 3-bromobiphenyl. -44 (2.34 g, 51%) was obtained.
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (Theoretical value: 664.26 g / mol, Measured value: 664 g / mol)
[합성예 45] Inv-45의 합성Synthesis Example 45 Synthesis of Inv-45
Figure PCTKR2013007669-appb-I000183
Figure PCTKR2013007669-appb-I000183
IC-1과 3-bromobiphenyl 대신 IC-11과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-45 (2.81 g, 49 %)를 얻었다.The above synthesis except for using IC-11 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole instead of IC-1 and 3-bromobiphenyl Inv-45 (2.81 g, 49%) was obtained by the same procedure as in Example 1.
GC-Mass (이론치: 830.32 g/mol, 측정치: 830 g/mol)GC-Mass (Theoretical value: 830.32 g / mol, Measured value: 830 g / mol)
[합성예 46] Inv-46의 합성Synthesis Example 46 Synthesis of Inv-46
Figure PCTKR2013007669-appb-I000184
Figure PCTKR2013007669-appb-I000184
IC-1 대신 IC-12를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-46 (4.05 g, 72 %)를 얻었다.Exc-46 (4.05 g, 72%) was obtained by the same procedure as in Synthesis Example 3, except that IC-12 was used instead of IC-1.
GC-Mass (이론치: 657.21 g/mol, 측정치: 657 g/mol)GC-Mass (Theoretical value: 657.21 g / mol, Measured value: 657 g / mol)
[합성예 47] Inv-47의 합성Synthesis Example 47 Synthesis of Inv-47
Figure PCTKR2013007669-appb-I000185
Figure PCTKR2013007669-appb-I000185
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-12와 2-(4-chlorophenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-47 (3.66 g, 65 %)를 얻었다.IC-12 and 2- (4-chlorophenyl) -4,6-diphenyl-1,3,5- instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using triazine was carried out the same procedure as in Synthesis Example 3 to obtain the target compound Inv-47 (3.66 g, 65%).
GC-Mass (이론치: 657.21 g/mol, 측정치: 657 g/mol)GC-Mass (Theoretical value: 657.21 g / mol, Measured value: 657 g / mol)
[합성예 48] Inv-48의 합성Synthesis Example 48 Synthesis of Inv-48
Figure PCTKR2013007669-appb-I000186
Figure PCTKR2013007669-appb-I000186
IC-1과 3-bromobiphenyl 대신 IC-12와 2-(3-bromophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-48 (2.64 g, 47 %)를 얻었다.Inv-48 (2.64) was prepared by the same procedure as in Synthesis Example 1, except that IC-12 and 2- (3-bromophenyl) -4,6-diphenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl. g, 47%).
GC-Mass (이론치: 656.22 g/mol, 측정치: 656 g/mol)GC-Mass (Theoretical value: 656.22 g / mol, Measured value: 656 g / mol)
[합성예 49] Inv-49의 합성Synthesis Example 49 Synthesis of Inv-49
Figure PCTKR2013007669-appb-I000187
Figure PCTKR2013007669-appb-I000187
IC-1 대신 IC-13을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-49 (3.90 g, 70 %)를 얻었다.Exc-49 (3.90 g, 70%) was obtained by the same procedure as in Synthesis Example 3, except that IC-13 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 50] Inv-50의 합성Synthesis Example 50 Synthesis of Inv-50
Figure PCTKR2013007669-appb-I000188
Figure PCTKR2013007669-appb-I000188
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-13과 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-50 (5.00 g, 73 %)를 얻었다.IC-13 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using -1,3,5-triazine, the same procedure as in Synthesis Example 3 was performed to obtain Inv-50 (5.00 g, 73%) as a target compound.
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (Theoretical value: 817.32 g / mol, Measured value: 817 g / mol)
[합성예 51] Inv-51의 합성Synthesis Example 51 Synthesis of Inv-51
Figure PCTKR2013007669-appb-I000189
Figure PCTKR2013007669-appb-I000189
IC-1 대신 IC-14를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-51 (3.85 g, 69 %)를 얻었다.Exc-51 (3.85 g, 69%) was obtained by the same procedure as in Synthesis Example 3, except that IC-14 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 52] Inv-52의 합성Synthesis Example 52 Synthesis of Inv-52
Figure PCTKR2013007669-appb-I000190
Figure PCTKR2013007669-appb-I000190
IC-1과 3-bromobiphenyl 대신 IC-15와 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-52 (2.90 g, 52 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that IC-15 and 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl. Inv-52 (2.90 g, 52%) was obtained as the target compound.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 53] Inv-53의 합성Synthesis Example 53 Synthesis of Inv-53
Figure PCTKR2013007669-appb-I000191
Figure PCTKR2013007669-appb-I000191
IC-1 대신 IC-15를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-53 (3.85 g, 69 %)를 얻었다.Exc-53 (3.85 g, 69%) was obtained by the same procedure as in Synthesis Example 3, except that IC-15 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 54] Inv-54의 합성Synthesis Example 54 Synthesis of Inv-54
Figure PCTKR2013007669-appb-I000192
Figure PCTKR2013007669-appb-I000192
IC-1과 3-bromobiphenyl 대신 IC-15와 2-(4-bromophenyl)-5-phenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-54 (2.66 g, 54 %)를 얻었다.Exc-54 (2.66 g, 54%).
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 55] Inv-55의 합성Synthesis Example 55 Synthesis of Inv-55
Figure PCTKR2013007669-appb-I000193
Figure PCTKR2013007669-appb-I000193
IC-1 대신 IC-16을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-55 (3.48 g, 68 %)를 얻었다.Exc-55 (3.48 g, 68%) was obtained by the same procedure as in Synthesis Example 3, except that IC-16 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 56] Inv-56의 합성Synthesis Example 56 Synthesis of Inv-56
Figure PCTKR2013007669-appb-I000194
Figure PCTKR2013007669-appb-I000194
IC-1과 3-bromobiphenyl 대신 IC-16과 2-(4-bromophenyl)pyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-56 (1.99 g, 49 %)를 얻었다.Inv-56 (1.99 g, 49%) was prepared by the same procedure as in Synthesis Example 1, except that IC-16 and 2- (4-bromophenyl) pyrimidine were used instead of IC-1 and 3-bromobiphenyl Got.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 57] Inv-57의 합성Synthesis Example 57 Synthesis of Inv-57
Figure PCTKR2013007669-appb-I000195
Figure PCTKR2013007669-appb-I000195
IC-1 대신 IC-17을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-57 (4.00 g, 71 %)를 얻었다.Exc-57 (4.00 g, 71%) was obtained by the same procedure as in Synthesis Example 3, except that IC-17 was used instead of IC-1.
GC-Mass (이론치: 657.21 g/mol, 측정치: 657 g/mol)GC-Mass (Theoretical value: 657.21 g / mol, Measured value: 657 g / mol)
[합성예 58] Inv-58의 합성Synthesis Example 58 Synthesis of Inv-58
Figure PCTKR2013007669-appb-I000196
Figure PCTKR2013007669-appb-I000196
IC-1과 3-bromobiphenyl 대신 IC-17과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-58 (2.89 g, 46 %)를 얻었다.The same as in Synthesis Example 1 except for using IC-17 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine instead of IC-1 and 3-bromobiphenyl The procedure was followed to obtain the target compound Inv-58 (2.89 g, 46%).
GC-Mass (이론치: 733.25 g/mol, 측정치: 733 g/mol)GC-Mass (Theoretical value: 733.25 g / mol, Measured value: 733 g / mol)
[합성예 59] Inv-59의 합성Synthesis Example 59 Synthesis of Inv-59
Figure PCTKR2013007669-appb-I000197
Figure PCTKR2013007669-appb-I000197
IC-1 대신 IC-18을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-59 (3.49 g, 69 %)를 얻었다.Exc-59 (3.49 g, 69%) was obtained by the same procedure as in Synthesis Example 3, except that IC-18 was used instead of IC-1.
GC-Mass (이론치: 754.28 g/mol, 측정치: 754 g/mol)GC-Mass (Theoretical value: 754.28 g / mol, Measured value: 754 g / mol)
[합성예 60] Inv-60의 합성Synthesis Example 60 Synthesis of Inv-60
Figure PCTKR2013007669-appb-I000198
Figure PCTKR2013007669-appb-I000198
IC-1과 3-bromobiphenyl 대신 IC-18과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-60 (2.49 g, 44 %)를 얻었다.The above synthesis except for using IC-18 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole instead of IC-1 and 3-bromobiphenyl The same procedure as in Example 1 was performed to obtain Inv-60 (2.49 g, 44%) as a target compound.
GC-Mass (이론치: 843.31 g/mol, 측정치: 843 g/mol)GC-Mass (Theoretical value: 843.31 g / mol, Measured value: 843 g / mol)
[합성예 61] Inv-61의 합성Synthesis Example 61 Synthesis of Inv-61
Figure PCTKR2013007669-appb-I000199
Figure PCTKR2013007669-appb-I000199
IC-1과 3-bromobiphenyl 대신 IC-19와 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-61 (1.62 g, 48 %)를 얻었다.Inv-61 (1.62 g, 48%) was obtained by the same procedure as in Synthesis Example 1, except that IC-19 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)GC-Mass (Theoretical value: 678.25 g / mol, Measured value: 678 g / mol)
[합성예 62] Inv-62의 합성Synthesis Example 62 Synthesis of Inv-62
Figure PCTKR2013007669-appb-I000200
Figure PCTKR2013007669-appb-I000200
IC-1과 3-bromobiphenyl 대신 IC-19와 1-bromo-3,5-diphenylbenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-62 (1.94 g, 47 %)를 얻었다.Inv-62 (1.94 g, 47%) was prepared in the same manner as in Synthesis Example 1, except that IC-19 and 1-bromo-3,5-diphenylbenzene were used instead of IC-1 and 3-bromobiphenyl )
GC-Mass (이론치: 830.32 g/mol, 측정치: 830 g/mol)GC-Mass (Theoretical value: 830.32 g / mol, Measured value: 830 g / mol)
[합성예 63] Inv-63의 합성Synthesis Example 63 Synthesis of Inv-63
Figure PCTKR2013007669-appb-I000201
Figure PCTKR2013007669-appb-I000201
IC-1 대신 IC-20을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-63 (3.79 g, 68 %)를 얻었다.Exc-63 (3.79 g, 68%) was obtained by the same procedure as in Synthesis Example 3, except that IC-20 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 64] Inv-64의 합성Synthesis Example 64 Synthesis of Inv-64
Figure PCTKR2013007669-appb-I000202
Figure PCTKR2013007669-appb-I000202
IC-1 대신 IC-21을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-64 (4.18 g, 75 %)를 얻었다.Exc-64 (4.18 g, 75%) was obtained by the same procedure as in Synthesis Example 3, except that IC-21 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665.26 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665.26 g / mol)
[합성예 65] Inv-65의 합성Synthesis Example 65 Synthesis of Inv-65
Figure PCTKR2013007669-appb-I000203
Figure PCTKR2013007669-appb-I000203
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-21과 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-65 (5.07 g, 74 %)를 얻었다.IC-21 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Except for using -1,3,5-triazine was carried out in the same manner as in Synthesis Example 3 to obtain the target compound Inv-65 (5.07 g, 74%).
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (Theoretical value: 817.32 g / mol, Measured value: 817 g / mol)
[합성예 66] Inv-66의 합성Synthesis Example 66 Synthesis of Inv-66
Figure PCTKR2013007669-appb-I000204
Figure PCTKR2013007669-appb-I000204
IC-1 대신 IC-22를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-66 (4.01 g, 72 %)를 얻었다.Exc-66 (4.01 g, 72%) was obtained by the same procedure as in Synthesis Example 3, except that IC-22 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 67] Inv-67의 합성Synthesis Example 67 Synthesis of Inv-67
Figure PCTKR2013007669-appb-I000205
Figure PCTKR2013007669-appb-I000205
IC-1과 3-bromobiphenyl 대신 IC-22과 2-(3-bromophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-67 (2.84 g, 51 %)를 얻었다.Inv-67 (2.84) was prepared by the same procedure as in Synthesis Example 1, except that IC-22 and 2- (3-bromophenyl) -4,6-diphenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl. g, 51%).
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (Theoretical value: 664.26 g / mol, Measured value: 664 g / mol)
[합성예 68] Inv-68의 합성Synthesis Example 68 Synthesis of Inv-68
Figure PCTKR2013007669-appb-I000206
Figure PCTKR2013007669-appb-I000206
IC-1 대신 IC-23을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-68 (3.74 g, 73 %)를 얻었다.Exc-68 (3.74 g, 73%) was obtained by the same procedure as in Synthesis Example 3, except that IC-23 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 69] Inv-69의 합성Synthesis Example 69 Synthesis of Inv-69
Figure PCTKR2013007669-appb-I000207
Figure PCTKR2013007669-appb-I000207
IC-1과 3-bromobiphenyl 대신 IC-23과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-69 (2.71 g, 48 %)를 얻었다.The same as in Synthesis Example 1 except for using IC-23 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine instead of IC-1 and 3-bromobiphenyl The procedure was followed to obtain the target compound Inv-69 (2.71 g, 48%).
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (Theoretical value: 817.32 g / mol, Measured value: 817 g / mol)
[합성예 70] Inv-70의 합성Synthesis Example 70 Synthesis of Inv-70
Figure PCTKR2013007669-appb-I000208
Figure PCTKR2013007669-appb-I000208
IC-1과 3-bromobiphenyl 대신 IC-24와 2-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-70 (2.07 g, 51 %)를 얻었다.Inv-70 (2.07 g, 51%) was prepared by the same procedure as in Synthesis Example 1, except that IC-24 and 2- (4-bromophenyl) pyridine were used instead of IC-1 and 3-bromobiphenyl. Got.
GC-Mass (이론치: 587.24 g/mol, 측정치: 587 g/mol)GC-Mass (Theoretical value: 587.24 g / mol, Measured value: 587 g / mol)
[합성예 71] Inv-71의 합성Synthesis Example 71 Synthesis of Inv-71
Figure PCTKR2013007669-appb-I000209
Figure PCTKR2013007669-appb-I000209
IC-1 대신 IC-24를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-71 (4.00 g, 78 %)를 얻었다.Exc-71 (4.00 g, 78%) was obtained by the same procedure as in Synthesis Example 3, except that IC-24 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 72] Inv-72의 합성Synthesis Example 72 Synthesis of Inv-72
Figure PCTKR2013007669-appb-I000210
Figure PCTKR2013007669-appb-I000210
IC-1과 3-bromobiphenyl 대신 IC-25와 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-72 (1.83 g, 53 %)를 얻었다.Exc-72 (1.83 g, 53%) was obtained by the same procedure as in Synthesis Example 1, except that IC-25 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 73] Inv-73의 합성Synthesis Example 73 Synthesis of Inv-73
Figure PCTKR2013007669-appb-I000211
Figure PCTKR2013007669-appb-I000211
IC-1과 3-bromobiphenyl 대신 IC-25와 1-bromo-3,5-diphenylbenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-73 (2.25 g, 52 %)를 얻었다.Inv-73 (2.25 g, 52%) was prepared in the same manner as in Synthesis Example 1, except that IC-25 and 1-bromo-3,5-diphenylbenzene were used instead of IC-1 and 3-bromobiphenyl. )
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 74] Inv-74의 합성Synthesis Example 74 Synthesis of Inv-74
Figure PCTKR2013007669-appb-I000212
Figure PCTKR2013007669-appb-I000212
IC-1 대신 IC-25를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-74 (1.91 g, 49 %)를 얻었다.Exc-74 (1.91 g, 49%) was obtained by the same procedure as in Synthesis Example 1, except that IC-25 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 75] Inv-75의 합성Synthesis Example 75 Synthesis of Inv-75
Figure PCTKR2013007669-appb-I000213
Figure PCTKR2013007669-appb-I000213
IC-1과 3-bromobiphenyl 대신 IC-26과 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-75 (1.55 g, 45 %)를 얻었다.Inv-75 (1.55 g, 45%) was obtained in the same manner as in Synthesis Example 1, except that IC-26 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 76] Inv-76의 합성Synthesis Example 76 Synthesis of Inv-76
Figure PCTKR2013007669-appb-I000214
Figure PCTKR2013007669-appb-I000214
IC-1과 3-bromobiphenyl 대신 IC-26과 4-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-76 (1.83 g, 47 %)를 얻었다.Inv-76 (1.83 g, 47%) was prepared by the same procedure as in Synthesis Example 1, except that IC-26 and 4- (4-bromophenyl) pyridine were used instead of IC-1 and 3-bromobiphenyl. Got.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 77] Inv-77의 합성Synthesis Example 77 Synthesis of Inv-77
Figure PCTKR2013007669-appb-I000215
Figure PCTKR2013007669-appb-I000215
IC-1과 3-bromobiphenyl 대신 IC-27과 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-77 (1.48 g, 43 %)를 얻었다.Inv-77 (1.48 g, 43%) was obtained in the same manner as in Synthesis Example 1, except that IC-27 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (Theoretical value: 589.23 g / mol, Measured value: 589 g / mol)
[합성예 78] Inv-78의 합성Synthesis Example 78 Synthesis of Inv-78
Figure PCTKR2013007669-appb-I000216
Figure PCTKR2013007669-appb-I000216
IC-1 대신 IC-27을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-78 (1.87 g, 48 %)를 얻었다.Exc-78 (1.87 g, 48%) was obtained in the same manner as in Synthesis Example 1, except that IC-27 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665 g / mol)
[합성예 79] Inv-79의 합성Synthesis Example 79 Synthesis of Inv-79
Figure PCTKR2013007669-appb-I000217
Figure PCTKR2013007669-appb-I000217
IC-1과 3-bromobiphenyl 대신 IC-27과 4-bromobiphenyl을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-79 (1.75 g, 45 %)를 얻었다.Inv-79 (1.75 g, 45%) was obtained in the same manner as in Synthesis Example 1, except that IC-27 and 4-bromobiphenyl were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665.26 g/mol)GC-Mass (Theoretical value: 665.26 g / mol, Measured value: 665.26 g / mol)
[합성예 80] Inv-80의 합성Synthesis Example 80 Synthesis of Inv-80
Figure PCTKR2013007669-appb-I000218
Figure PCTKR2013007669-appb-I000218
IC-1과 3-bromobiphenyl 대신 IC-27과 1-bromo-3,5-diphenylbenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-80 (2.12 g, 49 %)를 얻었다.Inv-80 (2.12 g, 49%) was prepared in the same manner as in Synthesis Example 1, except that IC-27 and 1-bromo-3,5-diphenylbenzene were used instead of IC-1 and 3-bromobiphenyl. )
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 81] Inv-81의 합성Synthesis Example 81 Synthesis of Inv-81
Figure PCTKR2013007669-appb-I000219
Figure PCTKR2013007669-appb-I000219
IC-1과 3-bromobiphenyl 대신 IC-28과 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-81 (1.79 g, 52 %)를 얻었다.Inv-81 (1.79 g, 52%) was obtained in the same manner as in Synthesis Example 1, except that IC-28 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 82] Inv-82의 합성Synthesis Example 82 Synthesis of Inv-82
Figure PCTKR2013007669-appb-I000220
Figure PCTKR2013007669-appb-I000220
IC-1과 3-bromobiphenyl 대신 IC-28과 1-bromo-3,5-diphenylbenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-82 (1.99 g, 46 %)를 얻었다.Inv-82 (1.99 g, 46%) was prepared in the same manner as in Synthesis Example 1, except that IC-28 and 1-bromo-3,5-diphenylbenzene were used instead of IC-1 and 3-bromobiphenyl. )
GC-Mass (이론치: 740.29 g/mol, 측정치: 740 g/mol)GC-Mass (Theoretical value: 740.29 g / mol, Measured value: 740 g / mol)
[합성예 83] Inv-83의 합성Synthesis Example 83 Synthesis of Inv-83
Figure PCTKR2013007669-appb-I000221
Figure PCTKR2013007669-appb-I000221
IC-1과 3-bromobiphenyl 대신 IC-14와 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-83 (3.54 g, 57 %)를 얻었다.The same as in Synthesis Example 1 except for using IC-14 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine instead of IC-1 and 3-bromobiphenyl The procedure was followed to obtain the target compound Inv-83 (3.54 g, 57%).
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (Theoretical value: 741.29 g / mol, Measured value: 741 g / mol)
[합성예 84] Inv-84의 합성Synthesis Example 84 Synthesis of Inv-84
Figure PCTKR2013007669-appb-I000222
Figure PCTKR2013007669-appb-I000222
IC-1과 3-bromobiphenyl 대신 IC-20과 2,2'-(5-bromo-1,3-phenylene)dipyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-84 (2.61 g, 53 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that IC-20 and 2,2 '-(5-bromo-1,3-phenylene) dipyridine were used instead of IC-1 and 3-bromobiphenyl. -84 (2.61 g, 53%) was obtained.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (Theoretical value: 588.23 g / mol, Measured value: 588 g / mol)
[합성예 85] Inv-85의 합성Synthesis Example 85 Synthesis of Inv-85
Figure PCTKR2013007669-appb-I000223
Figure PCTKR2013007669-appb-I000223
질소 기류 하에서 IC-29a (2.23 g, 10.0 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (3.21 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) 및 DMF(30 ml)를 혼합하고 상온에서 3시간 동안 교반하였다. 반응이 종결된 후 물을 넣고 고체 화합물을 filter한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 Inv-85 (3.77 g, yield : 83%)를 얻었다.Under nitrogen streams IC-29a (2.23 g, 10.0 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (3.21 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) and DMF ( 30 ml) were mixed and stirred at room temperature for 3 hours. After the reaction was completed, water was added, the solid compound was filtered and purified by column chromatography to obtain Inv-85 (3.77 g, yield: 83%) as a target compound.
GC-Mass (이론치: 454.55 g/mol, 측정치: 454 g/mol)GC-Mass (Theoretical value: 454.55 g / mol, Measured value: 454 g / mol)
[합성예 86] Inv-86의 합성Synthesis Example 86 Synthesis of Inv-86
Figure PCTKR2013007669-appb-I000224
Figure PCTKR2013007669-appb-I000224
질소 기류 하에서 IC-29a (2.23 g, 10.0 mmol), 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) 및 DMF(30 ml)를 혼합하고 상온에서 3시간 동안 교반하였다. 반응이 종결된 후 물을 넣고 고체 화합물을 filter한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 Inv-86 (3.45 g, yield : 65%)을 얻었다.IC-29a (2.23 g, 10.0 mmol), 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) under nitrogen stream ) And DMF (30 ml) were mixed and stirred at room temperature for 3 hours. After the reaction was completed, water was added, the solid compound was filtered and purified by column chromatography to obtain the title compound Inv-86 (3.45 g, yield: 65%).
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 87] Inv-87의 합성Synthesis Example 87 Synthesis of Inv-87
Figure PCTKR2013007669-appb-I000225
Figure PCTKR2013007669-appb-I000225
질소 기류 하에서 IC-29a (2.23 g, 10.0 mmol), 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) 및 DMF(30 ml)를 혼합하고 상온에서 3시간 동안 교반하였다. 반응이 종결된 후 물을 넣고 고체 화합물을 filter한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 Inv-87 (3.77 g, yield : 71%)을 얻었다.IC-29a (2.23 g, 10.0 mmol), 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) under nitrogen stream ) And DMF (30 ml) were mixed and stirred at room temperature for 3 hours. After the reaction was completed, water was added, the solid compound was filtered and purified by column chromatography to obtain the title compound Inv-87 (3.77 g, yield: 71%).
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 88] Inv-88의 합성Synthesis Example 88 Synthesis of Inv-88
IC-29a 대신 IC-29b (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-88 (3.45 g, yield : 65%)을 얻었다.Inv-88 (3.45 g, yield: 65%) was obtained in the same manner as in Synthesis Example 87, except that IC-29b (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 89] Inv-89의 합성Synthesis Example 89 Synthesis of Inv-89
Figure PCTKR2013007669-appb-I000227
Figure PCTKR2013007669-appb-I000227
IC-29a 대신 IC-30 (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-89 (3.33 g, yield : 63%)을 얻었다.Inv-89 (3.33 g, yield: 63%) was obtained in the same manner as in Synthesis Example 87, except that IC-30 (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 90] Inv-90의 합성Synthesis Example 90 Synthesis of Inv-90
IC-29a 대신 IC-31a (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-90 (3.18 g, yield : 60%)을 얻었다.Exv-90 (3.18 g, yield: 60%) was obtained in the same manner as in Synthesis Example 87, except that IC-31a (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 91] Inv-91의 합성Synthesis Example 91 Synthesis of Inv-91
Figure PCTKR2013007669-appb-I000229
Figure PCTKR2013007669-appb-I000229
IC-29a 대신 IC-31b (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-91 (3.28 g, yield : 62%)을 얻었다.Exv-91 (3.28 g, yield: 62%) was obtained in the same manner as in Synthesis Example 87, except that IC-31b (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 92] Inv-92의 합성Synthesis Example 92 Synthesis of Inv-92
Figure PCTKR2013007669-appb-I000230
Figure PCTKR2013007669-appb-I000230
IC-29a 대신 IC-32 (2.23 g, 10.0 mmol)을 사용하는 것을 제외하고는 합성예 85와 동일한 과정을 수행하여 Inv-92 (3.50 g, yield : 77%)을 얻었다.Exv-92 (3.50 g, yield: 77%) was obtained in the same manner as Synthesis Example 85 except for using IC-32 (2.23 g, 10.0 mmol) instead of IC-29a.
GC-Mass (이론치: 454.55 g/mol, 측정치: 454 g/mol)GC-Mass (Theoretical value: 454.55 g / mol, Measured value: 454 g / mol)
[합성예 93] Inv-93의 합성Synthesis Example 93 Synthesis of Inv-93
Figure PCTKR2013007669-appb-I000231
Figure PCTKR2013007669-appb-I000231
IC-1와 3-bromobiphenyl 대신 IC-33과 1-bromo-4-phenylisoquinoline을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-93(3.26 g, 수율 58%)를 얻었다.Inv-93 (3.26 g, Yield 58%) was obtained by the same procedure as in Synthesis Example 1, except that IC-33 and 1-bromo-4-phenylisoquinoline were used instead of IC-1 and 3-bromobiphenyl. Got it.
GC-Mass (이론치: 436.19 g/mol, 측정치: 436 g/mol)GC-Mass (Theoretical value: 436.19 g / mol, Measured value: 436 g / mol)
[합성예 94] Inv-94의 합성Synthesis Example 94 Synthesis of Inv-94
Figure PCTKR2013007669-appb-I000232
Figure PCTKR2013007669-appb-I000232
IC-1와 3-bromobiphenyl 대신 IC-34와 4-bromo-2,6-diphenylpyridine을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-94(3.11 g, 수율 63%)를 얻었다.Inv-94 (3.11 g, 63% yield) was carried out in the same manner as in Synthesis Example 1, except that IC-34 and 4-bromo-2,6-diphenylpyridine were used instead of IC-1 and 3-bromobiphenyl. )
GC-Mass (이론치: 586.24 g/mol, 측정치: 586 g/mol)GC-Mass (Theoretical value: 586.24 g / mol, Measured value: 586 g / mol)
[합성예 95] Inv-95 의 합성Synthesis Example 95 Synthesis of Inv-95
Figure PCTKR2013007669-appb-I000233
Figure PCTKR2013007669-appb-I000233
IC-29a 대신 IC-35 (2.23 g, 10.0 mmol)을 사용하는 것을 제외하고는 합성예 87와 동일한 과정을 수행하여 목적 화합물인 Inv-95 (3.40 g, yield : 64%)를 얻었다.Exc-95 (3.40 g, yield: 64%) was obtained in the same manner as in Synthesis Example 87, except that IC-35 (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (Theoretical value: 530.64 g / mol, Measured value: 530 g / mol)
[합성예 96] Inv-96의 합성Synthesis Example 96 Synthesis of Inv-96
Figure PCTKR2013007669-appb-I000234
Figure PCTKR2013007669-appb-I000234
질소 기류 하에서 IC-36 (3 g, 14.48 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (5.97 g, 17.37 mmol), Pd(OAc)2 (0.16 g, 5 mol%), NaO(t-bu) (2.78 g, 28.95 mmol), P(t-bu)3 (0.29 g, 1.45 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.IC-36 (3 g, 14.48 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (5.97 g, 17.37 mmol), Pd (OAc) 2 (0.16) under nitrogen stream g, 5 mol%), NaO (t-bu) (2.78 g, 28.95 mmol), P (t-bu) 3 (0.29 g, 1.45 mmol) and Toluene (100 ml) were mixed and 12 h at 110 ° C. Stirred.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 Inv-96 (5.59 g, 수율 75 %)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain Inv-96 (5.59 g, yield 75%). Got it.
GC-Mass (이론치: 514.18 g/mol, 측정치: 514 g/mol)GC-Mass (Theoretical value: 514.18 g / mol, Measured value: 514 g / mol)
[합성예 97] Inv-97의 합성Synthesis Example 97 Synthesis of Inv-97
Figure PCTKR2013007669-appb-I000235
Figure PCTKR2013007669-appb-I000235
IC-36 대신 IC-37을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-97 (5.29 g, 71 %)를 얻었다.Exc-97 (5.29 g, 71%) was obtained by the same procedure as in Synthesis Example 96, except that IC-37 was used instead of IC-36.
GC-Mass (이론치: 514.18 g/mol, 측정치: 514 g/mol)GC-Mass (Theoretical value: 514.18 g / mol, Measured value: 514 g / mol)
[합성예 98] Inv-98의 합성Synthesis Example 98 Synthesis of Inv-98
Figure PCTKR2013007669-appb-I000236
Figure PCTKR2013007669-appb-I000236
IC-36 대신 IC-38을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-98(5.44 g, 73 %)를 얻었다.Exc-98 (5.44 g, 73%) was obtained by the same procedure as in Synthesis Example 96, except that IC-38 was used instead of IC-36.
GC-Mass (이론치: 514.18 g/mol, 측정치: 514 g/mol)GC-Mass (Theoretical value: 514.18 g / mol, Measured value: 514 g / mol)
[합성예 99] Inv-99의 합성Synthesis Example 99 Synthesis of Inv-99
Figure PCTKR2013007669-appb-I000237
Figure PCTKR2013007669-appb-I000237
IC-36 대신 IC-39을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-99(4.62 g, 69 %)를 얻었다.Exc-99 (4.62 g, 69%) was obtained by the same procedure as in Synthesis Example 96, except that IC-39 was used instead of IC-36.
GC-Mass (이론치: 556.21 g/mol, 측정치: 556 g/mol)GC-Mass (Theoretical value: 556.21 g / mol, Measured value: 556 g / mol)
[합성예 100] Inv-100의 합성Synthesis Example 100 Synthesis of Inv-100
Figure PCTKR2013007669-appb-I000238
Figure PCTKR2013007669-appb-I000238
IC-36 대신 IC-40을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-100 (3.66 g, 67 %)를 얻었다.Exc-100 (3.66 g, 67%) was obtained by the same procedure as in Synthesis Example 96, except that IC-40 was used instead of IC-36.
GC-Mass (이론치: 680.24 g/mol, 측정치: 680 g/mol)GC-Mass (Theoretical value: 680.24 g / mol, Measured value: 680 g / mol)
[합성예 101] Inv-101의 합성Synthesis Example 101 Synthesis of Inv-101
Figure PCTKR2013007669-appb-I000239
Figure PCTKR2013007669-appb-I000239
IC-36 대신 IC-41을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-101(4.87 g, 76 %)를 얻었다.Exc-101 (4.87 g, 76%) was obtained by the same procedure as in Synthesis Example 96, except that IC-41 was used instead of IC-36.
GC-Mass (이론치: 578.10 g/mol, 측정치: 578 g/mol)GC-Mass (Theoretical value: 578.10 g / mol, Measured value: 578 g / mol)
[합성예 102] Inv-102의 합성Synthesis Example 102 Synthesis of Inv-102
Figure PCTKR2013007669-appb-I000240
Figure PCTKR2013007669-appb-I000240
IC-36 대신 IC-42을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-102(4.75 g, 74 %)를 얻었다.Exc-102 (4.75 g, 74%) was obtained in the same manner as in Synthesis Example 96, except that IC-42 was used instead of IC-36.
GC-Mass (이론치: 578.10 g/mol, 측정치: 578 g/mol)GC-Mass (Theoretical value: 578.10 g / mol, Measured value: 578 g / mol)
[합성예 103] Inv-103의 합성Synthesis Example 103 Synthesis of Inv-103
Figure PCTKR2013007669-appb-I000241
Figure PCTKR2013007669-appb-I000241
IC-36 대신 IC-43을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-103 (4.68 g, 73 %)를 얻었다.Exc-103 (4.68 g, 73%) was obtained by the same procedure as in Synthesis Example 96, except that IC-43 was used instead of IC-36.
GC-Mass (이론치: 578.10 g/mol, 측정치: 578 g/mol)GC-Mass (Theoretical value: 578.10 g / mol, Measured value: 578 g / mol)
[합성예 104] Inv-104의 합성Synthesis Example 104 Synthesis of Inv-104
Figure PCTKR2013007669-appb-I000242
Figure PCTKR2013007669-appb-I000242
질소 기류 하에서 IC-1 (10g, 35.44 mmol), 2-chloro-4-phenylquinazoline (10.2 g, 42.53 mmol), Cu powder (0.22 g, 3.544 mmol), K2CO3 (9.8 g, 70.88mmol), Na2SO4 (10 g, 70.88 mmol), nitrobenzene (350ml)를 혼합하고 190℃에서 12시간 동안 교반하였다.IC-1 (10 g, 35.44 mmol), 2-chloro-4-phenylquinazoline (10.2 g, 42.53 mmol), Cu powder (0.22 g, 3.544 mmol), K 2 CO 3 (9.8 g, 70.88 mmol) under a nitrogen stream, Na 2 SO 4 (10 g, 70.88 mmol) and nitrobenzene (350 ml) were mixed and stirred at 190 ° C. for 12 hours.
반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 Inv-104 (8.6 g, 수율 50%)을 얻었다.After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer to which water was removed, and then purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain Inv-104 (8.6 g, yield 50%).
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol)GC-Mass (Theoretical value: 486.18 g / mol, Measured value: 486 g / mol)
[합성예 105] Inv-105의 합성Synthesis Example 105 Synthesis of Inv-105
Figure PCTKR2013007669-appb-I000243
Figure PCTKR2013007669-appb-I000243
2-chloro-4-phenylquinazoline 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-105을 얻었다.Inv-105 was obtained by the same procedure as in Synthesis Example 104 except for using 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline instead of 2-chloro-4-phenylquinazoline.
GC-Mass (이론치: 612.23 g/mol, 측정치: 612 g/mol)GC-Mass (Theoretical value: 612.23 g / mol, Measured value: 612 g / mol)
[합성예 106] Inv-106의 합성Synthesis Example 106 Synthesis of Inv-106
Figure PCTKR2013007669-appb-I000244
Figure PCTKR2013007669-appb-I000244
IC-1 대신 IC-2를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-106을 얻었다.Inv-106 was obtained by the same procedure as in Synthesis Example 104 except for using IC-2 instead of IC-1.
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol) GC-Mass (Theoretical value: 486.18 g / mol, Measured value: 486 g / mol)
[합성예 107] Inv-107의 합성Synthesis Example 107 Synthesis of Inv-107
Figure PCTKR2013007669-appb-I000245
Figure PCTKR2013007669-appb-I000245
IC-1 대신 IC-4를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-107를 얻었다.Inv-107 was obtained by the same procedure as Synthesis Example 104 except for using IC-4 instead of IC-1.
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol) GC-Mass (Theoretical value: 486.18 g / mol, Measured value: 486 g / mol)
[합성예 108] Inv-108의 합성Synthesis Example 108 Synthesis of Inv-108
Figure PCTKR2013007669-appb-I000246
Figure PCTKR2013007669-appb-I000246
IC-1 대신 IC-3을 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-108을 얻었다.Inv-108 was obtained by the same procedure as Synthesis Example 104 except for using IC-3 instead of IC-1.
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol) GC-Mass (Theoretical value: 486.18 g / mol, Measured value: 486 g / mol)
[합성예 109] 화합물 1의 합성Synthesis Example 109 Synthesis of Compound 1
<단계 1> 2,5-Diphenylpyridine (L1)의 합성<Step 1> Synthesis of 2,5-Diphenylpyridine (L1)
Figure PCTKR2013007669-appb-I000247
Figure PCTKR2013007669-appb-I000247
질소 기류 하에서 23.70 g (0.1 mol)의 2,5-dibromopyridine, 30.48 g (0.25 mol)의 phenylboronic acid, 41.46 g (0.3 mol)의 무수 K2CO3와 800 ml/300 ml의 toluene/H2O를 넣고 교반하였다. 40℃에서 5.78 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 2,5-Diphenylpyridine (L1) 19.20 g (yield: 83 %)을 얻었다.23.70 g (0.1 mol) of 2,5-dibromopyridine, 30.48 g (0.25 mol) of phenylboronic acid, 41.46 g (0.3 mol) of anhydrous K 2 CO 3 and 800 ml / 300 ml of toluene / H 2 O under nitrogen stream Was added and stirred. 5.78 g (5 mol%) of Pd (PPh 3 ) 4 was added at 40 ° C. and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. After removal of the solvent of the filtered organic layer, 19.20 g (yield: 83%) of 2,5-Diphenylpyridine (L1) was obtained using column chromatography.
<단계 2> 2,5-Diphenylpyridinato iridium dimer (D1)의 합성<Step 2> Synthesis of 2,5-Diphenylpyridinato iridium dimer (D1)
Figure PCTKR2013007669-appb-I000248
Figure PCTKR2013007669-appb-I000248
질소 기류 하에서 5.0 g (13.8 mmol)의 IrCl3·xH2O와 상기 L1(9.6 g, 41.4 mmol)을 120 ml의 2-methoxyethanol과 40 ml의 물 혼합용매에 넣어 20 시간 동안 환류시켰다. 반응혼합물을 실온까지 온도를 내린 후 생성된 침전물을 여과하고 아세톤과 에탄올 1:1 비율의 용매로 생성물을 정제하여 D1 (9.31 g, 수율 98 %)을 얻었다.Under a nitrogen stream, 5.0 g (13.8 mmol) of IrCl 3 xH 2 O and the L 1 (9.6 g, 41.4 mmol) were added to 120 ml of 2-methoxyethanol and 40 ml of a mixed solvent and refluxed for 20 hours. After cooling the reaction mixture to room temperature, the resulting precipitate was filtered and the product was purified with acetone and ethanol 1: 1 solvent to give D1 (9.31 g, yield 98%).
<단계 3> 용매 배위 양이온성 중간체 (I1)의 합성Step 3 Synthesis of Solvent Coordination Cationic Intermediate (I1)
Figure PCTKR2013007669-appb-I000249
Figure PCTKR2013007669-appb-I000249
상기 D1 (8.0 g, 5.81 mmol)과 AgPF6 (3.67 g, 14.53 mmol)을 메틸렌클로라이드 300 ml와 메탄올 100 ml의 혼합용매에 넣어주고 질소 기류하에서 6시간동안 실온에서 교반시킨다. 반응 혼합물을 셀라이트를 통과시켜 AgCl를 제거하고 여액을 감압 증류하여 90 % 정도의 용매를 제거한 다음 추가로 에틸에테르와 헥산을 넣어주어 목적하는 중간체 화합물 I1 (8.62 g, 수율 86 %)을 분리하였다. D1 above (8.0 g, 5.81 mmol) and AgPF6 (3.67 g, 14.53 mmol) was added to a mixed solvent of 300 ml of methylene chloride and 100 ml of methanol and stirred at room temperature for 6 hours under a stream of nitrogen. The reaction mixture was passed through celite to remove AgCl, the filtrate was distilled under reduced pressure to remove about 90% of solvent, and then ethyl ether and hexane were added thereto to separate target intermediate compound I1 (8.62 g, yield 86%). .
<단계 4> 화합물 1의 합성Step 4 Synthesis of Compound 1
Figure PCTKR2013007669-appb-I000250
Figure PCTKR2013007669-appb-I000250
상기 중간체 화합물 I1 (8.62 g, 10.0 mmol)와 L1 (6.94 g, 30 mmol)을 300 ml의 에탄올에 넣어 20시간 동안 질소 대기 하에서 환류시켰다. 반응이 종결된 후 여과하여 얻어진 침전물을 컬럼 크로마토그래피로 정제하여 목적 화합물인 compound 1 (8.12 g, 수율 92 %)을 얻었다.The intermediate compound I1 (8.62 g, 10.0 mmol) and L1 (6.94 g, 30 mmol) were added to 300 ml of ethanol and refluxed under nitrogen atmosphere for 20 hours. After completion of the reaction, the precipitate obtained by filtration was purified by column chromatography to obtain compound 1 (8.12 g, yield 92%) as a target compound.
GC-Mass (이론치: 883.07 g/mol, 측정치: 883 g/mol)GC-Mass (Theoretical value: 883.07 g / mol, Measured value: 883 g / mol)
[합성예 110] 화합물 9의 합성Synthesis Example 110 Synthesis of Compound 9
<단계 1> 2-phenylpyridine (L2)의 합성<Step 1> Synthesis of 2-phenylpyridine (L2)
Figure PCTKR2013007669-appb-I000251
Figure PCTKR2013007669-appb-I000251
2,5-dibromopyridine 대신 2-bromopyridine을 사용한 것을 제외하고 상기 합성예 109의 <단계 1>과 동일한 방법을 이용하여 L2 (13.2 g, 수율 85 %)를 얻었다.L2 (13.2 g, yield 85%) was obtained by the same method as <Step 1> of Synthesis Example 109, except that 2-bromopyridine was used instead of 2,5-dibromopyridine.
<단계 2> 2- phenylpyridinato iridium dimer (D2)의 합성<Step 2> Synthesis of 2-phenylpyridinato iridium dimer (D2)
Figure PCTKR2013007669-appb-I000252
Figure PCTKR2013007669-appb-I000252
L1 대신 상기 L2을 사용한 것을 제외하고 상기 합성예 109의 <단계 2>와 동일한 방법을 이용하여 D2 (7.59 g, 수율 92 %)를 얻었다.D2 (7.59 g, Yield 92%) was obtained in the same manner as in <Step 2> of Synthesis Example 109 except for using L2 instead of L1.
<단계 3> 용매 배위 양이온성 중간체 (I2)의 합성Step 3 Synthesis of Solvent Coordination Cationic Intermediate (I2)
Figure PCTKR2013007669-appb-I000253
Figure PCTKR2013007669-appb-I000253
D1 대신 상기 D2를 사용한 것을 제외하고 상기 합성예 109의 <단계 3>과 동일한 방법을 이용하여 중간체 화합물 I2 (6.28 g, 수율 85 %)를 얻었다.Intermediate compound I2 (6.28 g, Yield 85%) was obtained by the same method as <Step 3> of Synthesis Example 109, except that D2 was used instead of D1.
<단계 4> 화합물 9의 합성Step 4 Synthesis of Compound 9
Figure PCTKR2013007669-appb-I000254
Figure PCTKR2013007669-appb-I000254
I1 대신 상기 I2를 사용한 것을 제외하고 상기 합성예 109의 <단계 4>와 동일한 방법을 이용하여 목적 화합물인 compound 9 (6.07 g, 수율 83 %)를 얻었다.Compound 9 (6.07 g, 83% yield) was obtained by the same method as <Step 4> of Synthesis Example 109, except that I2 was used instead of I1.
GC-Mass (이론치: 730.88 g/mol, 측정치:731 g/mol)GC-Mass (Theoretical value: 730.88 g / mol, Measured value: 731 g / mol)
[합성예 111] 화합물 149의 제조Synthesis Example 111 Preparation of Compound 149
<단계 1> 2-biphenyl-3-yl-pyridine (L3)의 합성<Step 1> Synthesis of 2-biphenyl-3-yl-pyridine (L3)
Figure PCTKR2013007669-appb-I000255
Figure PCTKR2013007669-appb-I000255
phenylboronic acid 대신 3-biphenylboronic acid를 사용한 것을 제외하고 상기 합성예 110의 <단계 1>과 동일한 방법을 이용하여 L3 (20.59 g, 수율 89 %)를 얻었다.L3 (20.59 g, yield 89%) was obtained by the same method as <step 1> of Synthesis Example 110, except that 3-biphenylboronic acid was used instead of phenylboronic acid.
<단계 2> 화합물 149의 합성Step 2 Synthesis of Compound 149
Figure PCTKR2013007669-appb-I000256
Figure PCTKR2013007669-appb-I000256
질소 기류 하에서 5.0 g (10.0 mmol)의 Ir(acac)3와 상기 L3 (6.94 g, 30.0 mmol)을 glycerol 30 ml에 넣고 24 시간 동안 환류시켰다. 반응이 종결된 후 여과하여 얻어진 침전물을 컬럼 크로마토그래피로 정제하여 목적 화합물인 compound 149 (2.47 g, 수율 28 %)을 얻었다.5.0 g (10.0 mmol) Ir (acac) under nitrogen stream3And L3 (6.94 g, 30.0 mmol) were added to 30 ml of glycerol and refluxed for 24 hours. After the reaction was completed, the precipitate obtained by filtration was purified by column chromatography to obtain compound 149 as a target compound. (2.47 g, yield 28%) was obtained.
GC-Mass (이론치: 883.07 g/mol, 측정치: 883 g/mol)GC-Mass (Theoretical value: 883.07 g / mol, Measured value: 883 g / mol)
[합성예 112] 화합물 164의 합성Synthesis Example 112 Synthesis of Compound 164
<단계 1> 2-phenylquinoline (L4)의 합성Step 1 Synthesis of 2-phenylquinoline (L4)
Figure PCTKR2013007669-appb-I000257
Figure PCTKR2013007669-appb-I000257
질소 기류 하에서 20.8 g (0.1 mol)의 2-bromoquinoline, 14.63 g (0.12 mol)의 phenylboronic acid, 41.46 g (0.3 mol)의 무수 K2CO3와 800 ml/300 ml의 toluene/H2O를 넣고 교반하였다. 40℃에서 5.78 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 2-phenylquinoline (L4) 16.40 g (yield: 80 %)을 얻었다.Add 20.8 g (0.1 mol) of 2-bromoquinoline, 14.63 g (0.12 mol) of phenylboronic acid, 41.46 g (0.3 mol) of anhydrous K 2 CO 3 and 800 ml / 300 ml of toluene / H 2 O under a nitrogen stream. Stirred. 5.78 g (5 mol%) of Pd (PPh 3 ) 4 was added at 40 ° C. and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride and MgSO 4 was added and filtered. After removal of the solvent of the filtered organic layer, 16.40 g (yield: 80%) of 2-phenylquinoline (L4) was obtained using column chromatography.
<단계 2> 2-phenylquinolinato iridium dimer (D4)의 합성<Step 2> Synthesis of 2-phenylquinolinato iridium dimer (D4)
Figure PCTKR2013007669-appb-I000258
Figure PCTKR2013007669-appb-I000258
질소 기류 하에서 5.0 g (13.8 mmol)의 IrCl3·xH2O와 상기 L4 (8.49 g, 41.4 mmol)을 120 ml의 2-methoxyethanol과 40 ml의 물 혼합용매에 넣어 20 시간 동안 환류시켰다. 반응혼합물을 실온까지 온도를 내린 후 생성된 침전물을 여과하고 아세톤과 에탄올 1:1 비율의 용매로 생성물을 정제하여 D4 (8.49 g, 수율 95 %)을 얻었다.Under nitrogen stream, 5.0 g (13.8 mmol) of IrCl 3 xH 2 O and the L4 (8.49 g, 41.4 mmol) were added to 120 ml of 2-methoxyethanol and 40 ml of a mixed solvent and refluxed for 20 hours. After cooling the reaction mixture to room temperature, the resulting precipitate was filtered and the product was purified with acetone and ethanol in a 1: 1 ratio solvent to obtain D4 (8.49 g, yield 95%).
<단계 3> 화합물 164의 합성Step 3 Synthesis of Compound 164
Figure PCTKR2013007669-appb-I000259
Figure PCTKR2013007669-appb-I000259
상기 D4 (5.01 g, 5.81 mmol)과 2,4-pentanedione (1.74 g, 17.4 mmol ), 무수 Na2CO3(4.82 g, 34.86 mol)을 120 ml의 2-ethoxyethanol에 넣어 환류시켰다. 반응혼합물을 실온까지 온도를 내린 후 생성된 침전물을 여과하고, 컬럼 크로마토그래피로 분리, 재결정하여 목적물인 compound 164 (2.64 g, 수율 92 %)을 얻었다.D4 above (5.01 g, 5.81 mmol) and 2,4-pentanedione (1.74 g, 17.4 mmol), anhydrous Na2CO3(4.82 g, 34.86 mol) was refluxed in 120 ml of 2-ethoxyethanol. After cooling the reaction mixture to room temperature, the resulting precipitate was filtered, separated by column chromatography, and recrystallized to obtain the desired compound 164 (2.64 g, yield 92%).
GC-Mass (이론치: 496.09 g/mol, 측정치: 496 g/mol)GC-Mass (Theoretical value: 496.09 g / mol, Measured value: 496 g / mol)
[실시예 1 내지 103][Examples 1 to 103]
합성예 1 내지 103에서 합성한 화합물 Inv-1 내지 Inv-103 및 합성예 109의 compound 1을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 전계 발광 소자를 제조하였다.Compounds Inv-1 to Inv-103 synthesized in Synthesis Examples 1 to 103 and compound 1 of Synthesis Example 109 were subjected to high purity sublimation purification by a conventionally known method, and then a green organic EL device was manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500 Å두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, the glass substrate coated with ITO (Indium tin oxide) with a thin film thickness of 1500 초음파 was ultrasonically washed with distilled water. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech), and then the substrate is cleaned for 5 minutes by UV and vacuum evaporator The substrate was transferred to.
이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/Inv-1 내지 Inv-103 각각의 화합물(90%) + 합성예 109의 화합물 1(10%) (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.M-MTDATA (60 nm) / TCTA (80 nm) / Inv-1 to Inv-103 compound (90%) + compound 1 (10%) of Synthesis Example 109 (300 nm) on the thus prepared ITO transparent substrate (electrode) ) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) were laminated in order to prepare an organic EL device.
[실시예 104 내지 114][Examples 104 to 114]
발광층 형성시 발광 호스트 물질로서 화합물 Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv-31, Inv-87을, 발광 도펀트 물질로서 합성예 110의 compound 9를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.Compound Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv-31, Inv- 87, a green organic electroluminescent device was manufactured in the same manner as in Example 1 except that Compound 9 of Synthesis Example 110 was used as a light emitting dopant material.
[실시예 115 내지 125][Examples 115 to 125]
발광층 형성시 발광 호스트 물질로서 화합물 Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv-31, Inv-87을, 발광 도펀트 물질로서 합성예 111의 compound 149를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.Compound Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv-31, Inv- 87, a green organic electroluminescent device was manufactured in the same manner as in Example 1, except that compound 149 of Synthesis Example 111 was used as the light emitting dopant material.
[실시예 126 내지 131][Examples 126 to 131]
발광층 형성시 발광 호스트 물질로서 화합물 Inv-18, Inv-104, Inv-105, Inv-106, Inv-107, Inv-108을, 발광 도펀트 물질로서 합성예 112의 compound 164를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.Except for using compound Inv-18, Inv-104, Inv-105, Inv-106, Inv-107, Inv-108 as a light emitting host material and compound 164 of Synthesis Example 112 as a light emitting dopant material. In the same manner as in Example 1, a green organic EL device was manufactured.
[비교예 1]Comparative Example 1
발광층 형성시 발광 호스트 물질로서 화합물 Inv-1 대신 CBP를, 발광 도펀트 물질로서 합성예 109의 compound 1 대신 Ir(ppy)3를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.A green organic electroluminescent device in the same manner as in Example 1, except that CBP instead of Compound Inv-1 and Ir (ppy) 3 instead of Compound 1 of Synthesis Example 109 are used as a light emitting dopant material when forming the emission layer. Was prepared.
[비교예 2]Comparative Example 2
발광층 형성시 발광 호스트 물질로서 화합물 Inv-18 대신 CBP를, 발광 도펀트 물질로서 합성예 112의 화합물 164 대신 Ir(piq)2(acac)를 사용하는 것을 제외하고는 실시예 126과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.Green organic light-emitting process was carried out in the same manner as in Example 126, except that CBP was used instead of Compound Inv-18 as a light emitting host material and Ir (piq) 2 (acac) was used instead of Compound 164 of Synthesis Example 112 as a light emitting dopant material. An electroluminescent device was manufactured.
사용된 m-MTDATA, TCTA, Ir(ppy)3, Ir(piq)2(acac), CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , Ir (piq) 2 (acac), CBP and BCP used are as follows.
Figure PCTKR2013007669-appb-I000260
Figure PCTKR2013007669-appb-I000260
Figure PCTKR2013007669-appb-I000261
Figure PCTKR2013007669-appb-I000261
[평가예 1][Evaluation Example 1]
실시예 1 내지 125 및 비교예 1 각각의 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 발광피크, 전류효율을 측정하고, 그 결과를 하기 표 1에 나타내었다. For each organic electroluminescent device of Examples 1 to 125 and Comparative Example 1, the driving voltage, the light emission peak, and the current efficiency at a current density of 10 mA / cm 2 were measured, and the results are shown in Table 1 below.
표 1
샘플 호스트 도펀트 구동 전압(V) EL 피크(nm) 전류효율(cd/A)
실시예 1 Inv-1 화합물 1 6.60 545 41.4
실시예 2 Inv-2 화합물 1 6.55 549 42.9
실시예 3 Inv-3 화합물 1 6.52 546 43.2
실시예 4 Inv-4 화합물 1 6.65 546 43.5
실시예 5 Inv-5 화합물 1 6.72 543 41.7
실시예 6 Inv-6 화합물 1 6.68 546 42.1
실시예 7 Inv-7 화합물 1 6.62 546 42.6
실시예 8 Inv-8 화합물 1 6.66 547 42.4
실시예 9 Inv-9 화합물 1 6.85 548 41.8
실시예 12 Inv-12 화합물 1 6.72 549 41.1
실시예 11 Inv-11 화합물 1 6.65 545 42.1
실시예 12 Inv-12 화합물 1 6.62 544 42.8
실시예 13 Inv-13 화합물 1 6.75 546 42.2
실시예 14 Inv-14 화합물 1 6.73 545 42.9
실시예 15 Inv-15 화합물 1 6.72 543 41.2
실시예 16 Inv-16 화합물 1 6.64 546 39.9
실시예 17 Inv-17 화합물 1 6.59 547 40.9
실시예 18 Inv-18 화합물 1 6.61 543 42.6
실시예 19 Inv-19 화합물 1 6.69 548 41.2
실시예 22 Inv-22 화합물 1 6.62 544 42.7
실시예 21 Inv-21 화합물 1 6.65 546 41.3
실시예 22 Inv-22 화합물 1 6.67 548 42.0
실시예 23 Inv-23 화합물 1 6.62 545 41.1
실시예 24 Inv-24 화합물 1 6.75 546 42.0
실시예 25 Inv-25 화합물 1 6.72 547 41.9
실시예 26 Inv-26 화합물 1 6.75 545 42.3
실시예 27 Inv-27 화합물 1 6.64 547 42.2
실시예 28 Inv-28 화합물 1 6.62 548 41.1
실시예 29 Inv-29 화합물 1 6.64 547 42.0
실시예 32 Inv-32 화합물 1 6.72 546 41.8
실시예 31 Inv-31 화합물 1 6.65 543 41.3
실시예 32 Inv-32 화합물 1 6.66 549 42.2
실시예 33 Inv-33 화합물 1 6.64 541 41.3
실시예 34 Inv-34 화합물 1 6.75 546 41.8
실시예 35 Inv-35 화합물 1 6.72 543 42.5
실시예 36 Inv-36 화합물 1 6.69 546 42.9
실시예 37 Inv-37 화합물 1 6.65 544 41.3
실시예 38 Inv-38 화합물 1 6.68 547 41.7
실시예 39 Inv-39 화합물 1 6.61 548 41.6
실시예 42 Inv-42 화합물 1 6.72 544 42.4
실시예 41 Inv-41 화합물 1 6.65 546 42.3
실시예 42 Inv-42 화합물 1 6.62 548 41.2
실시예 43 Inv-43 화합물 1 6.61 545 41.8
실시예 44 Inv-44 화합물 1 6.55 546 42.1
실시예 45 Inv-45 화합물 1 6.66 547 41.0
실시예 46 Inv-46 화합물 1 6.63 546 42.2
실시예 47 Inv-47 화합물 1 6.65 547 41.3
실시예 48 Inv-48 화합물 1 6.62 548 42.1
실시예 49 Inv-49 화합물 1 6.69 545 42.6
실시예 52 Inv-52 화합물 1 6.62 546 41.1
실시예 51 Inv-51 화합물 1 6.72 544 42.5
실시예 52 Inv-52 화합물 1 6.65 546 41.2
실시예 53 Inv-53 화합물 1 6.66 548 41.5
실시예 54 Inv-54 화합물 1 6.67 543 42.0
실시예 55 Inv-55 화합물 1 6.59 547 41.9
실시예 56 Inv-56 화합물 1 6.51 546 42.3
실시예 57 Inv-57 화합물 1 6.55 544 42.3
실시예 58 Inv-58 화합물 1 6.63 546 41.2
실시예 59 Inv-59 화합물 1 6.65 545 42.2
실시예 62 Inv-62 화합물 1 6.65 546 41.3
실시예 61 Inv-61 화합물 1 6.62 542 41.5
실시예 62 Inv-62 화합물 1 6.72 542 42.0
실시예 63 Inv-63 화합물 1 6.72 546 42.3
실시예 64 Inv-64 화합물 1 6.68 546 41.2
실시예 65 Inv-65 화합물 1 6.65 545 41.0
실시예 66 Inv-66 화합물 1 6.71 546 41.1
실시예 67 Inv-67 화합물 1 6.65 547 41.3
실시예 68 Inv-68 화합물 1 6.67 548 41.1
실시예 69 Inv-69 화합물 1 6.62 547 42.1
실시예 72 Inv-72 화합물 1 6.69 544 41.9
실시예 71 Inv-71 화합물 1 6.65 544 41.1
실시예 72 Inv-72 화합물 1 6.73 542 42.3
실시예 73 Inv-73 화합물 1 6.75 544 42.2
실시예 74 Inv-74 화합물 1 6.65 543 41.2
실시예 75 Inv-75 화합물 1 6.74 547 42.7
실시예 76 Inv-76 화합물 1 6.72 547 41.3
실시예 77 Inv-77 화합물 1 6.82 547 42.5
실시예 78 Inv-78 화합물 1 6.65 545 41.1
실시예 79 Inv-79 화합물 1 6.65 547 41.0
실시예 82 Inv-82 화합물 1 6.73 547 42.0
실시예 81 Inv-81 화합물 1 6.73 545 41.5
실시예 82 Inv-82 화합물 1 6.65 546 42.2
실시예 83 Inv-83 화합물 1 6.74 544 41.8
실시예 84 Inv-84 화합물 1 6.72 546 41.3
실시예 85 Inv-85 화합물 1 6.69 547 42.1
실시예 86 Inv-86 화합물 1 6.65 546 42.0
실시예 87 Inv-87 화합물 1 6.62 544 41.3
실시예 88 Inv-88 화합물 1 6.66 543 41.1
실시예 89 Inv-89 화합물 1 6.59 547 40.1
실시예 92 Inv-92 화합물 1 6.62 545 41.9
실시예 91 Inv-91 화합물 1 6.65 548 41.1
실시예 92 Inv-92 화합물 1 6.62 544 40.3
실시예 93 Inv-93 화합물 1 6.72 541 42.2
실시예 94 Inv-94 화합물 1 6.65 545 41.2
실시예 95 Inv-95 화합물 1 6.64 542 40.7
실시예 96 Inv-96 화합물 1 6.59 542 41.3
실시예 97 Inv-97 화합물 1 6.55 544 40.8
실시예 98 Inv-98 화합물 1 6.55 543 41.1
실시예 99 Inv-99 화합물 1 6.68 543 40.8
실시예 100 Inv-100 화합물 1 6.72 544 40.9
실시예 101 Inv-101 화합물 1 6.65 545 41.1
실시예 102 Inv-102 화합물 1 6.72 544 42.3
실시예 103 Inv-103 화합물 1 6.72 544 42.2
실시예 104 Inv-3 화합물 9 6.65 541 41.8
실시예 105 Inv-5 화합물 9 6.52 542 42.7
실시예 106 Inv-6 화합물 9 6.65 542 41.5
실시예 107 Inv-7 화합물 9 6.69 542 42.5
실시예 108 Inv-8 화합물 9 6.62 543 41.9
실시예 109 Inv-18 화합물 9 6.55 542 42.0
실시예 110 Inv-21 화합물 9 6.59 541 42.0
실시예 111 Inv-23 화합물 9 6.72 541 41.5
실시예 112 Inv-30 화합물 9 6.72 541 42.2
실시예 113 Inv-31 화합물 9 6.65 543 41.8
실시예 114 Inv-87 화합물 9 6.59 545 41.3
실시예 115 Inv-3 화합물 149 6.62 522 42.1
실시예 116 Inv-5 화합물 149 6.71 519 41.7
실시예 117 Inv-6 화합물 149 6.65 517 41.3
실시예 118 Inv-7 화합물 149 6.62 518 41.1
실시예 119 Inv-8 화합물 149 6.64 517 42.1
실시예 122 Inv-18 화합물 149 6.59 522 41.9
실시예 121 Inv-21 화합물 149 6.62 518 41.1
실시예 122 Inv-23 화합물 149 6.64 519 42.3
실시예 123 Inv-30 화합물 149 6.62 521 42.2
실시예 124 Inv-31 화합물 149 6.62 522 41.2
실시예 125 Inv-87 화합물 149 6.72 522 42.7
비교예 1 CBP Ir(ppy)3 6.93 516 38.2
Table 1
Sample Host Dopant Drive voltage (V) EL peak (nm) Current efficiency (cd / A)
Example 1 Inv-1 Compound 1 6.60 545 41.4
Example 2 Inv-2 Compound 1 6.55 549 42.9
Example 3 Inv-3 Compound 1 6.52 546 43.2
Example 4 Inv-4 Compound 1 6.65 546 43.5
Example 5 Inv-5 Compound 1 6.72 543 41.7
Example 6 Inv-6 Compound 1 6.68 546 42.1
Example 7 Inv-7 Compound 1 6.62 546 42.6
Example 8 Inv-8 Compound 1 6.66 547 42.4
Example 9 Inv-9 Compound 1 6.85 548 41.8
Example 12 Inv-12 Compound 1 6.72 549 41.1
Example 11 Inv-11 Compound 1 6.65 545 42.1
Example 12 Inv-12 Compound 1 6.62 544 42.8
Example 13 Inv-13 Compound 1 6.75 546 42.2
Example 14 Inv-14 Compound 1 6.73 545 42.9
Example 15 Inv-15 Compound 1 6.72 543 41.2
Example 16 Inv-16 Compound 1 6.64 546 39.9
Example 17 Inv-17 Compound 1 6.59 547 40.9
Example 18 Inv-18 Compound 1 6.61 543 42.6
Example 19 Inv-19 Compound 1 6.69 548 41.2
Example 22 Inv-22 Compound 1 6.62 544 42.7
Example 21 Inv-21 Compound 1 6.65 546 41.3
Example 22 Inv-22 Compound 1 6.67 548 42.0
Example 23 Inv-23 Compound 1 6.62 545 41.1
Example 24 Inv-24 Compound 1 6.75 546 42.0
Example 25 Inv-25 Compound 1 6.72 547 41.9
Example 26 Inv-26 Compound 1 6.75 545 42.3
Example 27 Inv-27 Compound 1 6.64 547 42.2
Example 28 Inv-28 Compound 1 6.62 548 41.1
Example 29 Inv-29 Compound 1 6.64 547 42.0
Example 32 Inv-32 Compound 1 6.72 546 41.8
Example 31 Inv-31 Compound 1 6.65 543 41.3
Example 32 Inv-32 Compound 1 6.66 549 42.2
Example 33 Inv-33 Compound 1 6.64 541 41.3
Example 34 Inv-34 Compound 1 6.75 546 41.8
Example 35 Inv-35 Compound 1 6.72 543 42.5
Example 36 Inv-36 Compound 1 6.69 546 42.9
Example 37 Inv-37 Compound 1 6.65 544 41.3
Example 38 Inv-38 Compound 1 6.68 547 41.7
Example 39 Inv-39 Compound 1 6.61 548 41.6
Example 42 Inv-42 Compound 1 6.72 544 42.4
Example 41 Inv-41 Compound 1 6.65 546 42.3
Example 42 Inv-42 Compound 1 6.62 548 41.2
Example 43 Inv-43 Compound 1 6.61 545 41.8
Example 44 Inv-44 Compound 1 6.55 546 42.1
Example 45 Inv-45 Compound 1 6.66 547 41.0
Example 46 Inv-46 Compound 1 6.63 546 42.2
Example 47 Inv-47 Compound 1 6.65 547 41.3
Example 48 Inv-48 Compound 1 6.62 548 42.1
Example 49 Inv-49 Compound 1 6.69 545 42.6
Example 52 Inv-52 Compound 1 6.62 546 41.1
Example 51 Inv-51 Compound 1 6.72 544 42.5
Example 52 Inv-52 Compound 1 6.65 546 41.2
Example 53 Inv-53 Compound 1 6.66 548 41.5
Example 54 Inv-54 Compound 1 6.67 543 42.0
Example 55 Inv-55 Compound 1 6.59 547 41.9
Example 56 Inv-56 Compound 1 6.51 546 42.3
Example 57 Inv-57 Compound 1 6.55 544 42.3
Example 58 Inv-58 Compound 1 6.63 546 41.2
Example 59 Inv-59 Compound 1 6.65 545 42.2
Example 62 Inv-62 Compound 1 6.65 546 41.3
Example 61 Inv-61 Compound 1 6.62 542 41.5
Example 62 Inv-62 Compound 1 6.72 542 42.0
Example 63 Inv-63 Compound 1 6.72 546 42.3
Example 64 Inv-64 Compound 1 6.68 546 41.2
Example 65 Inv-65 Compound 1 6.65 545 41.0
Example 66 Inv-66 Compound 1 6.71 546 41.1
Example 67 Inv-67 Compound 1 6.65 547 41.3
Example 68 Inv-68 Compound 1 6.67 548 41.1
Example 69 Inv-69 Compound 1 6.62 547 42.1
Example 72 Inv-72 Compound 1 6.69 544 41.9
Example 71 Inv-71 Compound 1 6.65 544 41.1
Example 72 Inv-72 Compound 1 6.73 542 42.3
Example 73 Inv-73 Compound 1 6.75 544 42.2
Example 74 Inv-74 Compound 1 6.65 543 41.2
Example 75 Inv-75 Compound 1 6.74 547 42.7
Example 76 Inv-76 Compound 1 6.72 547 41.3
Example 77 Inv-77 Compound 1 6.82 547 42.5
Example 78 Inv-78 Compound 1 6.65 545 41.1
Example 79 Inv-79 Compound 1 6.65 547 41.0
Example 82 Inv-82 Compound 1 6.73 547 42.0
Example 81 Inv-81 Compound 1 6.73 545 41.5
Example 82 Inv-82 Compound 1 6.65 546 42.2
Example 83 Inv-83 Compound 1 6.74 544 41.8
Example 84 Inv-84 Compound 1 6.72 546 41.3
Example 85 Inv-85 Compound 1 6.69 547 42.1
Example 86 Inv-86 Compound 1 6.65 546 42.0
Example 87 Inv-87 Compound 1 6.62 544 41.3
Example 88 Inv-88 Compound 1 6.66 543 41.1
Example 89 Inv-89 Compound 1 6.59 547 40.1
Example 92 Inv-92 Compound 1 6.62 545 41.9
Example 91 Inv-91 Compound 1 6.65 548 41.1
Example 92 Inv-92 Compound 1 6.62 544 40.3
Example 93 Inv-93 Compound 1 6.72 541 42.2
Example 94 Inv-94 Compound 1 6.65 545 41.2
Example 95 Inv-95 Compound 1 6.64 542 40.7
Example 96 Inv-96 Compound 1 6.59 542 41.3
Example 97 Inv-97 Compound 1 6.55 544 40.8
Example 98 Inv-98 Compound 1 6.55 543 41.1
Example 99 Inv-99 Compound 1 6.68 543 40.8
Example 100 Inv-100 Compound 1 6.72 544 40.9
Example 101 Inv-101 Compound 1 6.65 545 41.1
Example 102 Inv-102 Compound 1 6.72 544 42.3
Example 103 Inv-103 Compound 1 6.72 544 42.2
Example 104 Inv-3 Compound 9 6.65 541 41.8
Example 105 Inv-5 Compound 9 6.52 542 42.7
Example 106 Inv-6 Compound 9 6.65 542 41.5
Example 107 Inv-7 Compound 9 6.69 542 42.5
Example 108 Inv-8 Compound 9 6.62 543 41.9
Example 109 Inv-18 Compound 9 6.55 542 42.0
Example 110 Inv-21 Compound 9 6.59 541 42.0
Example 111 Inv-23 Compound 9 6.72 541 41.5
Example 112 Inv-30 Compound 9 6.72 541 42.2
Example 113 Inv-31 Compound 9 6.65 543 41.8
Example 114 Inv-87 Compound 9 6.59 545 41.3
Example 115 Inv-3 Compound 149 6.62 522 42.1
Example 116 Inv-5 Compound 149 6.71 519 41.7
Example 117 Inv-6 Compound 149 6.65 517 41.3
Example 118 Inv-7 Compound 149 6.62 518 41.1
Example 119 Inv-8 Compound 149 6.64 517 42.1
Example 122 Inv-18 Compound 149 6.59 522 41.9
Example 121 Inv-21 Compound 149 6.62 518 41.1
Example 122 Inv-23 Compound 149 6.64 519 42.3
Example 123 Inv-30 Compound 149 6.62 521 42.2
Example 124 Inv-31 Compound 149 6.62 522 41.2
Example 125 Inv-87 Compound 149 6.72 522 42.7
Comparative Example 1 CBP Ir (ppy) 3 6.93 516 38.2
상기 표 1을 참고하면, 본 발명에 따른 화합물(Inv-1 내지 Inv-103)을 발광층의 호스트로, 본 발명에 따른 화합물(화합물 1, 9 및 149)을 발광층의 도펀트로 적용한 본 발명의 유기 전계 발광 소자는 종래 유기 전계 발광 소자(비교예1)보다 효율 및 구동전압 면에서 보다 우수한 성능을 나타내며 도펀트에 따라 다양한 발광 파장을 가짐을 알 수 있다.Referring to Table 1, the organic compound of the present invention is applied to the compound (Inv-1 to Inv-103) according to the invention as a host of the light emitting layer, and the compound (compounds 1, 9 and 149) according to the present invention as a dopant of the light emitting layer The electroluminescent device exhibits better performance in terms of efficiency and driving voltage than the conventional organic electroluminescent device (Comparative Example 1) and has various emission wavelengths depending on the dopant.
[평가예 2][Evaluation Example 2]
실시예 126 내지 131 및 비교예 2 각각의 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 발광피크, 전류효율을 측정하고, 그 결과를 하기 표 2에 나타내었다.For each organic electroluminescent device of Examples 126 to 131 and Comparative Example 2, the driving voltage, the light emission peak, and the current efficiency at a current density of 10 mA / cm 2 were measured, and the results are shown in Table 2 below.
표 2
샘플 호스트 도펀트 구동 전압(V) EL 피크(nm) 전류효율(cd/A)
실시예 126 Inv-18 화합물 164 6.60 610 14.4
실시예 127 Inv-104 화합물 164 6.55 612 43.9
실시예 128 Inv-105 화합물 164 6.52 619 14.2
실시예 129 Inv-106 화합물 164 6.65 617 13.5
실시예 130 Inv-107 화합물 164 6.72 618 13.7
실시예 131 Inv-108 화합물 164 6.68 617 13.1
비교예 2 CBP Ir(piq)2(acac) 5.25 620 8.2
TABLE 2
Sample Host Dopant Drive voltage (V) EL peak (nm) Current efficiency (cd / A)
Example 126 Inv-18 Compound 164 6.60 610 14.4
Example 127 Inv-104 Compound 164 6.55 612 43.9
Example 128 Inv-105 Compound 164 6.52 619 14.2
Example 129 Inv-106 Compound 164 6.65 617 13.5
Example 130 Inv-107 Compound 164 6.72 618 13.7
Example 131 Inv-108 Compound 164 6.68 617 13.1
Comparative Example 2 CBP Ir (piq) 2 (acac) 5.25 620 8.2
상기 표 2를 참조하면, 본 발명에 따른 화합물(Inv-18, Inv-104 내지 Inv-108)을 발광층의 호스트로, 본 발명에 따른 화합물(화합물 164)을 발광층의 도펀트로 적용한 본 발명의 유기 전계 발광 소자는 종래 유기 전계 발광 소자(비교예2)보다 효율 및 구동전압 면에서 보다 우수한 성능을 나타냄을 알 수 있다.Referring to Table 2, the organic compound of the present invention is applied to the compound (Inv-18, Inv-104 to Inv-108) according to the invention as a host of the light emitting layer, the compound (compound 164) according to the present invention as a dopant of the light emitting layer It can be seen that the electroluminescent device exhibits better performance in terms of efficiency and driving voltage than the conventional organic electroluminescent device (Comparative Example 2).
본 발명의 유기 전계 발광 소자는 상기 화학식 1로 표시되는 인돌계 화합물을 발광층의 인광 호스트로, 상기 화학식 3으로 표시되는 이리듐 화합물을 발광층의 인광 도판트로 사용함에 따라 호스트-도판트 사이에서 효율적인 에너지 전달이 이루어져 발광성능, 구동전압 및 수명 등의 특성이 우수하다.The organic electroluminescent device of the present invention efficiently transfers energy between a host and a dopant by using the indole compound represented by Chemical Formula 1 as a phosphorescent host of the light emitting layer and the iridium compound represented by Chemical Formula 3 as a phosphorescent dopant of the light emitting layer. This makes it excellent in characteristics such as light emission performance, driving voltage and lifespan.

Claims (8)

  1. 양극; 음극; 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며,anode; cathode; And one or more organic material layers interposed between the anode and the cathode,
    상기 1층 이상의 유기물층 중 적어도 하나는 하기 화학식 1로 표시되는 화합물과 하기 화학식 3으로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자:At least one of the at least one organic material layer is an organic electroluminescent device comprising a compound represented by the following formula (1) and a compound represented by the following formula (3):
    [화학식 1][Formula 1]
    Figure PCTKR2013007669-appb-I000262
    Figure PCTKR2013007669-appb-I000262
    상기 화학식 1에서,In Chemical Formula 1,
    Y1 내지 Y4는 각각 독립적으로, N 또는 CR3이고,Y 1 to Y 4 are each independently N or CR 3 ,
    Y1과 Y2, Y2와 Y3, 또는 Y3와 Y4 중 하나는 하기 화학식 2로 표시되는 축합 고리를 형성하며, One of Y 1 and Y 2 , Y 2 and Y 3 , or Y 3 and Y 4 forms a condensed ring represented by the following Chemical Formula 2,
    [화학식 2][Formula 2]
    Figure PCTKR2013007669-appb-I000263
    Figure PCTKR2013007669-appb-I000263
    상기 화학식 2에서,In Chemical Formula 2,
    점선은 화학식 1의 화합물과 축합이 이루어지는 부위를 의미하며,The dashed line means a site where condensation occurs with the compound of Formula 1,
    Y5 내지 Y8은 각각 독립적으로, N 또는 CR4이고,Y 5 to Y 8 are each independently N or CR 4 ,
    상기 X1 및 X2는 각각 독립적으로, O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고, 이때, X1 및 X2 중에서 적어도 하나는 N(Ar1)이며,X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ), wherein At least one of X 1 and X 2 is N (Ar 1 ),
    상기 R1 내지 R4 및 Ar1 내지 Ar5는 각각 독립적으로, 수소, 중수소, 할로겐기, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되며,R 1 to R 4 and Ar 1 to Ar 5 are each independently hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C Alkynyl group of 2 to C 40 , cycloalkyl group of C 3 to C 40 , heterocycloalkyl group of 3 to 40 nuclear atoms, aryl group of C 6 to C 60 , heteroaryl group of 5 to 60 nuclear atoms, C 1 ~ C 40 alkyloxy group of, C 6 ~ aryloxy C 60, C 1 ~ C 40 alkyl silyl group, C 6 ~ aryl silyl group of C 60, C 1 ~ C 40 group of an alkyl boron, C 6 ~ arylboronic group of C 60, C 6 ~ C 60 aryl phosphine group, and selected from the group consisting of an aryl amine of the C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 of,
    상기 R1 내지 R4는 인접한 기와 결합하여 축합 고리를 형성할 수 있고,R 1 to R 4 may be bonded to an adjacent group to form a condensed ring,
    상기 R1 내지 R4 및 Ar1 내지 Ar5의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있고,The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group of R 1 to R 4 and Ar 1 to Ar 5 , Alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and arylamine group are each independently deuterium, halogen, cyano group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 Heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 boron alkyl group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ from the group consisting of an aryl amine of the C 60 of the May be substituted with one or more selected
    [화학식 3][Formula 3]
    Figure PCTKR2013007669-appb-I000264
    Figure PCTKR2013007669-appb-I000264
    상기 화학식 3에서,In Chemical Formula 3,
    X-Y는 유기 리간드로서, X는 핵원자수 3 내지 40의 헤테로아릴기이고, Y는 C6~C40의 아릴기 또는 핵원자수 3 내지 40의 헤테로아릴기이며,XY is an organic ligand, X is a hetero-aryl group of from 3 to 40 nuclear atoms, Y is a C 6 ~ C 40 heteroaryl group of the aryl group or nuclear atoms of 3 to 40,
    R11 내지 R18은 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,R 11 to R 18 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, amino group, C 1 -C 40 alkyl group, C 3 -C 40 cycloalkyl group, and nuclear atom 3 to 40 heterocyclo Alkyl group, C 6 -C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 to C 40 alkyloxy group, C 6 to C 60 aryloxy group, C 1 to C 40 alkylsilyl group, C 6 ~ C aryl silyl group of 60, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ aryl phosphine of C 60 It is selected from the group consisting of a pin oxide group and an arylamine group of C 6 ~ C 60 , can be combined with adjacent groups to form a condensed ring,
    n은 1 내지 3의 정수이다.n is an integer of 1-3.
  2. 제1항에 있어서,The method of claim 1,
    상기 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자:The compound represented by Chemical Formula 1 is selected from the group consisting of compounds represented by the following Chemical Formulas 1a to 1f:
    [화학식 1a][Formula 1a]
    Figure PCTKR2013007669-appb-I000265
    Figure PCTKR2013007669-appb-I000265
    [화학식 1b][Formula 1b]
    Figure PCTKR2013007669-appb-I000266
    Figure PCTKR2013007669-appb-I000266
    [화학식 1c][Formula 1c]
    [화학식 1d][Formula 1d]
    Figure PCTKR2013007669-appb-I000268
    Figure PCTKR2013007669-appb-I000268
    [화학식 1e][Formula 1e]
    Figure PCTKR2013007669-appb-I000269
    Figure PCTKR2013007669-appb-I000269
    [화학식 1f][Formula 1f]
    Figure PCTKR2013007669-appb-I000270
    Figure PCTKR2013007669-appb-I000270
    상기 화학식 1a 내지 1f에서, X1, X2 및 R1 내지 R4는 제1항에서 정의한 바와 같다.In Formulas 1a to 1f, X 1 , X 2 and R 1 to R 4 are the same as defined in claim 1.
  3. 제1항에 있어서,The method of claim 1,
    상기 화학식 3으로 표시되는 화합물은 하기 화학식 3a 내지 3d로 표시되는 화합물로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자:The compound represented by the formula (3) is an organic electroluminescent device, characterized in that selected from the group consisting of compounds represented by the formula (3a to 3d):
    [화학식 3a][Formula 3a]
    Figure PCTKR2013007669-appb-I000271
    Figure PCTKR2013007669-appb-I000271
    [화학식 3b][Formula 3b]
    Figure PCTKR2013007669-appb-I000272
    Figure PCTKR2013007669-appb-I000272
    [화학식 3c][Formula 3c]
    Figure PCTKR2013007669-appb-I000273
    Figure PCTKR2013007669-appb-I000273
    [화학식 3d][Formula 3d]
    Figure PCTKR2013007669-appb-I000274
    Figure PCTKR2013007669-appb-I000274
    상기 화학식 3a 내지 3d에서, X, Y, n 및 R11 내지 R18은 제1항에서 정의한 바와 같으며,In Chemical Formulas 3a to 3d, X, Y, n, and R 11 to R 18 are the same as defined in claim 1,
    상기 Ra 및 R21 내지 R25는 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,Ra and R 21 to R 25 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, nuclear atom 3 to 40 Heterocycloalkyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 Alkyl silyl group, C 6 ~ C 60 aryl silyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 Is selected from the group consisting of an aryl phosphine oxide group and an arylamine group of C 6 ~ C 60 , may be combined with adjacent groups to form a condensed ring,
    상기 m은 0 내지 3의 정수이다.M is an integer of 0-3.
  4. 제1항에 있어서,The method of claim 1,
    상기 화학식 1의 X1 및 X2는 각각 독립적으로, S 또는 N(Ar1)인 것을 특징으로 하는 유기 전계 발광 소자.X 1 and X 2 of Formula 1 are each independently S or N (Ar 1 ), characterized in that the organic electroluminescent device.
  5. 제1항에 있어서,The method of claim 1,
    상기 화학식 1의 Ar1 내지 Ar5는 각각 독립적으로 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자.Ar 1 to Ar 5 of Formula 1 is characterized in that each independently selected from the group consisting of C 6 ~ C 60 aryl group, a nuclear atoms aryl of from 5 to 60 heteroaryl group, and a C 6 ~ with an aryl amine of the C 60 Organic electroluminescent device.
  6. 제1항에 있어서,The method of claim 1,
    상기 화학식 3의 X-Y는 하기 A1 내지 A24로 표시되는 구조로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자:X-Y of Formula 3 is an organic electroluminescent device, characterized in that selected from the group consisting of the structures represented by A1 to A24:
    Figure PCTKR2013007669-appb-I000275
    Figure PCTKR2013007669-appb-I000275
    상기 R31 내지 R42는 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있다.R 31 to R 42 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, amino group, C 1 -C 40 alkyl group, C 3 -C 40 cycloalkyl group, or a hetero atom having 3 to 40 nuclear atoms. Cycloalkyl group, C 6 ~ C 60 aryl group, C 5 ~ C 60 heteroaryl group, C 1 ~ C 40 Alkyloxy group, C 6 ~ C 60 Aryloxy group, C 1 ~ C 40 Alkyl Silyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 aryl It is selected from the group consisting of a phosphine oxide group and an arylamine group of C 6 ~ C 60 , may be combined with adjacent groups to form a condensed ring.
  7. 제1항에 있어서,The method of claim 1,
    상기 화학식 1로 표시되는 화합물과 상기 화학식 3으로 표시되는 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층 및 발광층으로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자.The organic material layer including the compound represented by Formula 1 and the compound represented by Formula 3 is selected from the group consisting of a hole injection layer, a hole transport layer and a light emitting layer.
  8. 제1항에 있어서,The method of claim 1,
    상기 화학식 1로 표시되는 화합물과 상기 화학식 3으로 표시되는 화합물을 포함하는 유기물층은 발광층이며,The organic material layer including the compound represented by Formula 1 and the compound represented by Formula 3 is a light emitting layer,
    상기 화학식 1로 표시되는 화합물은 상기 발광층의 호스트 물질이고, 상기 화학식 3으로 표시되는 화합물은 상기 발광층의 도펀트 물질인 것을 특징으로 하는 유기 전계 발광 소자.The compound represented by Chemical Formula 1 is a host material of the light emitting layer, and the compound represented by Chemical Formula 3 is a dopant material of the light emitting layer.
PCT/KR2013/007669 2012-10-24 2013-08-27 Organic electroluminescent device WO2014065498A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2012-0118500 2012-10-24
KR1020120118500A KR101547623B1 (en) 2012-10-24 2012-10-24 Organic electroluminescent device

Publications (1)

Publication Number Publication Date
WO2014065498A1 true WO2014065498A1 (en) 2014-05-01

Family

ID=50544844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/007669 WO2014065498A1 (en) 2012-10-24 2013-08-27 Organic electroluminescent device

Country Status (2)

Country Link
KR (1) KR101547623B1 (en)
WO (1) WO2014065498A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2894157A1 (en) * 2014-01-14 2015-07-15 Samsung Electronics Co., Ltd Condensed cyclic compound and organic light-emitting device including the same
WO2015190718A1 (en) * 2014-06-09 2015-12-17 주식회사 두산 Organic electroluminescent device
EP3026056A1 (en) * 2014-11-28 2016-06-01 Samsung Electronics Co., Ltd. Organometallic compound and organic light-emitting device including the same
CN105646590A (en) * 2014-11-28 2016-06-08 三星电子株式会社 Organometallic compound and organic light-emitting device including the same
CN106892925A (en) * 2015-12-19 2017-06-27 西安瑞联新材料股份有限公司 A kind of OLED material based on pyrrolo carbazole derivatives and preparation method thereof
CN110373182A (en) * 2019-07-10 2019-10-25 吉林奥来德光电材料股份有限公司 A kind of organic luminescent compounds and preparation method thereof and device
US11168093B2 (en) 2018-12-21 2021-11-09 Celgene Corporation Thienopyridine inhibitors of RIPK2

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102261104B1 (en) * 2012-12-26 2021-06-04 에스에프씨 주식회사 An electroluminescent compound and an electroluminescent device comprising the same
KR102191019B1 (en) * 2012-12-26 2020-12-14 에스에프씨 주식회사 An electroluminescent compound and an electroluminescent device comprising the same
KR102307761B1 (en) * 2014-12-24 2021-10-05 솔루스첨단소재 주식회사 Method of preparing iridium complex and organic electroluminescent device using the iridium complex prepared thereby
KR102409384B1 (en) 2015-02-04 2022-06-15 삼성전자주식회사 Organometallic compound and organic light emitting device including the same
KR102456076B1 (en) * 2015-09-03 2022-10-19 삼성디스플레이 주식회사 Compound and Organic light emitting device comprising same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11144867A (en) * 1997-11-05 1999-05-28 Toray Ind Inc Electroluminescent element
KR20110016031A (en) * 2009-08-10 2011-02-17 삼성모바일디스플레이주식회사 Organic light emitting device
WO2011125020A1 (en) * 2010-04-06 2011-10-13 Basf Se Substituted carbazole derivatives and use thereof in organic electronics
JP2012140367A (en) * 2010-12-28 2012-07-26 Idemitsu Kosan Co Ltd Condensed polycyclic compound, material for organic electroluminescent element, and organic electroluminescent element using the material

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11144867A (en) * 1997-11-05 1999-05-28 Toray Ind Inc Electroluminescent element
KR20110016031A (en) * 2009-08-10 2011-02-17 삼성모바일디스플레이주식회사 Organic light emitting device
WO2011125020A1 (en) * 2010-04-06 2011-10-13 Basf Se Substituted carbazole derivatives and use thereof in organic electronics
JP2012140367A (en) * 2010-12-28 2012-07-26 Idemitsu Kosan Co Ltd Condensed polycyclic compound, material for organic electroluminescent element, and organic electroluminescent element using the material

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2894157A1 (en) * 2014-01-14 2015-07-15 Samsung Electronics Co., Ltd Condensed cyclic compound and organic light-emitting device including the same
CN104774210A (en) * 2014-01-14 2015-07-15 三星电子株式会社 Condensed cyclic compound and organic light-emitting device including the same
US9865820B2 (en) 2014-01-14 2018-01-09 Samsung Electronics Co., Ltd. Condensed cyclic compound and organic light-emitting device including the same
CN104774210B (en) * 2014-01-14 2019-02-01 三星电子株式会社 Fused ring compound and organic luminescent device including it
WO2015190718A1 (en) * 2014-06-09 2015-12-17 주식회사 두산 Organic electroluminescent device
EP3026056A1 (en) * 2014-11-28 2016-06-01 Samsung Electronics Co., Ltd. Organometallic compound and organic light-emitting device including the same
CN105646590A (en) * 2014-11-28 2016-06-08 三星电子株式会社 Organometallic compound and organic light-emitting device including the same
CN106892925A (en) * 2015-12-19 2017-06-27 西安瑞联新材料股份有限公司 A kind of OLED material based on pyrrolo carbazole derivatives and preparation method thereof
US11168093B2 (en) 2018-12-21 2021-11-09 Celgene Corporation Thienopyridine inhibitors of RIPK2
CN110373182A (en) * 2019-07-10 2019-10-25 吉林奥来德光电材料股份有限公司 A kind of organic luminescent compounds and preparation method thereof and device

Also Published As

Publication number Publication date
KR20140052418A (en) 2014-05-07
KR101547623B1 (en) 2015-08-26

Similar Documents

Publication Publication Date Title
WO2018080066A1 (en) Organic compound and organic electroluminescent device comprising same
WO2017179809A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2014065498A1 (en) Organic electroluminescent device
WO2018038401A1 (en) Organic compound and organic electroluminescence device including same
WO2018093107A1 (en) Organic compound and organic electroluminescent element comprising same
WO2018110958A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2013094999A2 (en) Organic compound, and organic electroluminescent device using same
WO2018038400A1 (en) Organic compound and organic electroluminescence device including same
WO2018080067A1 (en) Organic compound and organic electroluminescent device including same
WO2014142488A1 (en) Organic compound and organic electroluminescent element including same
WO2014025209A1 (en) Novel compound and organic electroluminescence device comprising same
WO2014092354A1 (en) Organic compound and organic electroluminescent element comprising same
WO2020130724A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2014010810A1 (en) Novel compound and electroluminescent device including same
WO2011145876A2 (en) Novel hybrid organic compound and organic electroluminescent device using same
WO2018038464A1 (en) Organic compound and organic electroluminescent device comprising same
WO2014046392A1 (en) Organic compound and electroluminescent element having same
WO2014027822A1 (en) Novel compound and organic electroluminescent device comprising same
WO2017023125A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2015111943A1 (en) Organic compound, and organic electroluminescent device containing same
WO2015111942A2 (en) Organic compound and organic electroluminescent element comprising same
WO2015125986A1 (en) Organic compound and organic electroluminescent device comprising same
WO2020027463A1 (en) Organic compound and organic electroluminescent device using same
WO2017023126A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2015020399A1 (en) Organic compound and organic electroluminescent light emitting diode comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13848902

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE112(1)EPC (EPO FORM 1205A DATED 27-08-2015 )

122 Ep: pct application non-entry in european phase

Ref document number: 13848902

Country of ref document: EP

Kind code of ref document: A1